FORM 6-K/A
(Amendment No. 2 to the Report on Form 6-K (Film No. 18987354))
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
August 6, 2018
Commission File Number 001-10257
Barclays Bank PLC
(Name of Registrant)
1 Churchill Place
London E14 5HP
England
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F.
Form 20-F | X | Form 40-F |
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
EXPLANATORY NOTE
This Report on Form 6-K/A (the Form 6-K/A) to the Report on Form 6-K (Film No. 18987354) (the Form 6-K), originally filed by Barclays Bank PLC with the Securities and Exchange Commission on August 2, 2018, is being filed solely for the purposes of adding Exhibit 101 and furnishing the Interactive Data file disclosure as Exhibit 101 in accordance with Rule 405 of Regulation S-T. Exhibit 101 was not previously filed.
Other than as expressly set forth above, this Form 6-K/A does not, and does not purport to, amend, update or restate the information in any other item of the Form 6-K, or reflect any events that have occurred after the Form 6-K was originally filed.
Barclays PLC |
EXHIBIT INDEX
Exhibit | Description | |
101.INS | XBRL Instance Document | |
101.SCH |
XBRL Taxonomy Extension Schema | |
101.CAL |
XBRL Taxonomy Extension Schema Calculation Linkbase | |
101.DEF |
XBRL Taxonomy Extension Schema Definition Linkbase | |
101.LAB |
XBRL Taxonomy Extension Schema Label Linkbase | |
101.PRE |
XBRL Taxonomy Extension Schema Presentation Linkbase |
Barclays PLC |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, each of the registrants has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.
BARCLAYS BANK PLC | ||||||
(Registrant) | ||||||
Date: August 6, 2018
|
By: | /s/ Garth Wright | ||||
Name: Garth Wright | ||||||
Title: Assistant Secretary |
Barclays PLC |
The movement in net assets relating to the disposal of Barclays Bank UK PLC of £18,546m is stated after the elimination of internal balances between Barclays Bank PLC and Barclays Bank UK PLC on 1 April 2018 of £2,231m
The balance sheet as at 30 June 2018 is on an IFRS 9 basis and hence the IFRS 9 balance sheet as at 1 January 2018 has been used to disclose the disposal of the UK banking business . For further details refer to Note 19, Transition disclosures on pages 53 to 55
Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, physical commodities and investment property
For further details , refer to Note 1 , Basis of preparation on pages 17 to 22
Comprise d of mandatory fair value assets of £130.2bn and designated fair value assets of £10.0bn
Includes the transfer of subordinated liabilities of £ 3,019 m on 1 April 2018 as part of the disposal of the UK banking business
Included UK banking business results for the period from 1 January 2018 to 31 March 2018.
Included UK banking business results for the period from 1 January 2017 to 30 June 2017 and BAGL results for the period from 1 January 2017 to 31 May 2017
Total loss after tax in respect o f discontinued operations in H117 was £2,030 m , which comprised of £595m loss after tax, £60m loss on the sale of BAGL and £1,375m loss on recycling of other comprehensive loss on reserves relating to the disposal of BAGL. Of the £595m loss after tax, £760m loss related to BAGL results and £165m profit related to UK banking business
Included UK banking business other comprehensive income for the period from 1 January 2018 to 31 March 2018
Included UK banking business other comprehensive income for the period from 1 January 2017 to 30 June 2017 and BAGL other comprehensive income for the period from 1 January 2017 to 31 May 2017
Include d UK banking business cash flows for the period from 1 January 2018 to 31 March 2018
Include d UK banking business cash flows for the period from 1 January 2017 to 30 June 2017 and BAGL cash flows for the period from 1 January 2017 to 31 May 2017
£176m of certain legacy capital instrument funding costs are now charged to Head Office, the impact of which would have been materially the same if the charges had been included in H117
Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint ventures and gains on acquisitions
Barclays Non-Core segment was closed on 1 July 2017, with financial performance subsequently reported in CIB, H ead Office and the UK banking business
The geographic region is based on counterparty location
B arclays B ank PLC introduced changes to the balance sheet presentation as at 31 December 2017 as a result of the adoption of new accounting policies on 1 January 2018. The impact of this is as follows: ‘Items in the course of collection from other banks’ ( December 2 017: £1,011m) and ‘prepayments, accrued income and other assets’ ( December 2017: £3,429m) a re reported in ‘other assets’ (December 2 017: £4,440m). Equally, ‘items in the course of c ollection due to other banks’ (December 2 017: £446m) and ‘accruals, deferred income and other liabilities’ (December 2 017: £6,885m) are re ported in ‘other liabilities’ (December 2 017: £7 , 331m). ‘Loans and advances to banks’ (December 2 017: £37,255m) and ‘loa ns and a dvances to customers’ (December 2 017: £388,960) have been disaggregated, with £364,670m of these balances now reported in ‘loans and advances at amortised cost’ and £61,545m now reported in ‘cash collateral and settlement bala nces’. ‘Deposits from banks’ ( December 2 017: £38, 364m) and ‘customer accounts’ (December 2 017: £448,079m) have been disaggregated with £427,185m of these balances now reported in ‘deposits at amortised cost’ and £59,258m now reported in ‘cash collateral and settlement balances’
Compr ised of both designated and mandatory fair value assets
The balance as at 30 June 2018 includes IFRS 9 expected credit losses on committed facilities and guarantees
Details of share capital, other equity instruments and other reserves are shown on pages 40 to 41
For notes to the Financial Statements see pages 17 to 56
For notes to the Financial Statements see pages 17 to 56
Reported net of tax
Following the adoption of IFRS 9, Financial Instruments on 1 January 2018, the fair value through other comprehensive income reserve was introduced replacing the available for sale reserve
For notes to the Financial Statements see pages 17 to 56
Does not include the UK banking business which was transferred on 1 April 2018 to Barclays Bank UK PLC. For details of the disposal of the business, refer to Note 2, Disposal of business and transfer of ownership of subsidiary on pages 23 to 24
Barclays Bank Group introduced changes to the balance sheet presentation as at 31 December 2017 as a result of the adoption of new accounting policies on 1 January 2018. Further detail on the adoption of new accounting policies can be found in Note 1, Basis of preparation on pages 17 to 22, within Note 19, Transition disclosures on pages 53 to 55 and the Credit risk disclosures on page 7
Details of non-controlling interests are shown on p age 29
Other financial assets on balance sheet subject to impairment not included in the table above include cash collateral and settlement balances and financial assets at fair value th rough other comprehensive income. These have a total gross exposure of £143.7bn and impairment allowance of £7m. In addition, there are off-balance sheet loan commitments and financial guarantee contracts with a gross exposure of £263.7bn and provision of £202m .
Balances as at 1 January 2018 include the IFRS 9 transition impact. Balances as at 31 December 2017 have been presented on an IAS 39 basis.
On 1 April 2018, £4.4bn of non-asset backed loans were transferred as part of the disposal of the UK banking business .
Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £5,066m and derivative financial liabilities were £5,293m.
I$SB]=6%G5LAJLEPY1H,@#%0A
M&RQ'=%>!OIJYI'^X3L3HJHJ_WX];D,O:Q6/R$;\!357_ &D5'3ZCH?H>OKS&
M#VO>C(_"=/\ EK(4*]#[@:$5'0]1]02/Z>LEPSI;G+.4< >36XLMUU-Y%\K*O;6!85F-'DL_ GX /':JXBU\QC[&*L6CE
M0*]9UA6O-%20<)GC$9S4_%SD7[8OGWC39^)R,/'>U9<3GKVSEA6Z^49I(V=?
M8VJ56?2CZ7T*R@E0?J ?7'SWB/S;R/G\-<\R;^AW!M3&9*"YDL38"WBF2-P9
M$T0-''KDBUQ"1T9E5V .DD%-=I:XH]J:RS;5]T-@:3,\5M<8.HQ-5(+)\(D:
M++CA:HVH2M.HS":BM1'#3^/!HVMN.^VKN:RW19$F]LKI)A4_N*,"RD]>CBJM
M]>A/IO[[V9B]^['RFQ
Document and Entity Information |
6 Months Ended |
---|---|
Jun. 30, 2018
shares
| |
Document And Entity Information [abstract] | |
Document Type | 6-K |
Amendment Flag | false |
Document Period End Date | Jun. 30, 2018 |
Document Fiscal Year Focus | 2018 |
Document Fiscal Period Focus | Q2 |
Entity Registrant Name | BARCLAYS BANK PLC |
Entity Central Index Key | 0000312070 |
Current Fiscal Year End Date | --12-31 |
Entity Well Known Seasoned Issuer | Yes |
Entity Current Reporting Status | Yes |
Entity Filer Category | Large Accelerated Filer |
Entity Common Stock Shares Outstanding | 2,342,558,515 |
Condensed consolidated statement of comprehensive income (unaudited) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
||||||||||||||||||||||||
Disclosure of operating segments [line items] | |||||||||||||||||||||||||
(Loss)/profit after tax | [1] | £ 300 | £ (729) | ||||||||||||||||||||||
Profit/(loss) after tax in respect of continuing operations | 347 | 1,301 | |||||||||||||||||||||||
(Loss)/profit after tax in respect of discontinued operation | (47) | (2,030) | |||||||||||||||||||||||
Other comprehensive income/(loss) not recycled to profit or loss from continuing operations: | |||||||||||||||||||||||||
Total comprehensive income for the period | [2] | (361) | (336) | ||||||||||||||||||||||
Attributable to: | |||||||||||||||||||||||||
Equity holders of the parent | (360) | (446) | |||||||||||||||||||||||
Non-controlling interests | (1) | 110 | |||||||||||||||||||||||
Total comprehensive income for the period | [2] | (361) | (336) | ||||||||||||||||||||||
Continuing operations [member] | |||||||||||||||||||||||||
Disclosure of operating segments [line items] | |||||||||||||||||||||||||
(Loss)/profit after tax | 347 | 1,301 | |||||||||||||||||||||||
Other comprehensive (loss)/income that may be recycled to profit or loss from continuing operations: | |||||||||||||||||||||||||
Currency translation reserves | [3],[4] | 350 | (629) | ||||||||||||||||||||||
Available for sale reserve | [2],[3],[4] | 0 | 96 | ||||||||||||||||||||||
Fair value through other comprehensive income reserve | [3],[4],[5] | (221) | 0 | ||||||||||||||||||||||
Cash flow hedging reserve | [2],[3],[4] | (403) | (382) | ||||||||||||||||||||||
Other | [2],[4] | 10 | 14 | ||||||||||||||||||||||
Other comprehensive (loss)/income that may be recycled to profit or loss | [4] | (264) | (901) | ||||||||||||||||||||||
Other comprehensive income/(loss) not recycled to profit or loss from continuing operations: | |||||||||||||||||||||||||
Retirement benefit remeasurements | [2],[3] | (54) | (29) | ||||||||||||||||||||||
Financial assets at fair value through other comprehensive income | [3],[5] | (267) | 0 | ||||||||||||||||||||||
Own credit | [2],[3] | (73) | 22 | ||||||||||||||||||||||
Other comprehensive income/(loss) not recycled to profit or loss, from continuing operations | [4] | (394) | (7) | ||||||||||||||||||||||
Other comprehensive income for the period | (658) | (908) | |||||||||||||||||||||||
Total comprehensive income for the period | [2] | (311) | 393 | ||||||||||||||||||||||
Attributable to: | |||||||||||||||||||||||||
Total comprehensive income for the period | [2] | (311) | 393 | ||||||||||||||||||||||
Discontinued operations [member] | |||||||||||||||||||||||||
Disclosure of operating segments [line items] | |||||||||||||||||||||||||
(Loss)/profit after tax | [7] | (47) | [6] | (595) | [8] | ||||||||||||||||||||
Other comprehensive (loss)/income that may be recycled to profit or loss from continuing operations: | |||||||||||||||||||||||||
Currency translation reserves | 0 | [9] | (38) | [10] | |||||||||||||||||||||
Available for sale reserve | [2] | 0 | [9] | (3) | [10] | ||||||||||||||||||||
Cash flow hedging reserve | [2] | 0 | [9] | 19 | [10] | ||||||||||||||||||||
Other comprehensive income/(loss) not recycled to profit or loss from continuing operations: | |||||||||||||||||||||||||
Financial assets at fair value through other comprehensive income | (3) | [9] | 0 | [10] | |||||||||||||||||||||
Other comprehensive income for the period | [5] | (3) | [9] | 1,301 | [10] | ||||||||||||||||||||
Total comprehensive income for the period | [2],[5] | (50) | (729) | ||||||||||||||||||||||
Attributable to: | |||||||||||||||||||||||||
Total comprehensive income for the period | [2],[5] | £ (50) | £ (729) | ||||||||||||||||||||||
|
Condensed consolidated balance sheet (unaudited) - GBP (£) £ in Millions |
Jun. 30, 2018 |
[1] | Dec. 31, 2017 |
[2] | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash and balances at central banks | £ 121,800 | £ 171,036 | |||||||||
Cash collateral and settlement balances | 91,549 | 77,172 | |||||||||
Loans and advances at amortised cost | 134,820 | 324,590 | |||||||||
Reverse repurchase agreements and other similar secured lending | 533 | 12,546 | |||||||||
Trading portfolio assets | 116,554 | 113,755 | |||||||||
Financial assets at fair value through the income statement | 142,443 | 116,282 | |||||||||
Derivative financial instruments | 229,002 | 237,987 | |||||||||
Financial investments | 0 | 58,963 | |||||||||
Financial assets at fair value through other comprehensive income | 53,302 | 0 | |||||||||
Investments in associates and joint ventures | 713 | 718 | |||||||||
Goodwill and intangible assets | 1,330 | 4,885 | |||||||||
Property, plant and equipment | 951 | 1,519 | |||||||||
Current tax assets | [3] | 1,272 | 376 | ||||||||
Deferred tax assets | [3] | 3,247 | 3,352 | ||||||||
Retirement benefit assets | [3] | 1,124 | 966 | ||||||||
Other assets | 2,944 | 4,003 | |||||||||
Assets included in disposal groups classified as held for sale | [3] | 1,761 | 1,193 | ||||||||
Total Assets | 903,345 | 1,129,343 | |||||||||
Liabilities | |||||||||||
Deposits at amortised cost | 193,990 | 399,189 | |||||||||
Cash collateral and settlement balances | 85,448 | 68,143 | |||||||||
Repurchase agreements and other similar secured borrowing | 8,645 | 40,338 | |||||||||
Debt securities in issue | 57,905 | 69,386 | |||||||||
Subordinated liabilities | [3] | 17,190 | 24,193 | ||||||||
Trading portfolio liabilities | 45,965 | 37,352 | |||||||||
Financial liabilities designated at fair value | 212,393 | 173,718 | |||||||||
Derivative financial instruments | 225,089 | 238,345 | |||||||||
Current tax liabilities | [3] | 667 | 494 | ||||||||
Deferred tax liabilities | [3] | 0 | 0 | ||||||||
Retirement benefit liabilities | [3] | 265 | 287 | ||||||||
Other liabilities | 4,601 | 8,862 | |||||||||
Provisions | [3] | 1,233 | 3,302 | ||||||||
Liabilities included in disposal groups classified as held for sale | [3] | 1,762 | 0 | ||||||||
Total liabilities | 855,153 | 1,063,609 | |||||||||
Equity | |||||||||||
Called up share capital and share premium | [3] | 14,453 | 14,453 | ||||||||
Other reserves | [3] | 3,071 | 3,808 | ||||||||
Retained earnings | 23,754 | 38,490 | |||||||||
Shareholders equity attributable to ordinary shareholders of the parent | 41,278 | 56,751 | |||||||||
Other equity instruments | [3] | 6,912 | 8,982 | ||||||||
Total equity excluding non-controlling interests | 48,190 | 65,733 | |||||||||
Non-controlling interests | [3] | 2 | 1 | ||||||||
Total equity | 48,192 | 65,734 | |||||||||
Total liabilities and equity | £ 903,345 | £ 1,129,343 | |||||||||
|
Condensed consolidated statement of changes in equity (unaudited) - GBP (£) £ in Millions |
Total |
Continuing operations [member] |
Discontinued operations [member] |
Called up share capital and share premium [member] |
Called up share capital and share premium [member]
Continuing operations [member]
|
Called up share capital and share premium [member]
Discontinued operations [member]
|
[1] | Other equity instruments [member] |
Other equity instruments [member]
Continuing operations [member]
|
Other equity instruments [member]
Discontinued operations [member]
|
[1] | Other reserves [member] |
Other reserves [member]
Continuing operations [member]
|
Other reserves [member]
Discontinued operations [member]
|
[1] | Retained earnings [member] |
Retained earnings [member]
Continuing operations [member]
|
Retained earnings [member]
Discontinued operations [member]
|
Total equity excluding non-controlling interests [member] |
Total equity excluding non-controlling interests [member]
Continuing operations [member]
|
Total equity excluding non-controlling interests [member]
Discontinued operations [member]
|
Non-controlling interests [member] |
Non-controlling interests [member]
Continuing operations [member]
|
[2] |
Non-controlling interests [member]
Discontinued operations [member]
|
[2] | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning Balance, equity at Dec. 31, 2016 | £ 70,955 | £ 14,462 | £ 6,486 | £ 4,295 | £ 42,190 | £ 67,433 | £ 3,522 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Effects of changes in accounting policies | 0 | 0 | [1] | 0 | [1] | (175) | [1] | 175 | 0 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
(Loss)/profit after tax | (729) | [3] | £ 1,301 | £ (595) | [4],[5] | £ 0 | £ 301 | £ 0 | £ 998 | £ 1,299 | £ 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Currency translation reserves | (629) | [6],[7] | (38) | [8] | 0 | 0 | (628) | 0 | (628) | (1) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Available for sale investments | 96 | [1],[6],[7] | (3) | [1],[8] | 0 | [1] | 0 | [1] | 96 | [1] | 0 | 96 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Cash flow hedges | (382) | [1],[6],[7] | 19 | [1],[8] | 0 | [1] | 0 | [1] | (382) | [1] | 0 | (382) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Retirement benefit remeasurements | (29) | [1],[6] | 0 | [1] | 0 | [1] | 0 | [1] | (29) | (29) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Own credit | 22 | [1],[6] | 0 | [1] | 0 | [1] | 22 | [1] | 0 | 22 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other | 14 | [1],[7] | 0 | [1] | 0 | [1] | 0 | [1] | 14 | 14 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income for the period | (336) | [1] | 393 | [1] | (729) | [1],[9] | 0 | 0 | [1] | £ 0 | 301 | [1] | 301 | [1] | £ 0 | 440 | [1] | (892) | [1] | £ 1,332 | (1,187) | 983 | £ (2,170) | (446) | 392 | £ (838) | 110 | [2] | 1 | £ 109 | ||||||||||||||||||||||||||||||||
Issue and exchange of other equity instruments | 1,250 | [1] | 0 | 1,250 | [1] | 0 | [1] | 0 | 1,250 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other equity instruments coupons paid | (219) | [1] | 0 | (301) | [1] | 0 | [1] | 82 | (219) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Redemption of preference shares, value | (1,130) | [1] | (7) | 0 | [1] | 11 | [1] | (1,134) | (1,130) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Equity settled share schemes | 0 | [1] | 0 | 0 | [1] | 0 | [1] | 0 | 0 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of Barclays PLC shares under sharebased payment schemes | (78) | [1] | 0 | 0 | [1] | 0 | [1] | (78) | (78) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid | (472) | [1] | 0 | 0 | [1] | 0 | [1] | (299) | (299) | (173) | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net equity impact of partial BAGL disposal | (3,802) | [1] | 0 | 0 | [1] | 0 | [1] | (359) | (359) | (3,443) | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other reserve movements | (1) | [1] | 0 | 0 | [1] | 0 | [1] | (69) | (69) | 68 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance, equity at Jun. 30, 2017 | 66,167 | 14,455 | [1] | 7,736 | [1] | 4,571 | [1] | 39,321 | 66,083 | 84 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
(Loss)/profit after tax | (1,069) | 0 | 338 | 0 | (1,409) | (1,071) | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Currency translation reserves | (681) | 0 | 0 | (681) | 0 | (681) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available for sale investments | 333 | [1] | 0 | [1] | 0 | [1] | 333 | [1] | 0 | 333 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Cash flow hedges | (392) | [1] | 0 | [1] | 0 | [1] | (392) | [1] | 0 | (392) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Retirement benefit remeasurements | 82 | [1] | 0 | [1] | 0 | [1] | 0 | [1] | 82 | 82 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Own credit | (33) | [1] | 0 | [1] | 0 | [1] | (33) | [1] | 0 | (33) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other | (21) | [1] | 0 | [1] | 0 | [1] | 0 | [1] | (21) | (21) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income for the period | (1,137) | [1] | (1,781) | [1] | 644 | [1] | 0 | 0 | [1] | 0 | 338 | [1] | 338 | [1] | 0 | (773) | [1] | (773) | [1] | 0 | (704) | (1,348) | 644 | (1,139) | (1,783) | 644 | 2 | [2] | 2 | 0 | ||||||||||||||||||||||||||||||||
Issue and exchange of other equity instruments | 1,246 | [1] | 0 | 1,246 | [1] | 0 | [1] | 0 | 1,246 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other equity instruments coupons paid | (246) | [1] | 0 | (338) | [1] | 0 | [1] | 92 | (246) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Redemption of preference shares, value | (208) | [1] | (2) | 0 | [1] | 3 | [1] | (209) | (208) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Equity settled share schemes | 550 | [1] | 0 | 0 | [1] | 0 | [1] | 550 | 550 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of Barclays PLC shares under sharebased payment schemes | 0 | [1] | 0 | 0 | [1] | 0 | [1] | 0 | 0 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid | (617) | [1] | 0 | 0 | [1] | 0 | [1] | (617) | (617) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net equity impact of partial BAGL disposal | (19) | [1] | 0 | 0 | [1] | 0 | [1] | 0 | 0 | (19) | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other reserve movements | (2) | [1] | 0 | 0 | [1] | 7 | [1] | 57 | 64 | (66) | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance, equity at Dec. 31, 2017 | 65,734 | [10] | 14,453 | [1] | 8,982 | [1] | 3,808 | [1] | 38,490 | 65,733 | 1 | [2] | ||||||||||||||||||||||||||||||||||||||||||||||||||
Effects of changes in accounting policies | (2,150) | (136) | [1] | (2,014) | (2,150) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Beginning Balance, equity at Dec. 31, 2017 | 65,734 | [10] | 14,453 | [1] | 8,982 | [1] | 3,808 | [1] | 38,490 | 65,733 | 1 | [2] | ||||||||||||||||||||||||||||||||||||||||||||||||||
(Loss)/profit after tax | 300 | [3] | 347 | (47) | [5],[11] | 0 | 310 | 0 | 38 | 348 | (1) | |||||||||||||||||||||||||||||||||||||||||||||||||||
Currency translation reserves | 350 | [6],[7] | 0 | [12] | 0 | 0 | 350 | 0 | 350 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value through other comprehensive income reserve | (488) | 0 | [1] | 0 | [1] | (488) | [1] | 0 | (488) | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Available for sale investments | [1] | 0 | [6],[7] | 0 | [12] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash flow hedges | (403) | [1],[6],[7] | 0 | [1],[12] | 0 | [1] | 0 | [1] | (403) | [1] | 0 | (403) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||
Retirement benefit remeasurements | (54) | [1],[6] | 0 | [1] | 0 | [1] | 0 | [1] | (54) | (54) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Own credit | (73) | [1],[6] | 0 | [1] | 0 | [1] | (73) | [1] | 0 | (73) | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other | 10 | [1],[7] | 0 | [1] | 0 | [1] | 0 | [1] | 10 | 10 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||
Total comprehensive income for the period | (361) | [1] | £ (311) | [1] | £ (50) | [1],[9] | 0 | £ 0 | [1] | £ 0 | 310 | [1] | £ 310 | [1] | £ 0 | (617) | [1] | £ (614) | [1] | £ (3) | (53) | £ (6) | £ (47) | (360) | £ (310) | £ (50) | (1) | [2] | £ (1) | £ 0 | ||||||||||||||||||||||||||||||||
Issue and exchange of other equity instruments | 0 | [1] | 0 | 0 | [1] | 0 | [1] | 0 | 0 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other equity instruments coupons paid | (226) | [1] | 0 | (310) | [1] | 0 | [1] | 84 | (226) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Redemption of preference shares, value | 0 | [1] | 0 | 0 | [1] | 0 | [1] | 0 | 0 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Equity settled share schemes | 208 | [1] | 0 | 0 | [1] | 0 | [1] | 208 | 208 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Vesting of Barclays PLC shares under sharebased payment schemes | (421) | [1] | 0 | 0 | [1] | 0 | [1] | (421) | (421) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Dividends paid | (14,274) | [1] | 0 | 0 | [1] | 0 | [1] | (14,274) | (14,274) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Distribution/transfer to Barclays PLC | 2,000 | [1] | 0 | 0 | [1] | 0 | [1] | 2,000 | 2,000 | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Net equity impact of partial BAGL disposal | (2,290) | [1] | 0 | (2,070) | [1] | 16 | [1] | (236) | (2,290) | 0 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Other reserve movements | (28) | [1] | 0 | 0 | [1] | 0 | [1] | (30) | (30) | 2 | [2] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Ending Balance, equity at Jun. 30, 2018 | 48,192 | [13] | 14,453 | [1] | 6,912 | [1] | 3,071 | [1] | 23,754 | 48,190 | 2 | [2] | ||||||||||||||||||||||||||||||||||||||||||||||||||
Equity, adjusted balance | £ 63,584 | £ 14,453 | £ 8,982 | £ 3,672 | £ 36,476 | £ 63,583 | £ 1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Condensed consolidated cash flow statement (unaudited) - GBP (£) £ in Millions |
6 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: | ||||||||||||
Profit (loss) before tax | £ 725 | £ 1,731 | ||||||||||
Net increase in cash and cash equivalents | (51,488) | 36,294 | ||||||||||
Cash and cash equivalents at beginning of the period | 204,452 | 143,932 | ||||||||||
Cash and cash equivalents at end of the period | 152,964 | 180,226 | ||||||||||
Continuing operations [member] | ||||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: | ||||||||||||
Profit (loss) before tax | 725 | 1,731 | ||||||||||
Adjustments for non-cash items | 2,240 | 1,768 | ||||||||||
Changes in operating assets and liabilities | (8,925) | 29,840 | ||||||||||
Corporate income tax paid | (166) | (518) | ||||||||||
Net cash from operating activities | (6,126) | 32,821 | ||||||||||
Net cash transferred as part of the UK banking business disposal | (37,331) | 0 | ||||||||||
Other investing activities | (6,030) | 2,240 | ||||||||||
Net cash from investing activities | (43,361) | 2,240 | ||||||||||
Net cash from financing activities | (1,937) | 1,057 | ||||||||||
Effect of exchange rates on cash and cash equivalents | 404 | (1,106) | ||||||||||
Net increase in cash and cash equivalents | (51,020) | 35,012 | ||||||||||
Discontinued operations [member] | ||||||||||||
Reconciliation of profit before tax to net cash flows from operating activities: | ||||||||||||
Profit (loss) before tax | 91 | [1] | (142) | [2] | ||||||||
Net cash from operating activities | (402) | [3] | 2,098 | [4] | ||||||||
Net cash from investing activities | 54 | [3] | (414) | [4] | ||||||||
Net cash from financing activities | (120) | [3] | (373) | [4] | ||||||||
Effect of exchange rates on cash and cash equivalents | 0 | [3] | (29) | [4] | ||||||||
Net increase in cash and cash equivalents | £ (468) | [3] | £ 1,282 | [4] | ||||||||
|
Basis of preparation |
6 Months Ended |
---|---|
Jun. 30, 2018 | |
Basis of preparation [Abstract] | |
Basis of preparation | These condensed consolidated interim financial statements for the six months ended 30 June 2018 have been prepared in accordance with the DTR of the UK’s Financial Conduct Authority (the UK FCA) and with IAS 34, Interim Financial Reporting, as published by the International Accounting Standards Board (IASB) and adopted by the EU. The condensed consolidated interim financial statements should be read in conjunction with the annual financial statements for the year ended 31 December 2017, which have been prepared in accordance with IFRSs as published by the IASB and as adopted by the EU. The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the same as those used in the Barclays Bank PLC Annual Report 2017, except as disclosed below. IFRS 9 Financial Instruments IFRS 9, Financial Instruments, which replaced IAS 39, Financial Instruments: Recognition and Measurement, was applied effective from 1 January 2018, including the early adoption of ‘Prepayment Features with Negative Compensation (Amendments to IFRS 9)’ which was endorsed by the EU in March 2018. IFRS 9 includes an accounting policy choice to continue to apply hedge accounting in accordance with IAS 39, which Barclays Bank Group has decided to apply. IFRS 9 was applied retrospectively by adjusting the opening balance sheet at the date of initial application, and comparative periods have not been restated. Changes in presentation The following voluntary changes in presentation have been made as a result of the review of accounting presentation following the adoption of IFRS 9, and is expected to provide more relevant information to the users of the financial statements. These presentational changes have no effect on the measurement of these items and therefore had no impact on retained earnings or profit for any period. The effect of these presentational changes on transition are included in the reconciliation on pages 54 to 55 and are noted below: ‘Items in the course of collection from other banks’ and ‘prepayments, accrued income and other assets’ are reported in ‘other assets’. Equally, ‘items in the course of collection due to other banks’ and ‘accruals, deferred income and other liabilities’ are reported in ‘other liabilities’; ‘Loans and advances to banks’ and ‘loans and advances to customers’ have been disaggregated and are now reported in ‘loans and advances at amortised cost’ and ‘cash collateral and settlement balances’; ‘Deposits from banks’ and ‘customer accounts’ have been disaggregated and are now reported in ‘deposits at amortised cost’ and ‘cash collateral and settlement balances’; Financial assets designated at fair value’ are now reported within ‘financial assets at fair value through the income statement’; The majority of available for sale assets which were previously reported in ‘financial investments’ are now reported in ‘financial assets at fair value through other comprehensive income’; and Held to maturity assets which were previously reported in ‘financial investments’ are now reported in ‘loans and advances at amortised cost’ Application of IFRS 9 The accounting policies which have been applied effective from 1 January 2018 as a result of adopting IFRS 9 are as follows. IFRS 9 requires financial assets to be classified on the basis of two criteria: i) the business model within which financial assets are managed; and ii) their contractual cash flow characteristics (whether the cash flows represent ‘solely payments of principal and interest’ (SPPI)). Business models were determined on initial application of IFRS 9. Barclays Bank Group assesses the business model criteria at a portfolio level. Information that is considered in determining the applicable business model includes (i) policies and objectives for the relevant portfolio, (ii) how the performance and risks of the portfolio are managed, evaluated and reported to management, and (iii) the frequency, volume and timing of sales in prior periods, sales expectation for future periods, and the reasons for such sales. The contractual cash flow characteristics of financial assets are assessed with reference to whether the cash flows represent SPPI. In assessing whether contractual cash flows are SPPI compliant, interest is defined as consideration primarily for the time value of money and the credit risk of the principal outstanding. The time value of money is defined as the element of interest that provides consideration only for the passage of time and not consideration for other risks or costs associated with holding the financial asset. Terms that could change the contractual cash flows so that it would not meet the condition for SPPI are considered, including: (i) contingent and leverage features, (ii) non-recourse arrangements and (iii) features that could modify the time value of money. Financial instruments measured at amortised cost Financial assets that are held in a business model to collect the contractual cash flows and that contain contractual terms that give rise on specified dates to cash flows that are SPPI, are measured at amortised cost. The carrying value of these financial assets at initial recognition includes any directly attributable transaction costs. In determining whether the business model is a ‘hold to collect’ model, the objective of the business model must be to hold the financial asset to collect contractual cash flows rather than holding the financial asset for trading or short-term profit taking purposes. While the objective of the business model must be to hold the financial asset to collect contractual cash flows this does not mean Barclays Bank Group is required to hold the financial assets until maturity. When determining if the business model objective is to collect contractual cash flows Barclays Bank Group will consider past sales and expectations about future sales. Financial assets measured at fair value through other comprehensive income (‘FVOCI’) Financial assets that are debt instruments held in a business model that is achieved by both collecting contractual cash flows and selling, and that contain contractual terms that give rise on specified dates to cash flows that are SPPI, are measured at FVOCI. They are subsequently remeasured at fair value and changes therein (except for those relating to impairment, interest income and foreign currency exchange gains and losses) are recognised in other comprehensive income, until the assets are sold. Upon disposal, the cumulative gains and losses in other comprehensive income are recognised in the income statement in net investment income. In determining whether the business model is achieved by both collecting contractual cash flows and selling financial assets, it is determined that both collecting contractual cash flows and selling financial assets are integral to achieving the objective of the business model. When determining if the business model is achieved by both collecting contractual cash flows and selling financial assets, Barclays Bank Group will consider past sales and expectations about future sales. Equity securities For equity securities that are not held for trading, Barclays Bank Group may make an irrevocable election to present subsequent changes in the fair value of the instrument in other comprehensive income (except for dividend income which is recognised in profit or loss). Gains or losses on the derecognition of these equity securities are not transferred to profit or loss. These assets are also not subject to the impairment requirements and therefore no amounts are recycled to the income statement. Where Barclays Bank Group has not made the irrevocable election to present subsequent changes in the fair value of the instrument in other comprehensive income, equity securities are measured at fair value through profit or loss. Financial instruments designated at fair value through profit or loss Financial assets, other than those held for trading, are classified in this category if they are so irrevocably designated at inception and the use of the designation removes or significantly reduces an accounting mismatch. Subsequent changes in fair value are recognised in the income statement in net investment income. Financial liabilities can be designated at fair value through profit or loss if they meet one or more of the criteria set out below and are so designated irrevocable at inception: the use of the designation removes or significantly reduces an accounting mismatch; when a group of financial assets and liabilities or a group of financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy; or where the financial liability contains one or more non-closely related embedded derivatives Subsequent changes in fair value are recognised in the income statement in net investment income, except if reporting it in trading income reduces an accounting mismatch. Financial assets at fair value through profit or loss Financial assets that are held for trading are recognised at fair value through profit or loss. In addition, financial assets are held at fair value through profit or loss if they do not contain contractual terms that give rise on specified dates to cash flows that are SPPI, or if the financial asset is not held in a business model that is either (i) a business model to collect the contractual cash flows or (ii) a business model that is achieved by both collecting contractual cash flows and selling. Subsequent changes in fair value for these instruments are recognised in the income statement in net investment income, except if reporting it in trading income reduces an accounting mismatch. Derivatives Derivative instruments are contracts whose value is derived from one or more underlying financial instruments or indices defined in the contract. All derivative instruments are held at fair value through profit or loss, except for derivatives that are in a designated cash flow or net investment hedge accounting relationship. This includes terms included in a contract or financial liability (the host), which, had it been a standalone contract, would have met the definition of a derivative. If these are separated from the host, i.e. when the economic characteristics of the embedded derivative are not closely related with those of the host contract and the combined instrument is not measured at fair value through profit or loss, then they are accounted for in the same way as derivatives. For financial assets, the requirements are whether the financial asset contain contractual terms that give rise on specified dates to cash flows that are SPPI, and consequently the requirements for accounting for embedded derivatives are not applicable to financial assets. Impairment Entities are required to recognise expected credit losses (ECLs) based on unbiased forward-looking information for all financial assets at amortised cost, lease receivables, debt financial assets at fair value through other comprehensive income, loan commitments and financial guarantee contracts. Intercompany exposures, including loan commitments and financial guarantee contracts, are also in scope under IFRS 9. At the reporting date, an allowance (or provision for loan commitments and financial guarantees) is required for the 12 month ECLs. If the credit risk has significantly increased since initial recognition (Stage 1), an allowance (or provision) should be recognised for the lifetime ECLs for financial instruments for which the credit risk has increased significantly since initial recognition (Stage 2) or which are credit impaired (Stage 3). The measurement of ECL is calculated using three main components: (i) probability of default (PD), (ii) loss given default (LGD) and (iii) the exposure at default (EAD). The 12 month ECL is calculated by multiplying the 12 month PD, LGD and the EAD. The 12 month and lifetime PDs represent the PD occurring over the next 12 months and the remaining maturity of the instrument respectively. The EAD represents the expected balance at default, taking into account the repayment of principal and interest from the balance sheet date to the default event together with any expected drawdowns of committed facilities. The LGD represents expected losses on the EAD given the event of default, taking into account, among other attributes, the mitigating effect of collateral value at the time it is expected to be realised and the time value of money. Determining a significant increase in credit risk since initial recognition: Barclays Bank Group assesses when a significant increase in credit risk has occurred based on quantitative and qualitative assessments. Exposures are considered to have resulted in a significant increase in credit risk and are moved to Stage 2 when: Quantitative test The annualised cumulative weighted average lifetime PD has increased by more than an agreed threshold relative to the equivalent at origination. PD deterioration thresholds are defined as percentage increases, and are set at an origination score band and segment level to ensure the test appropriately captures significant increases in credit risk at all risk levels. Generally, thresholds are inversely correlated to the origination PD, i.e. as the origination PD increases, the threshold value reduces. The assessment of materiality, i.e. at what point a PD increase is deemed ‘significant’, is based upon analysis of the portfolios’ risk profile against a common set of principles and performance metrics, incorporating expert credit judgement where appropriate. For existing/historic exposures where origination point scores/data are no longer available or do not represent a comparable estimate of lifetime PD, a proxy origination score is defined, based upon: Back-population of the approved lifetime PD score either to origination date or, where this is not feasible, as far back as possible, (subject to a data start point no later than 1 January 2015); or Use of available historic account performance data and other customer information, to derive a comparable ‘proxy’ estimation of origination PD Qualitative test Accounts meet the portfolio’s ‘high risk’ criteria and are subject to closer credit monitoring. High risk customers may not be in arrears but either through an event or an observed behaviour exhibit potential credit distress. The definition and assessment of high risk includes as wide a range of information as reasonably available, including industry and Barclays Bank Group wide customer level data wherever possible or relevant. Whilst the high risk populations applied for IFRS 9 impairment purposes are aligned with risk management processes, they are also regularly reviewed and validated to ensure that they capture any incremental segments where there is evidence of credit deterioration. Backstop criteria Accounts that are 30 calendar days or more past due. The 30 days past due criteria is a backstop rather than a primary driver of moving exposures into Stage 2. Exposures will move back to Stage 1 once they no longer meet the criteria for a significant increase in credit risk and when any cure criteria used for credit risk management are met. This is subject to all payments being up to date and the customer evidencing ability and willingness to maintain future payments. Barclays Bank Group does not rely on the low credit risk exemption which would assume facilities of investment grade are not significantly deteriorated. Determining the PD at initial recognition requires management estimates. Management overlays and other exceptions to model outputs are applied only if consistent with the objective of identifying significant increases in credit risk. Forward-looking information Credit losses are the expected cash shortfalls from what is contractually due over the expected life of the financial instrument, discounted at the original effective interest rate (EIR). ECLs are the unbiased probability-weighted credit losses determined by evaluating a range of possible outcomes and considering future economic conditions. When there is a non-linear relationship between forward-looking economic scenarios and their associated credit losses, five forward-looking economic scenarios are considered to ensure a sufficient unbiased representative sample of the complete distribution is included in determining the expected loss. Stress testing methodologies are leveraged within forecasting economic scenarios. The measurement of ECL involves increased complexity and judgement, including estimation of PDs, LGD, a range of unbiased future economic scenarios, estimation of expected lives, and estimation of EAD and assessing significant increases in credit risk. Impairment charges will tend to be more volatile and will be recognised earlier. Unsecured products with longer expected lives, such as revolving credit cards, are the most impacted. Barclays Group utilises an external consensus forecast as the baseline scenario. In addition, two adverse and two favourable scenarios are derived, with associated probability weightings. The adverse scenarios are calibrated to a similar severity to internal stress tests, whilst also incorporating IFRS 9 specific sensitivities and non-linearity. The most adverse scenarios are benchmarked to the Bank of England’s annual cyclical scenarios and to the most severe scenarios from Moody’s inventory, but are not designed to be the same. The favourable scenarios are calibrated to be symmetric to the adverse scenarios, subject to a ceiling calibrated to relevant recent favourable benchmark scenarios. The scenarios include six core variables, (GDP, unemployment and House Price Index in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The probability weights of the scenarios are estimated such that the baseline (reflecting current consensus outlook) has the highest weight and the weights of adverse and favourable scenarios depend on the deviation from the baseline; the further from the baseline, the smaller the weight. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macro-economic variables, for example, mortgages are highly sensitive to house prices and base rates, and credit cards and unsecured consumer loans are highly sensitive to unemployment. Definition of default, credit impaired assets, write-offs, and interest income recognition The definition of default for the purpose of determining ECLs has been aligned to the Regulatory Capital CRR Article 178 definition of default, which considers indicators that the debtor is unlikely to pay, includes exposures in forbearance and is no later than when the exposure is more than 90 days past due or 180 days past due in the case of UK mortgages. When exposures are identified as credit impaired or purchased or originated as such interest income is calculated on the carrying value net of the impairment allowance. Credit impaired is when the exposure has defaulted which is also anticipated to align to when an exposure is identified as individually impaired. Uncollectible loans are written off against the related allowance for loan impairment on completion of Barclays Bank Group’s internal processes and when all reasonably expected recoverable amounts have been collected. Subsequent recoveries of amounts previously written off are credited to the income statement. Loan modifications and renegotiations that are not credit-impaired When modification of a loan agreement occurs as a result of commercial restructuring activity rather than due to credit risk of the borrower, an assessment must be performed to determine whether the terms of the new agreement are substantially different from the terms of the existing agreement. This assessment considers both the change in cash flows arising from the modified terms as well as the change in overall instrument risk profile. Where terms are substantially different, the existing loan will be derecognised and new loan recognised at fair value, with any difference in valuation recognised immediately within the income statement, subject to observability criteria. Where terms are not substantially different, the loan carrying value will be adjusted to reflect the present value of modified cash flows discounted at the original EIR, with any resulting gain or loss recognised immediately within the income statement as a modification gain or loss. Expected life Lifetime ECLs must be measured over the expected life. This is restricted to the maximum contractual life and takes into account expected prepayment, extension, call and similar options. The exceptions are certain revolver financial instruments, such as credit cards and bank overdrafts, that include both a drawn and an undrawn component where the entity’s contractual ability to demand repayment and cancel the undrawn commitment does not limit the entity’s exposure to credit losses to the contractual notice period. The expected life for these revolver facilities is expected to be behavioural life. Where data is insufficient or analysis inconclusive, an additional ‘maturity factor’ may be incorporated to reflect the full estimated life of the exposures, based upon experienced judgement and/or peer analysis. Potential future modifications of contracts are not taken into account when determining the expected life or EAD until they occur. Discounting ECLs are discounted at the EIR at initial recognition or an approximation thereof and consistent with income recognition. For loan commitments the EIR is the rate that is expected to apply when the loan is drawn down and a financial asset is recognised. Issued financial guarantee contracts are discounted at the risk free rate. Lease receivables are discounted at the rate implicit in the lease. For variable/floating rate financial assets, the spot rate at the reporting date is used and projections of changes in the variable rate over the expected life are not made to estimate future interest cash flows or for discounting. Modelling techniques ECLs are calculated by multiplying three main components, being the PD, LGD and the EAD, discounted at the original EIR. The regulatory Basel Committee of Banking Supervisors (BCBS) ECL calculations are leveraged for IFRS 9 modelling but adjusted for key differences which include: BCBS requires 12 month through the economic cycle losses whereas IFRS 9 requires 12 months or lifetime point in time losses based on conditions at the reporting date and multiple forecasts of the future economic conditions over the expected lives IFRS 9 models do not include certain conservative BCBS model floors and downturn assessments and require discounting to the reporting date at the original EIR rather than using the cost of capital to the date of default Management adjustments are made to modelled output to account for situations where known or expected risk factors and information have not been considered in the modelling process, for example forecast economic scenarios for uncertain political events; and ECL is measured at the individual financial instrument level, however a collective approach where financial instruments with similar risk characteristics are grouped together, with apportionment to individual financial instruments, is used where effects can only be seen at a collective level, for example for forward-looking information For the IFRS 9 impairment assessment, Barclays Bank Group’s risk models are used to determine the PD, LGD and EAD. For Stage 2 and 3, Barclays Bank Group applies lifetime PDs but uses 12 month PDs for Stage 1. The ECL drivers of PD, EAD and LGD are modelled at an account level which considers vintage, among other credit factors. Also, the assessment of significant increase in credit risk is based on the initial lifetime PD curve, which accounts for the different credit risk underwritten over time. Forbearance A financial asset is subject to forbearance when it is modified due to the credit distress of the borrower. A modification made to the terms of an asset due to forbearance will typically be assessed as a non-substantial modification that does not result in derecognition of the original loan, except in circumstances where debt is exchanged for equity. Both performing and non-performing forbearance assets are classified as Stage 3 except where it is established that the concession granted has not resulted in diminished financial obligation and that no other regulatory definitions of default criteria has been triggered, in which case the asset is classified as Stage 2. The minimum probationary period for non-performing forbearance is 12 months and for performing forbearance, 24 months. Hence, a minimum of 36 months is required for non-performing forbearance to move out of a forborne state. No financial instrument in forbearance can transfer back to Stage 1 until all of the Stage 2 thresholds are no longer met and can only move out of Stage 3 when no longer credit impaired. IFRS 15 Revenue from Contracts with Customers IFRS 15 Revenue from Contracts with Customers, which replaced IAS 18 Revenue and IAS 11 Construction Contracts, was applied effective from 1 January 2018. It applies to all contracts with customers except leases, financial instruments and insurance contracts. The standard establishes a more systematic approach for revenue measurement and recognition by introducing a five-step model governing revenue recognition. The five-step model requires Barclays Bank Group to (i) identify the contract with the customer, (ii) identify each of the performance obligations included in the contract, (iii) determine the amount of consideration in the contract, (iv) allocate the consideration to each of the identified performance obligations and (v) recognise revenue as each performance obligation is satisfied. There are no significant impacts from the adoption of IFRS 15 in relation to the timing of when Barclays Bank Group recognises revenues or when revenue should be recognised gross as a principal or net as an agent. Therefore, Barclays Bank Group will continue to recognise fee and commission income charged for services provided by Barclays Bank Group as the services are provided (for example on completion of the underlying transaction). Revenue recognition for trading income and net investment income are recognised based on requirements of IFRS 9. Going concern Having reassessed the Principal Risks, the directors considered it appropriate to adopt the going concern basis of accounting in preparing the interim financial information. |
Disposal of business and transfer of ownership of subsidiary |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal of business and transfer of ownership of subsidiary | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal of business and transfer of ownership of subsidiary | 2. Disposal of business and transfer of ownership of subsidiary Following the court approval of the ring-fencing transfer scheme on 9 March 2018, the UK banking business largely comprising Personal Banking, Barclaycard Consumer UK and Business Banking customers, and related assets and liabilities was transferred to Barclays Bank UK PLC on 1 April 2018, to meet the regulatory ring-fencing requirement under the Financial Services (Banking Reform) Act 2013 and related legislation. The net assets transferred to Barclays Bank UK PLC on 1 April 2018 amounted to £16.0bn of which £12.9bn was transferred in exchange for one ordinary share with the remaining net assets transferred for no consideration. Following the transfer of the UK banking business on 1 April 2018, Barclays Bank PLC transferred the equity ownership in Barclays Bank UK PLC to Barclays PLC through a dividend in specie on the same day. The equity ownership in Barclays Bank UK PLC comprised net assets of £16.3bn, of which £0.3bn was already held by Barclays Bank UK PLC prior to the transfer of the UK banking business. Accordingly, Barclays Bank UK PLC ceased to be a subsidiary of Barclays Bank PLC and became a direct subsidiary of the ultimate parent, Barclays PLC. The condensed consolidated financial statements of Barclays Bank Group as at 30 June 2018 include the results of Barclays Bank UK PLC and its subsidiaries for the three months ended 31 March 2018, the date prior to the transfer of ownership to Barclays PLC. The transfer of the ownership of Barclays Bank UK PLC to Barclays PLC has resulted in a material change to the consolidated financial position and results of Barclays Bank Group in comparison to the prior period. The impact on the individual balance sheet line items as a result of the transfer of ownership is explained below:
The narrative below provides further granularity of the items transferred as part of the disposal of the UK banking business to Barclays Bank UK PLC. The items transferred included (but were not limited to):
The transfer of equity ownership in Barclays Bank UK PLC had no impact on the share capital and share premium of Barclays Bank PLC. Other equity instruments reduced by £2,070m relating to additional tier 1 (AT1) securities transferred to Barclays Bank UK PLC. The fair value through other comprehensive income reserve increased £16m and retained earnings reduced £14,261m. |
Discontinued operations and held for sale assets |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal of business and transfer of ownership of subsidiary | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discontinued oeprations and held for sale assets | 3. Discontinued operations and held for sale assets Discontinued operations As a result of the transfer of the equity ownership in Barclays Bank UK PLC to Barclays PLC on 1 April 2018, the UK banking business largely comprising of Personal Banking, Barclaycard Consumer UK and Business Banking customers, and related assets and liabilities met the requirement for presentation as a discontinued operation in Barclays Bank PLC. As such, the results, which have been presented as profit after tax in respect of discontinued operations on the face of the Barclays Bank Group income statement, are analysed in the income statement below. The income statement, statement of other comprehensive income and statement of cash flows for the half year ended 30 June 2018 represent the UK banking business results as a discontinued operation up to 31 March 2018, compared to six months for the half year ended 30 June 2017. The statements for the half year ended 30 June 2017 also include the results and cash flows for BAGL for the five months ended 31 May 2017.
Assets included in disposal groups classified as held for sale and associated liabilities The disposal group classified as held for sale as at 30 June 2018 primarily consisted of the Smart Investor portfolio. The Smart Investor portfolio is due to be transferred from Barclays Bank PLC to Barclays Bank UK PLC in H218. The disposal group classified as held for sale as at 31 December 2017 primarily consisted of a portfolio of Barclaycard US receivables which was sold in H118. Total assets classified as held for sale as at 30 June 2018 were £1,761m (December 2017: £1,193m) including loans and advances at amortised cost of £1,658m (December 2017: £1,164m). Total liabilities classified as held for sale as at 30 June 2018 were £1,762m (December 2017: £nil) including deposits at amortised cost of £1,660m (December 2017: £nil). |
Segmental reporting |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of operating segments [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segmental Reporting | 4. Segmental reporting Following the transfer of the UK banking business which largely comprised of Personal Banking, Barclaycard Consumer UK and Business Banking to Barclays Bank UK PLC on 1 April 2018 and the subsequent transfer of ownership of Barclays Bank UK PLC to Barclays PLC on the same day, the Barclays Bank Group activities have been segmented into CIB, Consumer, Cards and Payments, and Head Office. Comparatives have been restated to reflect the new segmentation. The segment results below reflect the continuing operations of Barclays Bank PLC and hence the UK banking business is excluded as it meets the requirement to be presented as a discontinued operation under IFRS 5, Non-current Assets Held for Sale and Discontinued Operations.
|
Fee and commission income |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee and commission income (expense) [abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee and commission income | 5. Fee and commission income Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenues from Contracts with Customers:
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. This includes interchange and merchant fee income generated from credit and bank card usage Advisory fees are generated from asset management services and advisory services related to mergers, acquisitions and financial restructuring. Brokerage and execution fees are earned for executing client transactions with exchanges and over-the-counter markets and assisting clients in clearing transactions. Underwriting and syndication fees are earned for the distribution of client equity or debt securities, and the arrangement and administration of a loan syndication. This includes commitment fees to provide loan financing. |
Tax |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||
Major components of tax expense (income) [abstract] | |||||||||||||||||||||||||||||||||||||||||||
Tax | 6. Tax
The deferred tax asset of £3,247m (December 2017: £3,352m) included £2,663m (December 2017: £2,647m) related to amounts in the US, with the majority of the remaining £584m (December 2017: £705m) related to amounts in the UK. Of the total deferred tax asset, £488m (December 2017: £596m) related to tax losses and £2,759m (December 2017: £2,756m) related to temporary differences. In H118 the regulatory ring-fencing requirement was implemented resulting in a transfer of substantial deferred tax assets and current tax liabilities to Barclays Bank UK PLC. This has caused the current tax assets of Barclays Bank PLC to have increased in H118. The decrease in deferred tax assets was largely offset by the recognition of deferred tax assets relating to the additional impairment from the adoption of IFRS 9. The tax charge for H118 was £378m (H117: £430m), representing an effective tax rate of 52.1% (H117: 24.8%). The effective tax rate is substantially higher than the UK statutory tax rate of 19% (2017: 19.25%) primarily due to charges for litigation and conduct which are non-deductible for tax purposes. |
Dividends on ordinary shares |
6 Months Ended | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||
Dividends on ordinary shares [abstract] | |||||||||||||||||||||||
Dividends on ordinary shares | 8. Dividends on ordinary shares
|
Fair value of financial instruments |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value of financial instruments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value of financial instruments | 9. Fair value of financial instruments This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays Bank PLC Annual Report 2017 and Note 1, Basis of preparation on pages 17 to 22, which provides more detail about accounting policies adopted, valuation methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There have been no changes in the accounting policies adopted or the valuation methodologies used. Valuation The following table shows Barclays Bank Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and balance sheet classification:
The following table shows Barclays Bank Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair value hierarchy) and product type:
Assets and liabilities reclassified between Level 1 and Level 2 During the period, there were no material transfers between Level 1 and Level 2 (period ended December 2017: £3,807m government bonds assets and £1,023m/£(950)m of commodity derivative assets and liabilities transferred from Level 1 to Level 2). Level 3 movement analysis The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level 3 during the period. Transfers have been reflected as if they had taken place at the beginning of the year. Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an unobservable input is deemed significant.
Derivative financial instruments are presented on a net basis. On a gross basis, derivative financial assets were £7,872m and derivative financial liabilities were £6,874m. Unrealised gains and losses on Level 3 financial assets and liabilities The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and liabilities held at the period end.
Valuation techniques and sensitivity analysis Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as well as the availability and reliability of observable proxy and historical data and the impact of using alternative models.
Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, physical commodities and investment property. The effect of stressing unobservable inputs to a range of reasonably possible alternatives alongside considering the impact of using alternative models, would be to increase fair values by up to £676m (December 2017: £763m) or to decrease fair values by up to £885m (December 2017: £984m) with substantially all the potential effect impacting profit and loss rather than reserves. Significant unobservable inputs The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level 3 are consistent with Note 17, Fair value of financial instruments in the Barclays Bank PLC Annual Report 2017. The description of the significant unobservable inputs and the sensitivity of fair value measurement of the instruments categorised as Level 3 assets or liabilities to increases in significant unobservable inputs is also found in Note 17, Fair value of financial instruments of the Barclays Bank PLC Annual Report 2017. Assets and liabilities included in disposal groups classified as held for sale are not included as these are measured at fair value on a non-recurring basis. Fair value adjustments Key balance sheet valuation adjustments are quantified below:
Portfolio exemption Barclays Bank Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial assets and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction between market participants at the balance sheet date under current market conditions. Accordingly, the Barclays Bank Group measures the fair value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at the measurement date. Unrecognised gains as a result of the use of valuation models using unobservable inputs The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial recognition, less amounts subsequently recognised, is £124m (December 2017: £109m) for financial instruments measured at fair value and £31m (December 2017: £253m) for financial instruments carried at amortised cost. The increase in financial instruments measured at fair value of £25m was driven by additions £44m (December 2017: £34m) offset by a transfer out of £15m (December 2017: £nil) to Barclays Bank UK PLC and £14m (December 2017: £104m) of amortisation and releases. The decrease of £222m in financial instruments carried at amortised cost was driven by the transfer out of £222m (December 2017: £nil) to Barclays Bank UK PLC and £1m (December 2017: £22m) of amortisation and releases offset by additions of £1m (December 2017: £119m). Third party credit enhancements Structured and brokered certificates of deposit issued by Barclays Bank Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that the Barclays Bank Group and other banks pay for deposit insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option includes this third party credit enhancement. The on-balance sheet value of these brokered certificates of deposit amounted to £3,862m (December 2017: £4,070m). Comparison of carrying amounts and fair values for assets and liabilities not held at fair value Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are consistent with the Barclays Bank PLC Annual Report 2017 disclosure. The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Barclays Bank Group’s balance sheet:
|
Non-controlling interests |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
Non-controlling interests [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
Non-controlling interests | 7. Non-controlling interests
|
Subordinated Liabilities |
6 Months Ended | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||
Subordinated liabilities [abstract] | ||||||||||||||||||||||||||||
Subordinated Liabilities |
Includes the transfer of subordinated liabilities of £3,019m on 1 April 2018 as part of the disposal of the UK banking business. Redemptions totalling £3,075m include £500m Fixed/Floating Rate Subordinated Callable Notes, €1,750m 6% Fixed Rate Subordinated Notes (£1,532m), $1,000m 7.75% Contingent Capital Notes (£713m), $99m 7.7% Undated Subordinated Notes (£72m), €40m Floating Rate Subordinated Notes 2018 (£35m), €235m CMS Linked Subordinated Notes (£206m), JPY 1,500m ShinGinko Tokyo Limited (£10m) and JPY 1,000m The Daisan Bank Limited (£7m). |
Provisions |
6 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||
Provisions [abstract] | |||||||||||||||||||||||||||||||||||||
Provisions |
The balance as at 30 June 2018 includes IFRS 9 expected credit losses on committed facilities and guarantees The provision balances related to the UK banking business which were transferred on 1 April 2018 consisted of £1,698m for PPI, £412m for other customer redress, £2m for legal, competition and other regulatory matters, £16m for redundancy and restructuring, £87m for undrawn contractual commitments, £48m for onerous contracts and £26m for sundry provisions. |
Retirement benefits |
6 Months Ended |
---|---|
Jun. 30, 2018 | |
Disclosure of defined benefit plans [abstract] | |
Retirement benefits | 12. Retirement benefits As at 30 June 2018, Barclays Bank Group’s IAS 19 pension surplus across all schemes was £0.9bn (December 2017: £0.7bn). The UK Retirement Fund (UKRF), which is Barclays Bank Group’s main scheme, had an IAS 19 pension surplus of £1.1bn (December 2017: £1.0bn). The movement for the UKRF was driven by an increase in the discount rate, payment of deficit contributions, and lower expected future price inflation, offset by lower than assumed asset returns and new early retirement and cash commutation factors. UKRF funding valuations The scheme actuary prepares an annual update of the UKRF funding position in addition to the full triennial actuarial valuation. The latest annual update was carried out as at 30 September 2017 and showed a deficit of £4.8bn and a funding level of 86.8%. The last triennial actuarial valuation of the UKRF had an effective date of 30 September 2016 and was completed in July 2017. This valuation showed a funding deficit of £7.9bn and a funding level of 81.5%. The improvement in funding position between 30 September 2016 and 30 September 2017 was largely due to payment of deficit contributions, higher than assumed asset returns, higher government bond yields and transfers out of the scheme. The recovery plan agreed as part of the 2016 triennial actuarial valuation requires Barclays Bank PLC to pay deficit contributions of £0.5bn per annum between 2018 and 2020, followed by £1.0bn per annum between 2021 and 2026. The deficit reduction contributions are in addition to the regular contributions to meet the Barclays Group’s share of the cost of benefits accruing over each year. The agreement with the UKRF Trustee also takes into account the changes to the Barclays Group structure that were implemented as a result of ring-fencing. Barclays Bank PLC remains as the principal employer of the UKRF. Additional support measures agreed include a collateral arrangement, joint participation of Barclays Bank UK PLC until 2025, and support from Barclays PLC should Barclays Bank PLC not pay the deficit contributions to the UKRF. The next triennial actuarial valuation of the UKRF is due to be completed in 2020 with an effective date of 30 September 2019. |
Called up share capital |
6 Months Ended | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||
Equity [abstract] | ||||||||||||||||||||||||||
Called up share capital | 13. Called up share capital Ordinary shares As at 30 June 2018 the issued ordinary share capital of Barclays Bank PLC comprised of 2,342 million (December 2017: 2,342 million) ordinary shares of £1 each. Preference shares As at 30 June 2018 the issued preference share capital of Barclays Bank PLC comprised of 1,000 Sterling Preference Shares of £1 each (December 2017: 1,000); 31,856 Euro Preference Shares of €100 each (December 2017: 31,856); 58,133 US Dollar Preference shares of $100 each (December 2017: 58,133); and 106 million US Dollar Preference Shares of $0.25 each (December 2017: 106 million).
|
Other equity instruments |
6 Months Ended |
---|---|
Jun. 30, 2018 | |
Other equity instruments [abstract] | |
Other equity instruments | 14. Other equity instruments Other equity instruments of £6,912m (December 2017: £8,982m) include AT1 securities issued to Barclays PLC by Barclays Bank PLC. The £2,070m decrease in AT1 securities was due to the transfer to Barclays Bank UK PLC. The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under CRD IV. AT1 securities are undated and are repayable, at the option of Barclays Bank PLC, in whole at the initial call date, or on any fifth anniversary after the initial call date. In addition, the AT1 securities are repayable, at the option of Barclays Bank PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any repayments require the prior consent of the PRA. |
Other reserves |
6 Months Ended | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||
Other reserves [abstract] | |||||||||||||||||||||||||||||||
Other reserves |
Currency translation reserve The currency translation reserve represents the cumulative gains and losses on the retranslation of Barclays Bank Group’s net investment in foreign operations, net of the effects of hedging. As at 30 June 2018, there was a credit balance of £3,434m (December 2017: £3,084m credit) in the currency translation reserve. The £350m credit movement principally reflected the strengthening of USD against GBP. Fair value through other comprehensive income reserve The fair value through other comprehensive income reserve represents the unrealised change in the fair value through other comprehensive income investments since initial recognition. Following the adoption of IFRS 9, accumulated fair value changes of £260m previously recognised in the available for sale reserve are now recorded in fair value through other comprehensive income. As at 30 June 2018, there was a debit balance of £215m (December 2017: £396m credit in the available for sale reserve) in the fair value through other comprehensive income reserve. The decrease of £611m is driven by a £136m transfer to retained earnings on IFRS 9 transition and a £329m reduction primarily due to changes in fair value of BAGL shares. There was also £151m of net gains transferred to net profit and a tax credit of £33m with the remaining balance related to exchange and other movements. Cash flow hedging reserve The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be recycled to the income statement when the hedged transactions affect profit or loss. As at 30 June 2018, there was a debit balance of £219m (December 2017: £184m credit) in the cash flow hedging reserve. The decrease of £403m principally reflected a £376m decrease in the fair value of interest rate swaps held for hedging purposes as interest rate forward curves increased and £161m of gains transferred to net profit, partially offset by a tax credit of £134m. Own credit reserve The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own credit reserve is not recycled to profit or loss in future periods. As at 30 June 2018, the amount of own credit recognised in the Barclays Bank Group’s other comprehensive income was a debit balance of £252m (December 2017: £179m debit). The movement of £73m is mainly attributable to the tightening of Barclays’ funding spreads of £98m offset by tax of £25m. Other reserves As at 30 June 2018, there was a credit balance of £323m (December 2017: £323m credit) in other reserves relating to redeemed ordinary and preference shares issued by Barclays Bank Group. |
Contingent liabilities and commitments |
6 Months Ended | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||
Contingent liabilities and commitments [abstract] | ||||||||||||||||||||||||||||||||||
Contingent liabilities and commitments | 16. Contingent liabilities and commitments
Contingent liabilities and commitment balances transferred to Barclays Bank UK PLC as part of the business disposal included guarantees and letters of credit pledged as collateral security of £793m and standby facilities, credit lines and other commitments of £67,791m Further details on contingent liabilities relating to legal, competition and regulatory matters can be found in Note 17, Legal, competition and regulatory matters. |
Legal, competition and regulatory matters |
6 Months Ended |
---|---|
Jun. 30, 2018 | |
Disclosure of legal, competition and regulatory matters [abstract] | |
Legal, competition and regulatory matters | 17. Legal, competition and regulatory matters Barclays Bank PLC and the Barclays Bank Group face legal, competition and regulatory challenges, many of which are beyond our control. The extent of the impact on Barclays of these matters cannot always be predicted but may materially impact our operations, financial results, condition and prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both, depending on the relevant facts and circumstances. In connection with the implementation of structural reform in the UK, on 1 April 2018, the UK banking business was transferred from Barclays Bank PLC to Barclays Bank UK PLC, a separate subsidiary of Barclays PLC. This transfer included the rights and liabilities in respect of certain of the matters described below (which are also disclosed in the financial statements of Barclays Bank UK PLC), although Barclays Bank PLC may remain the party on record to the relevant proceedings. Investigations into certain advisory services agreements and other matters and civil action The UK Serious Fraud Office (SFO), the Financial Conduct Authority (FCA), the US Department of Justice (DoJ) and the US Securities and Exchange Commission (SEC) have been conducting investigations into certain advisory services agreements entered into by Barclays Bank PLC. Background information Barclays Bank PLC entered into two advisory services agreements with Qatar Holding LLC (Qatar Holding) in June and October 2008 (the Agreements). The FCA commenced an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings). The existence of the June 2008 advisory services agreement was disclosed, but the entry into the advisory services agreement in October 2008 and the fees payable under the Agreements, which amounted to a total of £322m payable over a period of five years, were not disclosed in the announcements or public documents relating to the Capital Raisings. The SFO also commenced an investigation into the Agreements and into a $3bn loan (the Loan) provided by Barclays Bank PLC in November 2008 to the State of Qatar. SFO Proceedings In June 2017, the SFO charged Barclays PLC with two offences of conspiring with certain former senior officers and employees of Barclays to commit fraud by false representations relating to the Agreements and one offence of unlawful financial assistance contrary to section 151 of the Companies Act 1985 in relation to the Loan. In February 2018, the SFO also charged Barclays Bank PLC with the same offence in respect of the Loan. In May 2018, the Crown Court dismissed all charges against Barclays PLC and Barclays Bank PLC. In July 2018, the SFO made an application to the High Court seeking to reinstate against Barclays PLC and Barclays Bank PLC all of the charges dismissed by the Crown Court. Barclays intends to defend the application brought by the SFO. FCA Proceedings and other investigations In September 2013, the FCA issued warning notices (the Notices) finding that, while Barclays PLC and Barclays Bank PLC believed at the time of the execution of the Agreements that there should be at least some unspecified and undetermined value to be derived from them, the primary purpose of the Agreements was not to obtain advisory services but to make additional payments, which would not be disclosed, for the Qatari participation in the Capital Raisings. The Notices concluded that Barclays PLC and Barclays Bank PLC were in breach of certain disclosure-related listing rules and Barclays PLC was also in breach of Listing Principle 3 (the requirement to act with integrity towards holders and potential holders of the Company’s shares). In this regard, the FCA considers that Barclays PLC and Barclays Bank PLC acted recklessly. The financial penalty provided in the Notices against Barclays is £50m. Barclays PLC and Barclays Bank PLC continue to contest the findings. The FCA action has been stayed due to the SFO proceedings. In addition, the DoJ and the SEC have been conducting investigations relating to the Agreements. Civil Action In January 2016, PCP Capital Partners LLP and PCP International Finance Limited (PCP) served a claim on Barclays Bank PLC seeking damages for fraudulent misrepresentation and deceit, arising from alleged statements made by Barclays Bank PLC to PCP in relation to the terms on which securities were to be issued to potential investors, allegedly including PCP, in the November 2008 capital raising. PCP seeks damages of up to £1,477m (plus interest from November 2017) and costs. Barclays Bank PLC is defending the claim and trial is scheduled to commence in October 2019. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. PCP has made a claim against Barclays Bank PLC for damages of up to £1,477m plus interest and costs. This amount does not necessarily reflect Barclays Bank PLC’s potential financial exposure if a ruling were to be made against it in that matter. Investigations into certain business relationships In 2012, the DoJ and SEC commenced investigations in relation to whether certain relationships with third parties who assist Barclays PLC to win or retain business are compliant with the US Foreign Corrupt Practices Act. Various regulators in other jurisdictions are also being briefed on the investigations. Separately, Barclays is cooperating with the DoJ and SEC in relation to an investigation into certain of its hiring practices in Asia and elsewhere and is keeping certain regulators in other jurisdictions informed. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Investigations relating to whistleblowing systems and controls In April 2017, the FCA and the Prudential Regulation Authority (PRA) commenced investigations into the Barclays Group Chief Executive Officer (CEO), as to his individual conduct and senior manager responsibilities relating to Barclays’ whistleblowing programme and to his attempt in 2016 to identify the author of a letter that was treated by Barclays Bank PLC as a whistleblow, and into Barclays Bank PLC, as to its responsibilities relating to the attempt by the CEO to identify the author of the letter, as well as Barclays’ systems and controls and culture relating to whistleblowing. In May 2018, the FCA and PRA published final notices confirming their finding that the CEO’s actions in relation to this matter represented a breach of Individual Conduct Rule 2 (requirement to act with due skill, care and diligence). There were no findings by the FCA or PRA that the CEO acted with a lack of integrity nor any findings that he lacked fitness and propriety to continue to perform his role as Barclays Group Chief Executive Officer. In respect of its investigation relating to Barclays Bank PLC, the FCA and PRA concluded that they would not take enforcement action in respect of this matter. However, each of Barclays Bank PLC and Barclays Bank UK PLC have agreed to be subject to requirements to report to the FCA and PRA on certain aspects of their whistleblowing programmes. Barclays also continues to provide information to, and cooperate with, authorities in the US with respect to this matter. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Investigations into LIBOR and other benchmarks Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have been conducting investigations relating to Barclays Bank PLC’s involvement in manipulating certain financial benchmarks, such as LIBOR and EURIBOR. Background information In 2012, Barclays Bank PLC announced that it had reached settlements with the Financial Services Authority (FSA) (as predecessor to the FCA), the US Commodity Futures Trading Commission (CFTC) and the DoJ in relation to their investigations concerning certain benchmark interest rate submissions, and Barclays Bank PLC paid total penalties of £290m. The settlement with the DoJ was made by entry into a Non-Prosecution Agreement (NPA) which has now expired. Barclays PLC, Barclays Bank PLC and Barclays Capital Inc. (BCI) have reached settlements with certain other regulators and law enforcement agencies. Barclays Bank PLC continues to respond to requests for information from the SFO in relation to its ongoing LIBOR investigation, including in respect of Barclays Bank PLC. The investigation by the prosecutor’s office in Trani, Italy also remains pending. Claimed amounts/Financial impact Aside from the settlements discussed above, it is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. LIBOR and other benchmark civil actions A number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against Barclays and other banks in relation to LIBOR and/or other benchmarks. Background information Following settlement of the investigations referred to above in ‘Investigations into LIBOR and other Benchmarks’ various individuals and corporates in a range of jurisdictions have threatened or brought civil actions against Barclays. While certain cases have been dismissed or settled subject to approval from the court (and in the case of class actions, the right of class members to opt out of the settlement and to seek to file their own claims), other actions remain pending and their ultimate impact is unclear. USD LIBOR Cases in MDL Court The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes before a single judge in the US District Court in the Southern District of New York (SDNY) (MDL Court). The complaints are substantially similar and allege, amongst other things, that Barclays PLC, Barclays Bank PLC, BCI and other financial institutions individually and collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by manipulating USD LIBOR rates. Certain of the proposed class actions have been settled. Claims purportedly brought on behalf of plaintiffs that (i) engaged in USD LIBOR-linked over-the-counter transactions; (ii) purchased USD LIBOR-linked financial instruments on an exchange; (iii) purchased USD LIBOR-linked debt securities; or (iv) issued loans linked to USD LIBOR have been settled for $120m, $20m, $7.1m and $4m respectively. The settlements remain subject to final court approval and/or the right of class members to opt out of the settlement and to seek to file their own claims. The remaining putative class actions and individual actions seek unspecified damages with the exception of five lawsuits, in which the plaintiffs are seeking a combined total in excess of $1.25bn in actual damages against all defendants, including Barclays Bank PLC, plus punitive damages. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. EURIBOR Case in the SDNY In 2015, $94m was paid in settlement of a EURIBOR-related class action. The court entered an order granting final approval of Barclays’ settlement in May 2018. Additional USD LIBOR Case in the SDNY In 2015, an individual action against Barclays Bank PLC and other panel bank defendants was dismissed by the SDNY. The plaintiff alleged that the panel bank defendants conspired to increase USD LIBOR, which caused the value of bonds pledged as collateral for a loan to decrease, ultimately resulting in the sale of the bonds at a low point in the market. In March 2018, the court denied the plaintiff’s motion for leave to amend its complaint and dismissed the case. The plaintiff’s appeal of the court’s order is pending. Sterling LIBOR Case in SDNY In 2015, a putative class action was filed in the SDNY against Barclays Bank PLC and other Sterling LIBOR panel banks by a plaintiff involved in exchange-traded and over-the-counter derivatives that were linked to Sterling LIBOR. The complaint alleges, among other things, that defendants manipulated the Sterling LIBOR rate between 2005 and 2010 and, in so doing, committed CEA, Antitrust Act, and RICO violations. In early 2016, this class action was consolidated with an additional putative class action making similar allegations against Barclays Bank PLC and BCI and other Sterling LIBOR panel banks. The defendants’ motion to dismiss is pending. Japanese Yen LIBOR Cases in SDNY In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a plaintiff involved in exchange-traded derivatives. The complaint also names members of the Japanese Bankers Association’s Euroyen Tokyo Interbank Offered Rate (Euroyen TIBOR) panel, of which Barclays Bank PLC is not a member. The complaint alleges, amongst other things, manipulation of the Euroyen TIBOR and Yen LIBOR rates and breaches of the CEA and Antitrust Act between 2006 and 2010. In 2014, the court dismissed the plaintiff’s antitrust claims in full, but the plaintiff’s CEA claims remain pending. Discovery is ongoing. In March 2017, a second putative class action concerning Yen LIBOR which was filed in the SDNY against Barclays PLC, Barclays Bank PLC and BCI was dismissed in full. The complaint makes similar allegations to the 2012 class action. The plaintiffs have appealed the dismissal. SIBOR/SOR Case in the SDNY A putative class action filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR) was dismissed by the court in relation to claims against Barclays for failure to state a claim. The plaintiffs amended their complaint in September 2017, and the defendants’ motion to dismiss is pending. Non-US Benchmarks Cases In addition to US actions, legal proceedings have been brought or threatened against Barclays in connection with alleged manipulation of LIBOR and EURIBOR and other benchmarks in the UK, a number of other jurisdictions in Europe, Israel and Argentina. Additional proceedings in non-US jurisdictions may be brought in the future. Claimed amounts/Financial impact Aside from the settlements discussed above, it is not currently practicable to provide an estimate of any further financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Foreign Exchange investigations Various regulatory and enforcement authorities across multiple jurisdictions have been investigating a range of issues associated with Foreign Exchange sales and trading, including electronic trading. Background information In 2015 Barclays reached settlements with the CFTC, the DoJ, the New York State Department of Financial Services (NYDFS), the Board of Governors of the Federal Reserve System (Federal Reserve) and the FCA (together, the 2015 Resolving Authorities) in relation to investigations into certain sales and trading practices in the Foreign Exchange market. In connection with these settlements, Barclays paid total penalties of approximately $2.38bn and agreed to undertake certain remedial actions. Under the plea agreement with the DoJ, in addition to a criminal fine, Barclays PLC agreed to a term of probation of three years during which Barclays PLC, including its subsidiaries, must, amongst other things, (i) commit no crime whatsoever in violation of the federal laws of the US, (ii) implement and continue to implement a compliance program designed to prevent and detect the conduct that gave rise to the plea agreement, (iii) report credible evidence of criminal violations of US antitrust or fraud laws to the relevant US authority, and (iv) strengthen its compliance and internal controls as required by relevant regulatory or enforcement agencies. In January 2017, the US District Court for the District of Connecticut accepted the plea agreement and in accordance with the agreement sentenced Barclays PLC to pay $650m as a fine and $60m for violating the NPA (which amounts are part of the $2.38bn referred to above) and to serve three years of probation from the date of the sentencing order. Barclays also continues to provide relevant information to certain of the 2015 Resolving Authorities. The full text of the DoJ plea agreement, the orders of the CFTC, NYDFS and Federal Reserve, and the Final Notice issued by the FCA related to the settlements referred to above are publicly available on the 2015 Resolving Authorities’ respective websites. The European Commission is one of several authorities conducting an investigation into certain trading practices in the Foreign Exchange market. The DoJ has also conducted an investigation into conduct relating to certain trading activities in connection with certain transactions during 2011 and 2012. Barclays has been providing information to the DoJ and other relevant authorities reviewing this conduct. In February 2018, the DoJ concluded its investigation into conduct relating to certain trading activities in connection with one of these transactions. The DoJ issued a letter closing its investigation of Barclays in exchange for, among other things, Barclays’ agreement to pay $12.9m in disgorgement and restitution, which can be offset by any settlement amount paid as civil restitution. In January 2018, a Barclays employee currently under suspension was indicted in connection with this matter. Claimed amounts/Financial impact Aside from the settlements discussed above, and a provision of £240m recognised in Q417, it is not currently practicable to provide an estimate of any further financial impact of the actions described on Barclays or what effect they might have on Barclays’ operating results, cash flows or financial position in any particular period. Civil actions in respect of Foreign Exchange A number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against Barclays and other banks in relation to Foreign Exchange. Background information Following settlement of certain investigations referred to above in ‘Foreign Exchange Investigations’ a number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against Barclays and other banks in relation to Foreign Exchange or may do so in future. Certain of these cases have been dismissed or have been settled subject to final approval from the relevant court (and in the case of class actions, the right of class members to opt out of the settlement and to seek to file their own claims). Consolidated FX Action In 2014, a number of civil actions filed in the SDNY on behalf of proposed classes of plaintiffs alleging manipulation of Foreign Exchange markets under the Antitrust Act and New York state law and naming several international banks as defendants, including Barclays Bank PLC, were combined into a single consolidated action (Consolidated FX Action). In 2015, Barclays Bank PLC and BCI settled the Consolidated FX Action and paid $384m. Certain class members have opted out of the settlement and some of these may seek to file their own claims. The settlement is also subject to final court approval. ERISA FX Action Since 2015, several civil actions have been filed in the SDNY on behalf of proposed classes of plaintiffs purporting to allege different legal theories of injury (other than those alleged in the Consolidated FX Action) related to alleged manipulation of Foreign Exchange rates, including claims under the US Employee Retirement Income Security Act (ERISA) statute (ERISA Claims), and naming several international banks as defendants, including Barclays PLC, Barclays Bank PLC and BCI. The Court has dismissed the ERISA Claims. Retail Basis Action A putative action was filed in the Northern District of California (and subsequently transferred to the SDNY) against several international banks, including Barclays PLC and BCI, on behalf of a putative class of individuals that exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The Court has ruled that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently dismissed all Retail Basis Claims against Barclays and all other defendants. The plaintiffs amended their complaint and sought to expand the action to include credit card, debit card and wire transactions, which expansion the Court denied. The plaintiffs have asked the Court to reconsider the expansion decision. State Law FX Action In 2016, a putative class action was filed in the SDNY under federal, New York and California law on behalf of proposed classes of stockholders of Exchange Traded Funds and others who supposedly were indirect investors in FX Instruments. The defendants (including Barclays) moved to dismiss the action. The plaintiffs’ counsel then amended the complaint to bring claims on behalf of a proposed class of investors under federal and various state laws who traded FX Instruments through FX dealers or brokers not alleged to have manipulated Foreign Exchange Rates. A different group of plaintiffs subsequently filed another action based on the same theories and asserted substantively similar claims. These two actions have been consolidated and a consolidated complaint was filed in June 2017. The defendants (including Barclays) have moved to dismiss the action. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of any further financial impact of the actions described above on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Civil actions in respect of ISDAFIX In 2014, a number of ISDAFIX related civil actions were filed in the SDNY on behalf of proposed class of plaintiffs, alleging that Barclays Bank PLC, a number of other banks and one broker violated the Antitrust Act and several state laws by engaging in a conspiracy to manipulate the USD ISDAFIX. In 2016, Barclays Bank PLC and BCI entered into a settlement agreement with plaintiffs to resolve the consolidated action and paid $30m, fully resolving all ISDAFIX-related claims that were or could have been brought by the class. The court entered an order granting final approval of the settlement in June 2018. Claimed amounts/Financial impact The principal financial impact of the actions described on Barclays is reflected in the settlement described above. Metals investigations Barclays Bank PLC has provided information to the DoJ, the CFTC and other authorities in connection with investigations into metals and metals-based financial instruments. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Civil actions in respect of the gold and silver fix A number of civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the prices of gold and gold derivative contracts in violation of the CEA, the Antitrust Act, and state antitrust and consumer protection laws. Also in the US, a proposed class of plaintiffs filed a complaint against a number of banks, including Barclays Bank PLC, BCI and Barclays Capital Services Ltd., alleging manipulation of the price of silver in violation of the CEA and antitrust laws. The court has dismissed this action as against the Barclays entities. Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc., BCI and Barclays Capital PLC on behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices in violation of Canadian law. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. US residential and commercial mortgage-related activity and litigation There have been various investigations and civil litigation relating to secondary market trading of US Residential Mortgage-Backed Securities (RMBS) and US Commercial Mortgage-Backed Securities (CMBS). Background information Barclays’ activities within the US residential mortgage sector during the period from 2005 through 2008 included:
DoJ Civil Action In December 2016, the DoJ filed a civil complaint against Barclays Bank PLC, Barclays PLC, BCI, Barclays Group US Inc., Barclays US LLC, BCAP LLC, Securitized Asset Backed Receivables LLC and Sutton Funding LLC, as well as two former employees, in the US District Court in the Eastern District of New York (EDNY) containing a number of allegations, including mail and wire fraud, relating to mortgage-backed securities sold between 2005 and 2007. In March 2018, Barclays reached a settlement with the DoJ to resolve this complaint for a civil monetary penalty of $2bn which was paid in H118. RMBS Repurchase Requests Barclays was the sole provider of various loan-level representations and warranties (R&Ws) with respect to:
In addition, the Acquired Subsidiary provided R&Ws on all of the $19.4bn of loans it sold to third parties. R&Ws on the remaining Barclays sponsored securitisations were primarily provided by third-party originators directly to the securitisation trusts with a Barclays subsidiary, such as the depositor for the securitisation, providing more limited R&Ws. There are no stated expiration provisions applicable to most R&Ws made by Barclays, the Acquired Subsidiary or these third parties. Under certain circumstances, Barclays and/or the Acquired Subsidiary may be required to repurchase the related loans or make other payments related to such loans if the R&Ws are breached. The unresolved repurchase requests received on or before 30 June 2018 associated with all R&Ws made by Barclays or the Acquired Subsidiary on loans sold to GSEs and others and private-label activities had an original unpaid principal balance of approximately $2.1bn at the time of such sale. The unresolved repurchase requests discussed above relate to civil actions that have been commenced by the trustees for certain RMBS securitisations in which the trustees allege that Barclays and/or the Acquired Subsidiary must repurchase loans that violated the operative R&Ws. Such trustees and other parties making repurchase requests have also alleged that the operative R&Ws may have been violated with respect to a greater (but unspecified) amount of loans than the amount of loans previously stated in specific repurchase requests made by such trustees. This litigation is ongoing. In May 2018, the Acquired Subsidiary agreed to a settlement of a civil action relating to claims for indemnification for losses allegedly suffered by a loan purchaser as a result of alleged breaches of R&Ws provided by the Acquired Subsidiary in connection with loan sales to the purchaser during the period 1997 to 2007. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of any further financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Alternative trading systems and high-frequency trading The SEC, the New York State Attorney General (NYAG) and regulators in certain other jurisdictions investigated a range of issues associated with alternative trading systems (ATSs), including dark pools, and the activities of high-frequency traders. Background information In 2014, the NYAG filed a complaint (NYAG Complaint) against Barclays PLC and BCI in the Supreme Court of the State of New York alleging, amongst other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, Barclays’ SEC-registered ATS. In February 2016, Barclays reached separate settlement agreements with the SEC and the NYAG to resolve those agencies’ claims against Barclays PLC and BCI relating to the operation of LX and paid $35m to each. Barclays PLC and BCI have been named in a purported class action by an institutional financial services firm under California law based on allegations similar to those in the NYAG Complaint. In October 2016, the federal court in California granted the motion of Barclays PLC and BCI to dismiss the entire complaint and the plaintiffs appealed the court’s decision. In July 2018, the court of appeals affirmed the dismissal. Following the filing of the NYAG Complaint, Barclays PLC and BCI were also named in a putative shareholder securities class action along with certain current and former executives (Shareholder Class Action). The plaintiffs claim that holders of Barclays American Depository Receipts (ADRs) suffered damages when the ADRs declined in value as a result of the allegations in the NYAG Complaint. A motion to dismiss the complaint filed by the defendants (including Barclays PLC and BCI), was granted in part and denied in part by the court. In February 2016, the court certified the action as a class action. In November 2017, the appellate court affirmed the class certification. Claimed amounts/Financial impact The class actions seek unspecified monetary damages and injunctive relief. It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Electricity market action In 2013, the US Federal Energy Regulatory Commission (FERC) filed a civil action against Barclays Bank PLC in connection with allegations that Barclays Bank PLC manipulated the electricity markets in the Western US. The action was settled for $105m ($70m penalty and $35m disgorgement) which was paid in 2017. In 2015, a civil class action complaint seeking damages of $139.3m was filed in the US District Court for the SDNY against Barclays Bank PLC by Merced Irrigation District, a California utility company, asserting antitrust allegations in connection with purported manipulation of the electricity markets in and around California. The action has been settled in principle for $29m (subject to final court approval and to the right of class members to opt out of the settlement and to seek to file their own claims). Claimed amounts/Financial impact Barclays does not expect the financial impact of the actions described above to be material to Barclays’ operating results, cash flows or financial position. Treasury auction securities civil actions and related matters Various civil actions have been filed against Barclays Bank PLC, BCI and other financial institutions alleging violations of antitrust and other laws relating to the markets for US Treasury securities and Supranational, Sovereign and Agency securities. Certain governmental authorities are also conducting investigations relating to trading of certain government securities in various markets. Background information Numerous putative class action complaints have been filed in US Federal Court against Barclays Bank PLC, BCI and other financial institutions that have served as primary dealers in US Treasury securities. Those actions have been consolidated and in November 2017, plaintiffs in the putative class action filed a consolidated amended complaint in the US Federal Court in New York against the defendants as well as certain corporations that operate electronic trading platforms on which US Treasury securities are traded. The complaint purports to assert claims under US federal antitrust laws and state common law based on allegations that defendants (i) conspired to manipulate the US Treasury securities market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to boycott such trading platforms. The defendants have filed a motion to dismiss. In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions that have served as primary dealers in US Treasury securities. This complaint alleges that defendants conspired to fix and manipulate the US Treasury securities market in violation of US federal antitrust laws, the CEA and state common law. In 2017, Barclays PLC, Barclays Bank PLC, BCI, Barclays Services Limited, Barclays Capital Securities Limited and certain other financial institutions were named as defendants in a civil antitrust complaint that alleges that the defendants engaged in a conspiracy to fix prices and restrain competition in the market for US dollar-denominated Supranational, Sovereign and Agency bonds from 2005 through 2015. The defendants have moved to dismiss the action. Certain governmental authorities are conducting investigations into activities relating to the trading of certain government securities in various markets and Barclays has been providing information to various authorities on an ongoing basis. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Mexican Government Bond civil action Barclays PLC, Barclays Bank PLC, BCI, Barclays Bank Mexico, S.A., and Grupo Financiero Barclays Mexico, S.A., together with other financial institutions that deal in Mexican government bonds (MGB) are named as defendants in several putative class actions which were consolidated in the SDNY in June 2018. The class actions allege antitrust and state law claims arising out of an alleged conspiracy to fix the prices of MGB from 2006 through mid-2017. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. American Depositary Shares Barclays PLC, Barclays Bank PLC and various former members of Barclays Bank PLC's Board of Directors have been named as defendants in a securities class action consolidated in the SDNY that alleges misstatements and omissions in offering documents for certain American Depositary Shares issued by Barclays Bank PLC in April 2008 with an original face amount of approximately $2.5 billion (the April 2008 Offering). The plaintiffs assert claims under the Securities Act of 1933, alleging misstatements and omissions concerning (amongst other things) Barclays Bank PLC’s portfolio of mortgage-related (including US subprime-related) securities, Barclays Bank PLC’s exposure to mortgage and credit market risk, and Barclays Bank PLC’s financial condition. The plaintiffs have not specifically alleged the amount of their damages. In June 2016, the SDNY certified the action as a class action. In September 2017, the SDNY granted the defendants’ motion for summary judgment. The plaintiffs are appealing this decision. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the action described on Barclays or what effect that it might have upon Barclays’ operating results, cash flows or financial position in any particular period. BDC Finance L.L.C. BDC Finance L.L.C. (BDC) has filed a complaint against Barclays Bank PLC alleging breach of contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement (collectively, the Agreement). Background information In 2008, BDC filed a complaint in the NY Supreme Court alleging that Barclays Bank PLC breached the Agreement when it failed to transfer approximately $40m of alleged excess collateral in response to BDC’s 2008 demand (Demand). BDC asserts that under the Agreement Barclays Bank PLC was not entitled to dispute the Demand before transferring the alleged excess collateral and that even if the Agreement entitled Barclays Bank PLC to dispute the Demand before making the transfer, Barclays Bank PLC failed to dispute the Demand. BDC demands damages totalling $298m plus attorneys’ fees, expenses, and pre-judgement interest. A trial on liability issues concluded in April 2017 and the court’s decision is pending. In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious interference with business and prospective business relations. The parties agreed to stay this case. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. BDC has made claims against Barclays totalling $298m plus attorneys’ fees, expenses, and pre-judgement interest. This amount does not necessarily reflect Barclays’ potential financial exposure if a ruling were to be made against it. Civil actions in respect of the US Anti-Terrorism Act Civil complaints against Barclays Bank PLC and other banks allege engagement in a conspiracy and violation of the US Anti-Terrorism Act (ATA). Background information An amended civil complaint (the Amended Complaint), filed in the US Federal Court in the EDNY by a group of approximately 350 plaintiffs, alleges that Barclays Bank PLC and a number of other banks engaged in a conspiracy and violated the ATA by facilitating US dollar denominated transactions for the Government of Iran and various Iranian banks, which in turn funded Hezbollah and other attacks that injured or killed the plaintiffs’ family members. The plaintiffs seek to recover for pain, suffering and mental anguish pursuant to the provisions of the ATA, which allows for the tripling of any proven damages and attorneys' fees. Defendants have moved to dismiss the Amended Complaint. In November 2017, a separate civil complaint was filed in the US Federal Court in the SDNY by a group of approximately 160 plaintiffs, alleging claims under the ATA against Barclays Bank PLC and a number of other banks substantially similar to those in the Amended Complaint. The defendants have moved to dismiss this complaint. In May 2018, a civil complaint was filed in the US Federal Court in the Middle District of Florida by a single plaintiff acting for himself alleging claims under the ATA against Barclays Bank PLC and a number of other banks. Barclays Bank PLC has not been served with this complaint. In July 2018, the court dismissed the complaint subject to the right of the plaintiff to file a revised complaint. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Interest rate swap and credit default swap US civil actions Barclays PLC, Barclays Bank PLC, and BCI, together with other financial institutions are defendants in interest rate swap and credit default swap antitrust civil actions in the SDNY. Background information Barclays PLC, Barclays Bank PLC, and BCI, together with other financial institutions that act as market makers for interest rate swaps (IRS), Trade Web, and ICAP, are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages, treble damages and legal fees. Plaintiffs include certain swap execution facilities, as well as buy-side investors. The buy-side investors claim to represent a class that transacted in fixed-for-floating IRS with defendants in the US from 2008 to the present, including, for example, US retirement and pension funds, municipalities, university endowments, corporations, insurance companies and investment funds. The case is in discovery. In June 2017, a separate suit was filed in the US District Court in the SDNY against the same financial institution defendants in the IRS cases, including Barclays PLC, Barclays Bank PLC, and BCI, claiming that certain conduct alleged in the IRS cases also caused plaintiff to suffer harm with respect to the Credit Default Swaps market. Defendants have moved to dismiss this action. Separately, in June 2018, trueEX LLC filed an antitrust class action in the SDNY against eleven financial institutions that act as dealers in the IRS market, including Barclays Bank PLC and BCI, alleging that the defendants unlawfully conspired to block trueEX from successfully entering the market with its IRS trading platform. trueEX LLC also alleges that the defendants more generally boycotted other anonymous, all-to-all IRS trading platforms. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Portuguese Competition Authority investigation The Portuguese Competition Authority is investigating whether competition law was infringed by the exchange of information about retail credit products amongst 15 banks in Portugal, including Barclays, over a period of 11 years with particular reference to mortgages, consumer lending and lending to small and medium enterprises. Barclays is cooperating with the investigation. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the action described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Investigation into suspected money laundering related to foreign exchange transactions in South African operation Absa Bank Limited, which was a subsidiary within the Barclays Group at the relevant time, identified potentially fraudulent activity by certain of its customers using advance payments for imports in 2014 and 2015 to effect foreign exchange transfers from South Africa to beneficiary accounts located in East Asia, the UK, Europe and the US. As a result, Barclays conducted a review of relevant activity, processes, systems and controls. Barclays is continuing to provide information to relevant authorities as part of Barclays’ ongoing cooperation. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Investigations relating to retail structured deposits and capital protected structured notes In 2015, the FCA commenced an enforcement investigation relating to the design, manufacture and sale of structured deposits by Barclays from November 2009. The investigation is at an advanced stage. In January 2018, the FCA also commenced an enforcement investigation relating to the design, manufacture and sale of capital protected structured notes by Barclays from June 2008 to July 2014. Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the investigations on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. Investigation into collections and recoveries relating to unsecured lending In February 2018, the FCA commenced an enforcement investigation in relation to whether or not Barclays, from July 2015, implemented effective systems and controls with respect to collections and recoveries and whether or not it paid due consideration to the interests of customers in default and arrears.
Claimed amounts/Financial impact It is not currently practicable to provide an estimate of the financial impact of the investigation on Barclays or what effect that it might have upon Barclays’ operating results, cash flows or financial position in any particular period. HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax In March 2018 HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and unless withdrawn by HMRC would correspond to assessments of approximately £184m, inclusive of interest, of which Barclays would expect to attribute an amount of approximately £130m to Barclays Bank UK PLC and £54m to Barclays Bank PLC. At Barclays’ request, HMRC is conducting a further review, and if the assessments are not withdrawn Barclays is able to challenge the assessments by initiating proceedings with the First Tier Tribunal (Tax Chamber). Claimed amounts/Financial impact The total amount of the HMRC assessments is approximately £184m, inclusive of interest General Barclays Bank PLC and its subsidiaries are engaged in various other legal, competition and regulatory matters in the UK and US and a number of other overseas jurisdictions. The Barclays Bank Group is subject to legal proceedings brought by and against Barclays which arise in the ordinary course of business from time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud, trusts, client assets, competition, data protection, money laundering, financial crime, employment, environmental and other statutory and common law issues. The Barclays Bank Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities in which Barclays is or has been engaged. Barclays is cooperating with the relevant authorities and keeping all relevant agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis. At the present time, Barclays Bank PLC does not expect the ultimate resolution of any of these other matters to have a material adverse effect on its financial position. However, in light of the uncertainties involved in such matters and the matters specifically described in this note, there can be no assurance that the outcome of a particular matter or matters will not be material to Barclays Bank PLC’s results, operations or cash flow for a particular period, depending on, amongst other things, the amount of the loss resulting from the matter(s) and the amount of profit otherwise reported for the reporting period. |
Related party transactions |
6 Months Ended | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||
Related party transactions [abstract] | |||||||||||||||||||||||||
Related party transactions | 18. Related party transactions The disposal of the UK banking business to Barclays Bank UK PLC and transfer of ownership of Barclays Bank UK PLC to Barclays PLC has materially affected the financial position and the performance of the Barclays Bank Group during this period with regards to its related party transactions. Refer to Note 2, Disposal of business and transfer of ownership of subsidiary for further details, including intra-group balances. Parent company The parent company, which is also the ultimate parent company, is Barclays PLC, which holds 100% of the issued ordinary shares of Barclays Bank PLC. Fellow subsidiaries Transactions between the Barclays Bank Group and other subsidiaries of the parent company meet the definition of related party transactions. Amounts included in the Barclays Bank Group’s financial statements with other Barclays Group companies are as follows:
Except for the above, no related party transactions that have taken place in the half year ended 30 June 2018 have materially affected the financial position or performance of the Barclays Bank Group during this period. |
Transition disclosures |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transition disclosures | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transition disclosures | 19. Transition disclosures Impairment allowance reconciliations Reconciliation from IAS 39 to IFRS 9 - financial assets under IFRS 9 subject to an increase in impairment allowance The table below reconciles the closing impairment allowances for financial assets in accordance with IAS 39 and provisions for loan commitments and financial guarantee contracts in accordance with IAS 37, Provisions, Contingent Liabilities and Contingent Assets as at 31 December 2017 and the opening ECLs determined in accordance with IFRS 9 as at 1 January 2018.
For further details, refer to Note 1, Basis of preparation on pages 17 to 22. IFRS 9 classification and measurement This column represents the changes to the balance sheet from classification and measurement. The net effect is a decrease in shareholders’ equity of £17m, with no significant offsetting movements. The classification changes include the transfer of certain Barclays International Prime Services and Equities positions from an amortised cost to a fair value approach. IFRS 9 impairment change Additional impairment from the adoption of IFRS 9 is shown in the impairment change column. The increase in impairment results in the recognition of a deferred tax asset that will amortise to current tax over time. The post-tax impact is a reduction in shareholders’ equity of £2.2bn. Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale portfolios the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision. |
Barclays Bank PLC parent condensed balance sheet |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Barclays Bank PLC condensed balance sheet [abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Barclays Bank PLC balance sheet (The Bank) | 20. Barclays Bank PLC parent condensed balance sheet
|
Significant accounting policy (Policy) |
6 Months Ended |
---|---|
Jun. 30, 2018 | |
Basis of preparation [Abstract] | |
IFRS 9 Financial Instruments | IFRS 9 Financial Instruments IFRS 9, Financial Instruments, which replaced IAS 39, Financial Instruments: Recognition and Measurement, was applied effective from 1 January 2018, including the early adoption of ‘Prepayment Features with Negative Compensation (Amendments to IFRS 9)’ which was endorsed by the EU in March 2018. IFRS 9 includes an accounting policy choice to continue to apply hedge accounting in accordance with IAS 39, which Barclays Bank Group has decided to apply. IFRS 9 was applied retrospectively by adjusting the opening balance sheet at the date of initial application, and comparative periods have not been restated. Changes in presentation The following voluntary changes in presentation have been made as a result of the review of accounting presentation following the adoption of IFRS 9, and is expected to provide more relevant information to the users of the financial statements. These presentational changes have no effect on the measurement of these items and therefore had no impact on retained earnings or profit for any period. The effect of these presentational changes on transition are included in the reconciliation on pages 54 to 55 and are noted below: Items in the course of collection from other banks’ and ‘prepayments, accrued income and other assets’ are reported in ‘other assets’. Equally, ‘items in the course of collection due to other banks’ and ‘accruals, deferred income and other liabilities’ are reported in ‘other liabilities’; ‘Loans and advances to banks’ and ‘loans and advances to customers’ have been disaggregated and are now reported in ‘loans and advances at amortised cost’ and ‘cash collateral and settlement balances’; ‘Deposits from banks’ and ‘customer accounts’ have been disaggregated and are now reported in ‘deposits at amortised cost’ and ‘cash collateral and settlement balances’; Financial assets designated at fair value’ are now reported within ‘financial assets at fair value through the income statement’; The majority of available for sale assets which were previously reported in ‘financial investments’ are now reported in ‘financial assets at fair value through other comprehensive income’; and Held to maturity assets which were previously reported in ‘financial investments’ are now reported in ‘loans and advances at amortised cost’ Application of IFRS 9 The accounting policies which have been applied effective from 1 January 2018 as a result of adopting IFRS 9 are as follows. IFRS 9 requires financial assets to be classified on the basis of two criteria: i) the business model within which financial assets are managed; and ii) their contractual cash flow characteristics (whether the cash flows represent ‘solely payments of principal and interest’ (SPPI)). Business models were determined on initial application of IFRS 9. Barclays Bank Group assesses the business model criteria at a portfolio level. Information that is considered in determining the applicable business model includes (i) policies and objectives for the relevant portfolio, (ii) how the performance and risks of the portfolio are managed, evaluated and reported to management, and (iii) the frequency, volume and timing of sales in prior periods, sales expectation for future periods, and the reasons for such sales. The contractual cash flow characteristics of financial assets are assessed with reference to whether the cash flows represent SPPI. In assessing whether contractual cash flows are SPPI compliant, interest is defined as consideration primarily for the time value of money and the credit risk of the principal outstanding. The time value of money is defined as the element of interest that provides consideration only for the passage of time and not consideration for other risks or costs associated with holding the financial asset. Terms that could change the contractual cash flows so that it would not meet the condition for SPPI are considered, including: (i) contingent and leverage features, (ii) non-recourse arrangements and (iii) features that could modify the time value of money. Financial instruments measured at amortised cost Financial assets that are held in a business model to collect the contractual cash flows and that contain contractual terms that give rise on specified dates to cash flows that are SPPI, are measured at amortised cost. The carrying value of these financial assets at initial recognition includes any directly attributable transaction costs. In determining whether the business model is a ‘hold to collect’ model, the objective of the business model must be to hold the financial asset to collect contractual cash flows rather than holding the financial asset for trading or short-term profit taking purposes. While the objective of the business model must be to hold the financial asset to collect contractual cash flows this does not mean Barclays Bank Group is required to hold the financial assets until maturity. When determining if the business model objective is to collect contractual cash flows Barclays Bank Group will consider past sales and expectations about future sales. Financial assets measured at fair value through other comprehensive income (‘FVOCI’) Financial assets that are debt instruments held in a business model that is achieved by both collecting contractual cash flows and selling, and that contain contractual terms that give rise on specified dates to cash flows that are SPPI, are measured at FVOCI. They are subsequently remeasured at fair value and changes therein (except for those relating to impairment, interest income and foreign currency exchange gains and losses) are recognised in other comprehensive income, until the assets are sold. Upon disposal, the cumulative gains and losses in other comprehensive income are recognised in the income statement in net investment income. In determining whether the business model is achieved by both collecting contractual cash flows and selling financial assets, it is determined that both collecting contractual cash flows and selling financial assets are integral to achieving the objective of the business model. When determining if the business model is achieved by both collecting contractual cash flows and selling financial assets, Barclays Bank Group will consider past sales and expectations about future sales. Equity securities For equity securities that are not held for trading, Barclays Bank Group may make an irrevocable election to present subsequent changes in the fair value of the instrument in other comprehensive income (except for dividend income which is recognised in profit or loss). Gains or losses on the derecognition of these equity securities are not transferred to profit or loss. These assets are also not subject to the impairment requirements and therefore no amounts are recycled to the income statement. Where Barclays Bank Group has not made the irrevocable election to present subsequent changes in the fair value of the instrument in other comprehensive income, equity securities are measured at fair value through profit or loss. Financial instruments designated at fair value through profit or loss Financial assets, other than those held for trading, are classified in this category if they are so irrevocably designated at inception and the use of the designation removes or significantly reduces an accounting mismatch. Subsequent changes in fair value are recognised in the income statement in net investment income. Financial liabilities can be designated at fair value through profit or loss if they meet one or more of the criteria set out below and are so designated irrevocable at inception: the use of the designation removes or significantly reduces an accounting mismatch; when a group of financial assets and liabilities or a group of financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy; or where the financial liability contains one or more non-closely related embedded derivatives Subsequent changes in fair value are recognised in the income statement in net investment income, except if reporting it in trading income reduces an accounting mismatch. Financial assets at fair value through profit or loss Financial assets that are held for trading are recognised at fair value through profit or loss. In addition, financial assets are held at fair value through profit or loss if they do not contain contractual terms that give rise on specified dates to cash flows that are SPPI, or if the financial asset is not held in a business model that is either (i) a business model to collect the contractual cash flows or (ii) a business model that is achieved by both collecting contractual cash flows and selling. Subsequent changes in fair value for these instruments are recognised in the income statement in net investment income, except if reporting it in trading income reduces an accounting mismatch. Derivatives Derivative instruments are contracts whose value is derived from one or more underlying financial instruments or indices defined in the contract. All derivative instruments are held at fair value through profit or loss, except for derivatives that are in a designated cash flow or net investment hedge accounting relationship. This includes terms included in a contract or financial liability (the host), which, had it been a standalone contract, would have met the definition of a derivative. If these are separated from the host, i.e. when the economic characteristics of the embedded derivative are not closely related with those of the host contract and the combined instrument is not measured at fair value through profit or loss, then they are accounted for in the same way as derivatives. For financial assets, the requirements are whether the financial asset contain contractual terms that give rise on specified dates to cash flows that are SPPI, and consequently the requirements for accounting for embedded derivatives are not applicable to financial assets. Impairment Entities are required to recognise expected credit losses (ECLs) based on unbiased forward-looking information for all financial assets at amortised cost, lease receivables, debt financial assets at fair value through other comprehensive income, loan commitments and financial guarantee contracts. Intercompany exposures, including loan commitments and financial guarantee contracts, are also in scope under IFRS 9. At the reporting date, an allowance (or provision for loan commitments and financial guarantees) is required for the 12 month ECLs. If the credit risk has significantly increased since initial recognition (Stage 1), an allowance (or provision) should be recognised for the lifetime ECLs for financial instruments for which the credit risk has increased significantly since initial recognition (Stage 2) or which are credit impaired (Stage 3). The measurement of ECL is calculated using three main components: (i) probability of default (PD), (ii) loss given default (LGD) and (iii) the exposure at default (EAD). The 12 month ECL is calculated by multiplying the 12 month PD, LGD and the EAD. The 12 month and lifetime PDs represent the PD occurring over the next 12 months and the remaining maturity of the instrument respectively. The EAD represents the expected balance at default, taking into account the repayment of principal and interest from the balance sheet date to the default event together with any expected drawdowns of committed facilities. The LGD represents expected losses on the EAD given the event of default, taking into account, among other attributes, the mitigating effect of collateral value at the time it is expected to be realised and the time value of money. Determining a significant increase in credit risk since initial recognition: Barclays Bank Group assesses when a significant increase in credit risk has occurred based on quantitative and qualitative assessments. Exposures are considered to have resulted in a significant increase in credit risk and are moved to Stage 2 when: Quantitative test The annualised cumulative weighted average lifetime PD has increased by more than an agreed threshold relative to the equivalent at origination. PD deterioration thresholds are defined as percentage increases, and are set at an origination score band and segment level to ensure the test appropriately captures significant increases in credit risk at all risk levels. Generally, thresholds are inversely correlated to the origination PD, i.e. as the origination PD increases, the threshold value reduces. The assessment of materiality, i.e. at what point a PD increase is deemed ‘significant’, is based upon analysis of the portfolios’ risk profile against a common set of principles and performance metrics, incorporating expert credit judgement where appropriate. For existing/historic exposures where origination point scores/data are no longer available or do not represent a comparable estimate of lifetime PD, a proxy origination score is defined, based upon: Back-population of the approved lifetime PD score either to origination date or, where this is not feasible, as far back as possible, (subject to a data start point no later than 1 January 2015); or Use of available historic account performance data and other customer information, to derive a comparable ‘proxy’ estimation of origination PD Qualitative test Accounts meet the portfolio’s ‘high risk’ criteria and are subject to closer credit monitoring. High risk customers may not be in arrears but either through an event or an observed behaviour exhibit potential credit distress. The definition and assessment of high risk includes as wide a range of information as reasonably available, including industry and Barclays Bank Group wide customer level data wherever possible or relevant. Whilst the high risk populations applied for IFRS 9 impairment purposes are aligned with risk management processes, they are also regularly reviewed and validated to ensure that they capture any incremental segments where there is evidence of credit deterioration. Backstop criteria Accounts that are 30 calendar days or more past due. The 30 days past due criteria is a backstop rather than a primary driver of moving exposures into Stage 2. Exposures will move back to Stage 1 once they no longer meet the criteria for a significant increase in credit risk and when any cure criteria used for credit risk management are met. This is subject to all payments being up to date and the customer evidencing ability and willingness to maintain future payments. Barclays Bank Group does not rely on the low credit risk exemption which would assume facilities of investment grade are not significantly deteriorated. Determining the PD at initial recognition requires management estimates. Management overlays and other exceptions to model outputs are applied only if consistent with the objective of identifying significant increases in credit risk. Forward-looking information Credit losses are the expected cash shortfalls from what is contractually due over the expected life of the financial instrument, discounted at the original effective interest rate (EIR). ECLs are the unbiased probability-weighted credit losses determined by evaluating a range of possible outcomes and considering future economic conditions. When there is a non-linear relationship between forward-looking economic scenarios and their associated credit losses, five forward-looking economic scenarios are considered to ensure a sufficient unbiased representative sample of the complete distribution is included in determining the expected loss. Stress testing methodologies are leveraged within forecasting economic scenarios. The measurement of ECL involves increased complexity and judgement, including estimation of PDs, LGD, a range of unbiased future economic scenarios, estimation of expected lives, and estimation of EAD and assessing significant increases in credit risk. Impairment charges will tend to be more volatile and will be recognised earlier. Unsecured products with longer expected lives, such as revolving credit cards, are the most impacted. Barclays Group utilises an external consensus forecast as the baseline scenario. In addition, two adverse and two favourable scenarios are derived, with associated probability weightings. The adverse scenarios are calibrated to a similar severity to internal stress tests, whilst also incorporating IFRS 9 specific sensitivities and non-linearity. The most adverse scenarios are benchmarked to the Bank of England’s annual cyclical scenarios and to the most severe scenarios from Moody’s inventory, but are not designed to be the same. The favourable scenarios are calibrated to be symmetric to the adverse scenarios, subject to a ceiling calibrated to relevant recent favourable benchmark scenarios. The scenarios include six core variables, (GDP, unemployment and House Price Index in both the UK and US markets), and expanded variables using statistical models based on historical correlations. The probability weights of the scenarios are estimated such that the baseline (reflecting current consensus outlook) has the highest weight and the weights of adverse and favourable scenarios depend on the deviation from the baseline; the further from the baseline, the smaller the weight. A single set of five scenarios is used across all portfolios and all five weights are normalised to equate to 100%. The impacts across the portfolios are different because of the sensitivities of each of the portfolios to specific macro-economic variables, for example, mortgages are highly sensitive to house prices and base rates, and credit cards and unsecured consumer loans are highly sensitive to unemployment. Definition of default, credit impaired assets, write-offs, and interest income recognition The definition of default for the purpose of determining ECLs has been aligned to the Regulatory Capital CRR Article 178 definition of default, which considers indicators that the debtor is unlikely to pay, includes exposures in forbearance and is no later than when the exposure is more than 90 days past due or 180 days past due in the case of UK mortgages. When exposures are identified as credit impaired or purchased or originated as such interest income is calculated on the carrying value net of the impairment allowance. Credit impaired is when the exposure has defaulted which is also anticipated to align to when an exposure is identified as individually impaired. Uncollectible loans are written off against the related allowance for loan impairment on completion of Barclays Bank Group’s internal processes and when all reasonably expected recoverable amounts have been collected. Subsequent recoveries of amounts previously written off are credited to the income statement. Loan modifications and renegotiations that are not credit-impaired When modification of a loan agreement occurs as a result of commercial restructuring activity rather than due to credit risk of the borrower, an assessment must be performed to determine whether the terms of the new agreement are substantially different from the terms of the existing agreement. This assessment considers both the change in cash flows arising from the modified terms as well as the change in overall instrument risk profile. Where terms are substantially different, the existing loan will be derecognised and new loan recognised at fair value, with any difference in valuation recognised immediately within the income statement, subject to observability criteria. Where terms are not substantially different, the loan carrying value will be adjusted to reflect the present value of modified cash flows discounted at the original EIR, with any resulting gain or loss recognised immediately within the income statement as a modification gain or loss. Expected life Lifetime ECLs must be measured over the expected life. This is restricted to the maximum contractual life and takes into account expected prepayment, extension, call and similar options. The exceptions are certain revolver financial instruments, such as credit cards and bank overdrafts, that include both a drawn and an undrawn component where the entity’s contractual ability to demand repayment and cancel the undrawn commitment does not limit the entity’s exposure to credit losses to the contractual notice period. The expected life for these revolver facilities is expected to be behavioural life. Where data is insufficient or analysis inconclusive, an additional ‘maturity factor’ may be incorporated to reflect the full estimated life of the exposures, based upon experienced judgement and/or peer analysis. Potential future modifications of contracts are not taken into account when determining the expected life or EAD until they occur. Discounting ECLs are discounted at the EIR at initial recognition or an approximation thereof and consistent with income recognition. For loan commitments the EIR is the rate that is expected to apply when the loan is drawn down and a financial asset is recognised. Issued financial guarantee contracts are discounted at the risk free rate. Lease receivables are discounted at the rate implicit in the lease. For variable/floating rate financial assets, the spot rate at the reporting date is used and projections of changes in the variable rate over the expected life are not made to estimate future interest cash flows or for discounting. Modelling techniques ECLs are calculated by multiplying three main components, being the PD, LGD and the EAD, discounted at the original EIR. The regulatory Basel Committee of Banking Supervisors (BCBS) ECL calculations are leveraged for IFRS 9 modelling but adjusted for key differences which include: BCBS requires 12 month through the economic cycle losses whereas IFRS 9 requires 12 months or lifetime point in time losses based on conditions at the reporting date and multiple forecasts of the future economic conditions over the expected lives IFRS 9 models do not include certain conservative BCBS model floors and downturn assessments and require discounting to the reporting date at the original EIR rather than using the cost of capital to the date of default Management adjustments are made to modelled output to account for situations where known or expected risk factors and information have not been considered in the modelling process, for example forecast economic scenarios for uncertain political events; and ECL is measured at the individual financial instrument level, however a collective approach where financial instruments with similar risk characteristics are grouped together, with apportionment to individual financial instruments, is used where effects can only be seen at a collective level, for example for forward-looking information For the IFRS 9 impairment assessment, Barclays Bank Group’s risk models are used to determine the PD, LGD and EAD. For Stage 2 and 3, Barclays Bank Group applies lifetime PDs but uses 12 month PDs for Stage 1. The ECL drivers of PD, EAD and LGD are modelled at an account level which considers vintage, among other credit factors. Also, the assessment of significant increase in credit risk is based on the initial lifetime PD curve, which accounts for the different credit risk underwritten over time. Forbearance A financial asset is subject to forbearance when it is modified due to the credit distress of the borrower. A modification made to the terms of an asset due to forbearance will typically be assessed as a non-substantial modification that does not result in derecognition of the original loan, except in circumstances where debt is exchanged for equity. Both performing and non-performing forbearance assets are classified as Stage 3 except where it is established that the concession granted has not resulted in diminished financial obligation and that no other regulatory definitions of default criteria has been triggered, in which case the asset is classified as Stage 2. The minimum probationary period for non-performing forbearance is 12 months and for performing forbearance, 24 months. Hence, a minimum of 36 months is required for non-performing forbearance to move out of a forborne state. No financial instrument in forbearance can transfer back to Stage 1 until all of the Stage 2 thresholds are no longer met and can only move out of Stage 3 when no longer credit impaired. |
IFRS 15 Revenue from contracts with customers | IFRS 15 Revenue from Contracts with Customers IFRS 15 Revenue from Contracts with Customers, which replaced IAS 18 Revenue and IAS 11 Construction Contracts, was applied effective from 1 January 2018. It applies to all contracts with customers except leases, financial instruments and insurance contracts. The standard establishes a more systematic approach for revenue measurement and recognition by introducing a five-step model governing revenue recognition. The five-step model requires Barclays Bank Group to (i) identify the contract with the customer, (ii) identify each of the performance obligations included in the contract, (iii) determine the amount of consideration in the contract, (iv) allocate the consideration to each of the identified performance obligations and (v) recognise revenue as each performance obligation is satisfied. There are no significant impacts from the adoption of IFRS 15 in relation to the timing of when Barclays Bank Group recognises revenues or when revenue should be recognised gross as a principal or net as an agent. Therefore, Barclays Bank Group will continue to recognise fee and commission income charged for services provided by Barclays Bank Group as the services are provided (for example on completion of the underlying transaction). Revenue recognition for trading income and net investment income are recognised based on requirements of IFRS 9. |
Disposal of business and transfer of ownership of subsidiary (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal of business and transfer of ownership of subsidiary | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The impact on the individual balance sheet line item as a result of the transfer of the ownership of subsidiary |
|
Discontinued operations and held for sale assets (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of subsidiaries [line items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disposal groups Income statement |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Statement of other comprehensive income from discontinued operations |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash flows from discontinued operations |
|
Segmental reporting (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of operating segments [abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analysis of results by business |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Income by geographic region (audited) |
|
Fee and commission income (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fee and commission income (expense) [abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total fees in scope of IFRS 15 Revenues from Contracts with Customers |
|
Tax (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||
Major components of tax expense (income) [abstract] | |||||||||||||||||||||||||||||||||||||||||||
Current and deferred tax assets and liabilities |
|
Non-controlling interests (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||
Non-controlling interests [abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||
Detailed information of non controlling interest by group |
|
Dividends on ordinary shares (Tables) |
6 Months Ended | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||
Dividends on ordinary shares [abstract] | |||||||||||||||||||||||
Dividends on ordinary shares |
|
Fair value of financial instruments (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of products and services [line items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and liabilities held at fair value |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Analysis of movements in Level 3 assets and liabilities |
Derivative financial instruments are presented on a net basis. On a gross basis, derivative financial assets were £7,872m and derivative financial liabilities were £6,874m. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sensitivity analysis of valuations using unobservable inputs |
Other includes commercial real estate loans, fund and fund-linked products, asset backed loans, physical commodities and investment property. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value adjustments |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
By Product type [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disclosure of products and services [line items] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assets and liabilities held at fair value |
|
Subordinated Liabilities (Tables) |
6 Months Ended | |||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||
Subordinated liabilities [abstract] | ||||||||||||||||||||||||||||
Subordinated liabilities |
Includes the transfer of subordinated liabilities of £3,019m on 1 April 2018 as part of the disposal of the UK banking business. |
Provisions (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||
Provisions [abstract] | |||||||||||||||||||||||||||||||||||||
Provisions |
The balance as at 30 June 2018 includes IFRS 9 expected credit losses on committed facilities and guarantees |
Called up share capital (Tables) |
6 Months Ended | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||
Equity [abstract] | ||||||||||||||||||||||||||
Called up share capital |
|
Other reserves (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||
Other reserves [abstract] | |||||||||||||||||||||||||||||||
Other reserves |
|
Contingent liabilities and commitments (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||
Contingent liabilities and commitments [abstract] | ||||||||||||||||||||||||||||||||||
Contingent liabilities and commitments |
|
Related party transactions (Tables) |
6 Months Ended | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||
Related party transactions [abstract] | |||||||||||||||||||||||||
Parent and Fellow subsidiaries |
|
Transition disclosures (Tables) |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Transition disclosures | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reconciliation from IAS 39 to IFRS 9 - financial assets under IFRS 9 subject to an increase in impairment allowance |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Movement in loans and advances at amortsed cost |
Other financial assets on balance sheet subject to impairment not included in the table above include cash collateral and settlement balances and financial assets at fair value through other comprehensive income. These have a total gross exposure of £143.7bn and impairment allowance of £7m. In addition, there are off-balance sheet loan commitments and financial guarantee contracts with a gross exposure of £263.7bn and provision of £202m. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Balance sheet movement - impact of transition to IFRS 9 and IFRS 15 |
For further details, refer to Note 1, Basis of preparation on pages 17 to 22. |
Barclays Bank PLC parent condensed balance sheet (Tables) |
6 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Barclays Bank PLC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consolidated and separate financial statements [line items] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Barclays Bank PLC condensed balance sheet |
|
Disposal of business and transfer of ownership of subsidiary - The transfer of the ownership of BBUKPLC to Barclays PLC (Details) - GBP (£) £ in Millions |
6 Months Ended | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 01, 2018 |
Jan. 01, 2018 |
Jun. 30, 2018 |
||||||||||||||
Assets [abstract] | ||||||||||||||||
Cash and balances at central banks | [1] | £ 171,036 | £ 171,036 | |||||||||||||
Cash collateral and settlement balances | [1] | 77,172 | 77,172 | |||||||||||||
Loans and advances at amortised cost | [1] | 324,590 | 324,590 | |||||||||||||
Reverse repurchase agreements | [1] | 12,546 | 12,546 | |||||||||||||
Trading portfolio assets | [1] | 113,755 | 113,755 | |||||||||||||
Derivative financial assets | [1] | 237,987 | 237,987 | |||||||||||||
Financial assets at fair value through other comprehensive income | [1] | 0 | 0 | |||||||||||||
Beginning balance, Property, plant and equipment | [1] | 1,519 | 1,519 | |||||||||||||
Investments in associates and joint ventures | [1] | 718 | 718 | |||||||||||||
Intangible assets and goodwill | [1] | 4,885 | 4,885 | |||||||||||||
Current tax assets | [1],[2] | 376 | 376 | |||||||||||||
Deferred tax assets | [1],[2] | 3,352 | 3,352 | |||||||||||||
Retirement benefit assets | [1],[2] | 966 | 966 | |||||||||||||
Other assets | [1] | 4,003 | 4,003 | |||||||||||||
Assets included in disposal groups held for sale | [1],[2] | 1,193 | 1,193 | |||||||||||||
Beginning balance, assets | [1] | 1,129,343 | 1,129,343 | |||||||||||||
Liabilities [abstract] | ||||||||||||||||
Deposits at amortised cost | [1] | 399,189 | 399,189 | |||||||||||||
Cash collateral and settlement balance liabilities | [1] | 68,143 | 68,143 | |||||||||||||
Repurchase agreements and other similar secured borrowing | [1] | 40,338 | 40,338 | |||||||||||||
Debt securities in issue | [1] | 69,386 | 69,386 | |||||||||||||
Subordinated liabilities | [1],[2] | 24,193 | 24,193 | |||||||||||||
Trading portfolio liabilities | [1] | 37,352 | 37,352 | |||||||||||||
Financial liabilities designated at fair value | 449,415 | 449,415 | ||||||||||||||
Derivative financial instruments | [1] | 238,345 | 238,345 | |||||||||||||
Current tax liabilities | [1],[2] | 494 | 494 | |||||||||||||
Deferred tax liabilities | [1],[2] | 0 | 0 | |||||||||||||
Retirement benefit liabilities | [1],[2] | 287 | 287 | |||||||||||||
Other liabilities | [1] | 8,862 | 8,862 | |||||||||||||
Provisions, Beginning balance | [1],[2] | 3,302 | 3,302 | |||||||||||||
Liabilities included in disposal groups held for sale | [1],[2] | 0 | 0 | |||||||||||||
Beginning balance, liabilities | [1] | 1,063,609 | 1,063,609 | |||||||||||||
Assets ending balance [abstract] | ||||||||||||||||
Cash and balances at central banks | 171,036 | [3] | 121,800 | [4] | ||||||||||||
Cash collateral and settlement balances | 74,769 | [3] | 91,549 | [4] | ||||||||||||
Loans and advances at amortised cost | 317,744 | [3] | 134,820 | [4] | ||||||||||||
Reverse repurchase agreements | 597 | [3] | 533 | [4] | ||||||||||||
Trading portfolio assets | 114,168 | [3] | 116,554 | [4] | ||||||||||||
Other financial assets at fair value through the income statement | 140,211 | [3] | 142,443 | |||||||||||||
Derivative financial assets | 237,987 | [3] | 229,002 | [4] | ||||||||||||
Financial assets at fair value through other comprehensive income | 53,288 | [3] | 53,302 | [4] | ||||||||||||
Ending balance, Property, plant and equipment | 1,519 | [3] | 951 | [4] | ||||||||||||
Investments in associates and joint ventures | 699 | [3] | 713 | [4] | ||||||||||||
Intangible assets and goodwill | 4,885 | [3] | 1,330 | [4] | ||||||||||||
Current tax assets | 376 | [3] | 1,272 | [2],[4] | ||||||||||||
Deferred tax assets | 3,979 | [3] | 3,247 | [2],[4] | ||||||||||||
Retirement benefit assets | 966 | [3] | 1,124 | [2],[4] | ||||||||||||
Other assets | 4,119 | [3] | 2,944 | [4] | ||||||||||||
Assets included in disposal groups held for sale | 1,193 | [3] | 1,761 | [2],[4] | ||||||||||||
Ending balance, assets | 1,127,536 | [3] | 903,345 | [4] | ||||||||||||
Liabilities ending balance [abstract] | ||||||||||||||||
Deposits at amortised cost | 380,329 | [3] | 193,990 | [4] | ||||||||||||
Cash collateral and settlement balance liabilities | 65,925 | [3] | 85,448 | [4] | ||||||||||||
Repurchase agreements and other similar secured borrowing | 15,053 | [3] | 8,645 | [4] | ||||||||||||
Debt securities in issue | 69,386 | [3] | 57,905 | [4] | ||||||||||||
Subordinated liabilities | 24,193 | [3] | 17,190 | [2],[4] | ||||||||||||
Trading portfolio liabilities | 37,352 | [3] | 45,965 | [4] | ||||||||||||
Financial liabilities designated at fair value | 220,083 | [3] | 483,447 | |||||||||||||
Derivative financial instruments | 238,345 | [3] | 225,089 | [4] | ||||||||||||
Current tax liabilities | 494 | [3] | 667 | [2],[4] | ||||||||||||
Deferred tax liabilities | [2],[4] | 0 | ||||||||||||||
Retirement benefit liabilities | 287 | [3] | 265 | [2],[4] | ||||||||||||
Other liabilities | 8,862 | [3] | 4,601 | [4] | ||||||||||||
Provisions, Ending balance | 3,643 | [3] | 1,233 | [2],[4] | ||||||||||||
Liabilities included in disposal groups held for sale | 0 | [3] | 1,762 | [2],[4] | ||||||||||||
Ending balance, liabilities | £ 1,063,952 | [3] | 855,153 | [4] | ||||||||||||
Other movements for the period [member] | ||||||||||||||||
Movement in assets [abstract] | ||||||||||||||||
Increase (decrease) in cash and balances at central bank | (11,905) | |||||||||||||||
Increase (decrease) in cash collateral and settlement balances | 19,097 | |||||||||||||||
Increase (decrease) in loans and advances at amortised cost | 1,731 | |||||||||||||||
Increase (decrease) in reverse repurchase agreements and other similar secured lending | 351 | |||||||||||||||
Increase (decrease) in trading portfolio assets | 2,386 | |||||||||||||||
Increase (decrease) in other financial assets at fair value through the income statement | 7,848 | |||||||||||||||
Increase (decrease) in derivative financial assets | (8,877) | |||||||||||||||
Increase (decrease) in financial assets at fair value through other comprehensive income statement | 5,558 | |||||||||||||||
Increase (decrease) in property, plant and equipment | (58) | |||||||||||||||
Increase (decrease) in investments in associates and joint ventures | 14 | |||||||||||||||
Increase (decrease) in intangible assets and goodwill | (18) | |||||||||||||||
Increase (decrease) in current tax assets | 896 | |||||||||||||||
Increase (decrease) in deferred tax assets | 15 | |||||||||||||||
Increase (decrease) retirement benefit assets | 158 | |||||||||||||||
Increase (decrease) in other assets | 207 | |||||||||||||||
Increase (decrease) in assets included in disposal groups classified as held for sale | 568 | |||||||||||||||
Total increase (decrease) in assets | 17,971 | |||||||||||||||
Movement in liabilities [abstract] | ||||||||||||||||
Increase (decrease) in deposits at amortised cost | 4,133 | |||||||||||||||
Increase (decrease) in cash collateral and settlement balance liabilities | 19,523 | |||||||||||||||
Increase (decrease) in repurchase agreements and other similar secured borrowing | 5,159 | |||||||||||||||
Increase (decrease) in debt securities | 822 | |||||||||||||||
Increase (decrease) in subordinated liabilities | (3,984) | |||||||||||||||
Increase (decrease) in financial liabilities at fair value through profit or loss that meet definition of held for trading | 10,378 | |||||||||||||||
Increase (decrease) in financial liabilities, at fair value | (7,690) | |||||||||||||||
Increase (decrease) in derivative financial liabilities | (13,250) | |||||||||||||||
Increase (decrease) in current tax liabilities | 850 | |||||||||||||||
Increase (decrease) in retirement benefit liabilities | (22) | |||||||||||||||
Increase (decrease) in other liabilities | (2,743) | |||||||||||||||
Increase (decrease) in provisions | (121) | |||||||||||||||
Increase (decrease) in liabilities included in disposal groups held for sale | 1,762 | |||||||||||||||
Increase (decrease) in liabilities | 14,817 | |||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | ||||||||||||||||
Movement in assets [abstract] | ||||||||||||||||
Increase (decrease) in cash and balances at central bank | [5] | (37,331) | ||||||||||||||
Increase (decrease) in cash collateral and settlement balances | [5] | (2,317) | ||||||||||||||
Increase (decrease) in loans and advances at amortised cost | £ (184,655) | (184,655) | [5] | |||||||||||||
Increase (decrease) in reverse repurchase agreements and other similar secured lending | [5] | (415) | ||||||||||||||
Increase (decrease) in trading portfolio assets | [5] | 0 | ||||||||||||||
Increase (decrease) in other financial assets at fair value through the income statement | [5] | (5,616) | ||||||||||||||
Increase (decrease) in derivative financial assets | [5] | (108) | ||||||||||||||
Increase (decrease) in financial assets at fair value through other comprehensive income statement | [5] | (5,544) | ||||||||||||||
Increase (decrease) in property, plant and equipment | (510) | (510) | [5] | |||||||||||||
Increase (decrease) in investments in associates and joint ventures | [5] | 0 | ||||||||||||||
Increase (decrease) in intangible assets and goodwill | [5] | (3,537) | ||||||||||||||
Increase (decrease) in current tax assets | [5] | 0 | ||||||||||||||
Increase (decrease) in deferred tax assets | £ (747) | (747) | [5] | |||||||||||||
Increase (decrease) retirement benefit assets | [5] | 0 | ||||||||||||||
Increase (decrease) in other assets | [5] | (1,382) | ||||||||||||||
Increase (decrease) in assets included in disposal groups classified as held for sale | [5] | 0 | ||||||||||||||
Total increase (decrease) in assets | [5] | (242,162) | ||||||||||||||
Movement in liabilities [abstract] | ||||||||||||||||
Increase (decrease) in deposits at amortised cost | [5] | (190,472) | ||||||||||||||
Increase (decrease) in cash collateral and settlement balance liabilities | [5] | 0 | ||||||||||||||
Increase (decrease) in repurchase agreements and other similar secured borrowing | [5] | (11,567) | ||||||||||||||
Increase (decrease) in debt securities | [5] | (12,303) | ||||||||||||||
Increase (decrease) in subordinated liabilities | [5] | (3,019) | ||||||||||||||
Increase (decrease) in financial liabilities at fair value through profit or loss that meet definition of held for trading | [5] | (1,765) | ||||||||||||||
Increase (decrease) in financial liabilities, at fair value | [5] | 0 | ||||||||||||||
Increase (decrease) in derivative financial liabilities | [5] | (6) | ||||||||||||||
Increase (decrease) in current tax liabilities | [5] | (677) | ||||||||||||||
Increase (decrease) in retirement benefit liabilities | [5] | 0 | ||||||||||||||
Increase (decrease) in other liabilities | [5] | (1,518) | ||||||||||||||
Increase (decrease) in provisions | [5] | (2,289) | ||||||||||||||
Increase (decrease) in liabilities included in disposal groups held for sale | [5] | 0 | ||||||||||||||
Increase (decrease) in liabilities | [5] | £ (223,616) | ||||||||||||||
|
Disposal of business and transfer of ownership of subsidiary (Narrative) (Details) £ in Millions |
6 Months Ended | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 01, 2018
GBP (£)
shares
|
Jun. 30, 2018
GBP (£)
|
Dec. 31, 2017
GBP (£)
|
Jun. 30, 2017
GBP (£)
|
Mar. 31, 2018
GBP (£)
|
Jan. 01, 2018
GBP (£)
|
[3] | ||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Investments accounted for using equity method | £ 713 | [1] | £ 718 | [2] | £ 699 | |||||||||||||||
Increase in investment of subsidiary | [4] | (2,290) | (19) | £ (3,802) | ||||||||||||||||
Financial assets, at fair value | 541,312 | 522,023 | ||||||||||||||||||
Financial liabilities, at fair value | 483,447 | 449,415 | £ 220,083 | |||||||||||||||||
Other equity instruments [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase in investment of subsidiary | [4] | (2,070) | 0 | 0 | ||||||||||||||||
Other reserves [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase in investment of subsidiary | [4] | 16 | 0 | 0 | ||||||||||||||||
Retained earnings [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase in investment of subsidiary | (236) | £ 0 | £ (359) | |||||||||||||||||
Ordinary shares [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in equity | 0 | |||||||||||||||||||
UK Banking Businesses [member] | Elimination of intersegment amounts [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Assets (liabilities), net | £ (2,231) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Net asset (liability) in business disposed | 16,000 | |||||||||||||||||||
Assets (liabilities), net | 16,300 | £ 300 | ||||||||||||||||||
Increase in investment of subsidiary | (18,546) | |||||||||||||||||||
Increase (decrease) in loans and advances at amortised cost | (184,655) | (184,655) | [5] | |||||||||||||||||
Increase (decrease) in other financial assets at fair value through the income statement | [5] | (5,616) | ||||||||||||||||||
Increase (decrease) in property, plant and equipment | (510) | (510) | [5] | |||||||||||||||||
Increase (decrease) in intangible assets and goodwill | [5] | (3,537) | ||||||||||||||||||
Increase (decrease) in deferred tax assets | (747) | (747) | [5] | |||||||||||||||||
Increase (decrease) in deferred tax liabilities | (677) | |||||||||||||||||||
Increase (decrease) in other assets | [5] | (1,382) | ||||||||||||||||||
Increase (decrease) in deposits at amortised cost | [5] | (190,472) | ||||||||||||||||||
Increase (decrease) in debt securities | [5] | (12,303) | ||||||||||||||||||
Increase (decrease) in other liabilities | [5] | £ (1,518) | ||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Loans and advances [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other financial assets at fair value through the income statement | (4,233) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Covered bonds [Member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in debt securities | (8,302) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Other debt securities [Member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in debt securities | (4,001) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Accruals and deferred income [Member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other liabilities | (278) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Sundry creditors [Member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other liabilities | (1,160) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Other equity instruments [member] | AT1 Securities [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in equity | (2,070) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Reserve of gains and losses on financial assets measured at fair value through other comprehensive income [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in equity | 16 | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Retained earnings [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in equity | (14,261) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Goodwill [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other financial assets at fair value through the income statement | (3,526) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Licences and other [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in intangible assets and goodwill | (11) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Cost [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in property, plant and equipment | (971) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Cost [member] | Licences and other [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in intangible assets and goodwill | (90) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Accumulated depreciation, amortisation and impairment [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in property, plant and equipment | (461) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | Accumulated depreciation, amortisation and impairment [member] | Licences and other [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in intangible assets and goodwill | (79) | |||||||||||||||||||
UK Banking Businesses [member] | BBUKPLC [member] | At fair value [member] | Derivative financial liabilities [Member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Financial liabilities, at fair value | 6 | |||||||||||||||||||
UK Banking Businesses [member] | Reverse repurchase agreements and other similar secured lending [Member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other financial assets at fair value through the income statement | (1,383) | |||||||||||||||||||
UK Banking Businesses [member] | Prepayments [Member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other assets | (106) | |||||||||||||||||||
Increase (decrease) in deposits at amortised cost | (190,472) | |||||||||||||||||||
UK Banking Businesses [member] | Items in the course of collection from other banks [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other assets | (588) | |||||||||||||||||||
UK Banking Businesses [member] | Sundry receivables [Member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other assets | (535) | |||||||||||||||||||
UK Banking Businesses [member] | Accrued income [Member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in other assets | (146) | |||||||||||||||||||
UK Banking Businesses [member] | Home loans [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in loans and advances at amortised cost | (133,641) | |||||||||||||||||||
UK Banking Businesses [member] | Credit cards, unsecured and other retail lending [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in loans and advances at amortised cost | (22,621) | |||||||||||||||||||
UK Banking Businesses [member] | Corporate loans [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Increase (decrease) in loans and advances at amortised cost | (27,396) | |||||||||||||||||||
UK Banking Businesses [member] | Derivatives [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Notional amount | 3,313 | |||||||||||||||||||
UK Banking Businesses [member] | Derivative financial assets [Member] | BBUKPLC [member] | At fair value [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Financial assets, at fair value | 108 | |||||||||||||||||||
UK Banking Businesses [member] | in exchange for ordinary share [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Net asset (liability) in business disposed | £ 12,900 | |||||||||||||||||||
UK Banking Businesses [member] | Ordinary shares [member] | BBUKPLC [member] | ||||||||||||||||||||
Disclosure of operating segments [line items] | ||||||||||||||||||||
Number of shares issued as consideration | shares | 1 | |||||||||||||||||||
|
Discontinued operations and held for sale assets - Income statement (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
||||||||||||
Profit (loss) [abstract] | |||||||||||||
Net interest income | £ 1,501 | £ 2,097 | |||||||||||
Net fees and commissions | [1] | 2,862 | 3,021 | ||||||||||
Net trading income | 2,319 | 1,685 | |||||||||||
Net investment income | 494 | 468 | |||||||||||
Other income | 77 | 30 | |||||||||||
Credit impairment releases/(charges) and other provisions | (156) | (656) | |||||||||||
Net operating income | 7,097 | 6,645 | |||||||||||
Staff costs | (2,438) | (2,205) | |||||||||||
Administration and general expenses | (3,946) | (2,954) | |||||||||||
Operating expenses | (6,384) | (5,159) | |||||||||||
Share of post-tax results of associates and joint ventures | 12 | 245 | |||||||||||
(Loss)/profit before tax | 725 | 1,731 | |||||||||||
Tax charge | [1] | (378) | (430) | ||||||||||
(Loss)/profit after tax | [1] | 300 | (729) | ||||||||||
Profit (loss), attributable to [abstract] | |||||||||||||
Equity holders of the parent | 301 | (871) | |||||||||||
Non-controlling interests | (1) | 142 | |||||||||||
(Loss)/profit after tax | [1] | 300 | (729) | ||||||||||
Discontinued operations [member] | |||||||||||||
Profit (loss) [abstract] | |||||||||||||
Net interest income | 1,449 | [2] | 3,862 | [3] | |||||||||
Net fees and commissions | 296 | [2] | 1,107 | [3] | |||||||||
Net trading income | (5) | [2] | 133 | [3] | |||||||||
Net investment income | 6 | [2] | 89 | [3] | |||||||||
Other income | 2 | [2] | 68 | [3] | |||||||||
Total income | 1,748 | [2] | 5,259 | [3] | |||||||||
Credit impairment releases/(charges) and other provisions | (201) | [2] | (575) | [3] | |||||||||
Net operating income | 1,547 | [2] | 4,684 | [3] | |||||||||
Staff costs | (321) | [2] | (1,737) | [3] | |||||||||
Administration and general expenses | (1,135) | [2] | (3,093) | [3] | |||||||||
Operating expenses | (1,456) | [2] | (4,830) | [3] | |||||||||
Share of post-tax results of associates and joint ventures | 0 | [2] | 4 | [3] | |||||||||
(Loss)/profit before tax | 91 | [2] | (142) | [3] | |||||||||
Tax charge | (138) | [2] | (453) | [3] | |||||||||
(Loss)/profit after tax | [4] | (47) | [2] | (595) | [3] | ||||||||
Profit (loss), attributable to [abstract] | |||||||||||||
Equity holders of the parent | (47) | [2] | (735) | [3] | |||||||||
Non-controlling interests | 0 | [2] | 140 | [3] | |||||||||
(Loss)/profit after tax | [4] | £ (47) | [2] | £ (595) | [3] | ||||||||
|
Discontinued operations and held for sale assets - Income statement (Narrative) (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
||||||||||||
Disclosure of subsidiaries [line items] | |||||||||||||
Profit (loss) from discontinued operations | £ (47) | £ (2,030) | |||||||||||
Profit (loss) | [1] | 300 | (729) | ||||||||||
Discontinued operations [member] | |||||||||||||
Disclosure of subsidiaries [line items] | |||||||||||||
Profit (loss) | [3] | £ (47) | [2] | (595) | [4] | ||||||||
Barclay's Africa Banking Group Limited (BAGL) [member] | |||||||||||||
Disclosure of subsidiaries [line items] | |||||||||||||
Profit (loss) from discontinued operations | (760) | ||||||||||||
Gain (loss) on Disposal of discontinued operation | (60) | ||||||||||||
Other comprehensive income that may be recycled to profit or loss | (1,375) | ||||||||||||
UK Banking Businesses [member] | |||||||||||||
Disclosure of subsidiaries [line items] | |||||||||||||
Profit (loss) from discontinued operations | £ 165 | ||||||||||||
|
Discontinued operations and held for sale assets - Comprehensive Income (Details) - Discontinued operations [member] - GBP (£) £ in Millions |
6 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
||||||||||
Statement of comprehensive income [abstract] | |||||||||||
Available for sale assets | [1] | £ 0 | [2] | £ (3) | [3] | ||||||
Currency translation reserves | 0 | [2] | (38) | [3] | |||||||
Cash flow hedge reserves | [1] | 0 | [2] | 19 | [3] | ||||||
Other comprehensive income, discountinued operations | £ (3) | £ (22) | |||||||||
|
Discontinued operations and held for sale assets - Cash flow (Details) - GBP (£) £ in Millions |
6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|||||||
Cash flows from continuing and discontinued operations [abstract] | ||||||||
Net increase in cash and cash equivalents | £ (51,488) | £ 36,294 | ||||||
Discontinued operations [member] | ||||||||
Cash flows from continuing and discontinued operations [abstract] | ||||||||
Net cash from operating activities | (402) | [1] | 2,098 | [2] | ||||
Net cash from investing activities | 54 | [1] | (414) | [2] | ||||
Net cash from financing activities | (120) | [1] | (373) | [2] | ||||
Effect of exchange rates on cash and cash equivalents | 0 | [1] | (29) | [2] | ||||
Net increase in cash and cash equivalents | £ (468) | [1] | £ 1,282 | [2] | ||||
|
Discontinued operations and held for sale assets (Narrative) (Details) - Held for sale [member] - GBP (£) |
Jun. 30, 2018 |
Dec. 31, 2017 |
---|---|---|
Disclosure of subsidiaries [line items] | ||
Assets included in disposal groups classified as held for sale | £ 1,761,000,000 | £ 1,193,000,000 |
Loans and advances at amortised cost | 1,658,000,000 | 1,164,000,000 |
Liabilities included in disposal groups classified as held for sale | 1,762,000,000 | 0 |
Deposits at amortised cost | £ 1,660,000,000 | £ 0 |
Segmental reporting - Analysis of results by business (Details) - GBP (£) £ in Millions |
6 Months Ended | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|||||||||
Disclosure of operating segments [line items] | ||||||||||
Total income | £ 7,253 | £ 7,301 | ||||||||
Credit impairment charges and other provisions | (156) | (656) | ||||||||
Net operating income | 7,097 | 6,645 | ||||||||
Operating expenses | (6,384) | (5,159) | ||||||||
Other net (expenses)/income | 12 | 245 | ||||||||
Profit before tax | 725 | 1,731 | ||||||||
Operating segments [member] | Corporate and investment bank [Member] | ||||||||||
Disclosure of operating segments [line items] | ||||||||||
Total income | 5,373 | 5,384 | [1] | |||||||
Credit impairment charges and other provisions | 182 | (50) | ||||||||
Net operating income | 5,555 | 5,334 | ||||||||
Operating expenses | (3,628) | (3,779) | ||||||||
Other net (expenses)/income | [2] | 8 | 115 | |||||||
Profit before tax | 1,935 | 1,670 | ||||||||
Operating segments [member] | Consumer, cards and payments [member] | ||||||||||
Disclosure of operating segments [line items] | ||||||||||
Total income | 2,137 | 2,398 | [1] | |||||||
Credit impairment charges and other provisions | (343) | (575) | ||||||||
Net operating income | 1,794 | 1,823 | ||||||||
Operating expenses | (1,134) | (1,000) | ||||||||
Other net (expenses)/income | [2] | 17 | 99 | |||||||
Profit before tax | 677 | 922 | ||||||||
Operating segments [member] | Barclays Non-core [member] | ||||||||||
Disclosure of operating segments [line items] | ||||||||||
Total income | [1],[3] | (527) | ||||||||
Credit impairment charges and other provisions | (30) | |||||||||
Net operating income | (557) | |||||||||
Operating expenses | (279) | |||||||||
Other net (expenses)/income | [2],[3] | 197 | ||||||||
Profit before tax | (639) | |||||||||
Head Office [member] | ||||||||||
Disclosure of operating segments [line items] | ||||||||||
Total income | (257) | 46 | ||||||||
Credit impairment charges and other provisions | 5 | (1) | ||||||||
Net operating income | (252) | 45 | ||||||||
Operating expenses | (1,622) | (101) | ||||||||
Other net (expenses)/income | (13) | (166) | ||||||||
Profit before tax | (1,887) | £ (222) | ||||||||
Certain legacy capital instrument funding costs | £ 176 | |||||||||
|
Segmental reporting - Income by geographic region (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
||||
Disclosure of operating segments [line items] | |||||
Total income | £ 7,253 | £ 7,301 | |||
UK [member] | |||||
Disclosure of operating segments [line items] | |||||
Total income | [1] | 2,118 | 2,120 | ||
Europe [member] | |||||
Disclosure of operating segments [line items] | |||||
Total income | [1] | 1,026 | 724 | ||
Americas [member] | |||||
Disclosure of operating segments [line items] | |||||
Total income | [1] | 3,735 | 4,053 | ||
Africa and middle east [member] | |||||
Disclosure of operating segments [line items] | |||||
Total income | [1] | 62 | 138 | ||
Asia [member] | |||||
Disclosure of operating segments [line items] | |||||
Total income | [1] | £ 312 | £ 266 | ||
|
Fee and commission income (Details) - GBP (£) £ in Millions |
6 Months Ended | |||
---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | £ 3,682 | |||
Other non-contract fee income | 55 | |||
Fee and commission income | 3,737 | |||
Fee and commission expenses | (875) | |||
Net fee and commission income | [1] | 2,862 | £ 3,021 | |
Transactional member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 1,257 | |||
Advisory [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 377 | |||
Brokerage and execution [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 583 | |||
Underwriting and syndication [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 1,368 | |||
Other [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 97 | |||
Corporate and investment bank [Member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 2,449 | |||
Other non-contract fee income | 55 | |||
Fee and commission income | 2,504 | |||
Fee and commission expenses | (337) | |||
Net fee and commission income | 2,167 | |||
Corporate and investment bank [Member] | Transactional member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 185 | |||
Corporate and investment bank [Member] | Advisory [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 340 | |||
Corporate and investment bank [Member] | Brokerage and execution [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 553 | |||
Corporate and investment bank [Member] | Underwriting and syndication [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 1,368 | |||
Corporate and investment bank [Member] | Other [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 3 | |||
Consumer, cards and payments [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 1,217 | |||
Other non-contract fee income | 0 | |||
Fee and commission income | 1,217 | |||
Fee and commission expenses | (538) | |||
Net fee and commission income | 679 | |||
Consumer, cards and payments [member] | Transactional member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 1,072 | |||
Consumer, cards and payments [member] | Advisory [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 37 | |||
Consumer, cards and payments [member] | Brokerage and execution [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 30 | |||
Consumer, cards and payments [member] | Underwriting and syndication [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 0 | |||
Consumer, cards and payments [member] | Other [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 78 | |||
Head Office [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 16 | |||
Other non-contract fee income | 0 | |||
Fee and commission income | 16 | |||
Fee and commission expenses | 0 | |||
Net fee and commission income | 16 | |||
Head Office [member] | Transactional member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 0 | |||
Head Office [member] | Advisory [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 0 | |||
Head Office [member] | Brokerage and execution [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 0 | |||
Head Office [member] | Underwriting and syndication [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | 0 | |||
Head Office [member] | Other [member] | ||||
Fee and commission income [abstract] | ||||
Revenue from contracts with customers | £ 16 | |||
|
Tax - Current and deferred tax assets and liabilities - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[3] | Dec. 31, 2017 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Major components of tax expense (income) [abstract] | ||||||||||||||
Current tax assets | £ 1,272 | [1],[2] | £ 376 | £ 376 | [2],[4] | |||||||||
Deferred tax assets | 3,247 | [1],[2] | 3,979 | 3,352 | [2],[4] | |||||||||
Total current and deferred tax assets | 4,519 | 3,728 | ||||||||||||
Current tax liabilities | (667) | [1],[2] | £ (494) | (494) | [2],[4] | |||||||||
Deferred tax liabilities | [2] | 0 | [1] | 0 | [4] | |||||||||
Total current and deferred tax liabilities | £ (667) | £ (494) | ||||||||||||
|
Tax (Narrative) (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jan. 01, 2018 |
[3] | Dec. 31, 2017 |
|||||||||||||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | |||||||||||||||||
Deferred tax assets | £ 3,247 | [1],[2] | £ 3,979 | £ 3,352 | [2],[4] | ||||||||||||
Tax charge | [5] | £ 378 | £ 430 | ||||||||||||||
Average effective tax rate | 52.10% | 24.80% | |||||||||||||||
Statutory tax rate | 19.00% | 19.25% | |||||||||||||||
United States [Member] | |||||||||||||||||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | |||||||||||||||||
Deferred tax assets | £ 2,663 | 2,647 | |||||||||||||||
United Kingdom [member] | |||||||||||||||||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | |||||||||||||||||
Deferred tax assets | 584 | 705 | |||||||||||||||
Unused tax losses [member] | |||||||||||||||||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | |||||||||||||||||
Deferred tax assets | 488 | 596 | |||||||||||||||
Temporary differences [member] | |||||||||||||||||
Disclosure of temporary difference, unused tax losses and unused tax credits [line items] | |||||||||||||||||
Deferred tax assets | £ 2,759 | £ 2,756 | |||||||||||||||
|
Non-controlling interests - by group (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Dec. 31, 2017 |
|||||||||
Profit (loss), attributable to non-controlling interests | £ (1) | £ 142 | |||||||||
Equity attributable to non-controlling interest | [2] | 2 | [1] | £ 1 | [3] | ||||||
Barclay's Africa Banking Group Limited [member] | |||||||||||
Profit (loss), attributable to non-controlling interests | 0 | 140 | |||||||||
Equity attributable to non-controlling interest | 0 | 0 | |||||||||
Other non-controlling interests [member] | |||||||||||
Profit (loss), attributable to non-controlling interests | (1) | £ 2 | |||||||||
Equity attributable to non-controlling interest | 2 | 1 | |||||||||
Other non-controlling interests [member] | Barclay's Africa Banking Group Limited [member] | |||||||||||
Equity attributable to non-controlling interest | £ 2 | £ 1 | |||||||||
|
Dividends on ordinary shares (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2018 |
Dec. 31, 2017 |
Jun. 30, 2017 |
|||
Total | [1] | £ 14,274 | £ 617 | £ 472 | |
Equity attributable to owners of parent [member] | |||||
Dividends paid, ordinary shares | 14,168 | 165 | |||
Dividends paid, preference shares | 106 | 134 | |||
Total | £ 14,274 | £ 617 | £ 299 | ||
|
Dividends on ordinary shares (Narrative) (Details) - Barclays PLC - GBP (£) £ in Millions |
6 Months Ended | ||
---|---|---|---|
Sep. 11, 2018 |
Aug. 01, 2018 |
Jun. 30, 2018 |
|
Aggregated measurement [member] | After reporting period [Member] | |||
Disclosure of transactions between related parties [line items] | |||
Dividend in specie | £ 269 | ||
Interim dividend | £ 149 | ||
Barclays UK [member] | |||
Disclosure of transactions between related parties [line items] | |||
Dividend in specie | £ 14,000 |
Fair value of financial instruments - Assets and liabilities held at fair value (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[2] | Dec. 31, 2017 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Trading portfolio assets | £ 116,554 | [1] | £ 114,168 | £ 113,755 | [3] | |||||||||
Financial assets at fair value through the income statement | 142,443 | [1] | 116,282 | [3] | ||||||||||
Derivative financial instruments | 229,002 | [1] | 237,987 | 237,987 | [3] | |||||||||
Financial assets at fair value through other comprehensive income | 53,302 | [1] | 53,288 | 0 | [3] | |||||||||
Assets included in disposal groups classified as held for sale | 1,761 | [1],[4] | 1,193 | 1,193 | [3],[4] | |||||||||
Total assets | 541,312 | 522,023 | ||||||||||||
Trading portfolio liabilities | (45,965) | [1] | (37,352) | (37,352) | [3] | |||||||||
Financial liabilities designated at fair value | (212,393) | [1] | (173,718) | [3] | ||||||||||
Derivative financial liabilities | (225,089) | [1] | (238,345) | (238,345) | [3] | |||||||||
Total liabilities | (483,447) | £ (220,083) | (449,415) | |||||||||||
At fair value [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Trading portfolio assets | 116,554 | 113,755 | ||||||||||||
Derivative financial instruments | 229,002 | 237,987 | ||||||||||||
Financial assets at fair value through other comprehensive income | 53,302 | 53,854 | ||||||||||||
Investment property | 11 | 116 | ||||||||||||
Assets included in disposal groups classified as held for sale | 29 | |||||||||||||
Trading portfolio liabilities | (45,965) | (37,352) | ||||||||||||
Financial liabilities designated at fair value | (212,393) | (173,718) | ||||||||||||
Derivative financial liabilities | (225,089) | (238,345) | ||||||||||||
Level 1 of fair value hierarchy [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Total assets | 89,027 | 94,899 | ||||||||||||
Total liabilities | (28,910) | (24,536) | ||||||||||||
Level 1 of fair value hierarchy [member] | At fair value [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Trading portfolio assets | 55,851 | 63,925 | ||||||||||||
Financial assets at fair value through the income statement | 5,497 | 4,347 | ||||||||||||
Derivative financial instruments | 4,374 | 3,786 | ||||||||||||
Financial assets at fair value through other comprehensive income | 23,305 | 22,841 | ||||||||||||
Investment property | 0 | 0 | ||||||||||||
Assets included in disposal groups classified as held for sale | 0 | |||||||||||||
Trading portfolio liabilities | (25,047) | (20,905) | ||||||||||||
Financial liabilities designated at fair value | 0 | 0 | ||||||||||||
Derivative financial liabilities | (3,863) | (3,631) | ||||||||||||
Level 2 of fair value hierarchy [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Total assets | 439,583 | 411,526 | ||||||||||||
Total liabilities | (448,907) | (419,198) | ||||||||||||
Level 2 of fair value hierarchy [member] | At fair value [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Trading portfolio assets | 56,862 | 47,853 | ||||||||||||
Financial assets at fair value through the income statement | 133,267 | 104,188 | ||||||||||||
Derivative financial instruments | 219,562 | 228,867 | ||||||||||||
Financial assets at fair value through other comprehensive income | 29,892 | 30,618 | ||||||||||||
Investment property | 0 | 0 | ||||||||||||
Assets included in disposal groups classified as held for sale | 0 | |||||||||||||
Trading portfolio liabilities | (20,918) | (16,443) | ||||||||||||
Financial liabilities designated at fair value | (212,056) | (173,238) | ||||||||||||
Derivative financial liabilities | (215,933) | (229,517) | ||||||||||||
Level 3 of fair value hierarchy [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Total assets | 12,702 | 15,598 | ||||||||||||
Total liabilities | (5,630) | (5,681) | ||||||||||||
Level 3 of fair value hierarchy [member] | At fair value [member] | ||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||
Trading portfolio assets | 3,841 | 1,977 | ||||||||||||
Financial assets at fair value through the income statement | 3,679 | 7,747 | ||||||||||||
Derivative financial instruments | 5,066 | 5,334 | ||||||||||||
Financial assets at fair value through other comprehensive income | 105 | 395 | ||||||||||||
Investment property | 11 | 116 | ||||||||||||
Assets included in disposal groups classified as held for sale | 29 | |||||||||||||
Trading portfolio liabilities | 0 | (4) | ||||||||||||
Financial liabilities designated at fair value | (337) | (480) | ||||||||||||
Derivative financial liabilities | £ (5,293) | £ (5,197) | ||||||||||||
|
Fair value of financial instruments - Assets and liabilities held at fair value by product type (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[1] | Dec. 31, 2017 |
|||||
---|---|---|---|---|---|---|---|---|---|
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | £ 541,312 | £ 522,023 | |||||||
Financial liabilities, at fair value | (483,447) | £ (220,083) | (449,415) | ||||||
Quoted market prices (Level 1) [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 89,027 | 94,899 | |||||||
Financial liabilities, at fair value | (28,910) | (24,536) | |||||||
Quoted market prices (Level 1) [member] | Issued debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Assets and liabilities classified as held for sale [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | ||||||||
Financial liabilities, at fair value | 0 | ||||||||
Quoted market prices (Level 1) [member] | Asset-backed securities [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Government and government sponsored debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 43,762 | 34,782 | |||||||
Financial liabilities, at fair value | (9,721) | (13,079) | |||||||
Quoted market prices (Level 1) [member] | Corporate debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Certificates of deposit, commercial paper and other money market instruments [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Reverse repurchase and repurchase agreements [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Non-asset-backed loans [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Equity cash products [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 40,882 | 56,323 | |||||||
Financial liabilities, at fair value | (15,326) | (7,826) | |||||||
Quoted market prices (Level 1) [member] | Private equity investments [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 9 | 8 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Other [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | [2] | 0 | 0 | ||||||
Financial liabilities, at fair value | [2] | 0 | 0 | ||||||
Quoted market prices (Level 1) [member] | Interest rate derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Foreign exchange derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Credit derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Quoted market prices (Level 1) [member] | Equity derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 4,374 | 3,786 | |||||||
Financial liabilities, at fair value | (3,863) | (3,631) | |||||||
Quoted market prices (Level 1) [member] | Commodity derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Observable inputs (Level 2) [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 439,583 | 411,526 | |||||||
Financial liabilities, at fair value | (448,907) | (419,198) | |||||||
Observable inputs (Level 2) [member] | Issued debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | (40,993) | (38,177) | |||||||
Observable inputs (Level 2) [member] | Assets and liabilities classified as held for sale [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | ||||||||
Financial liabilities, at fair value | 0 | ||||||||
Observable inputs (Level 2) [member] | Asset-backed securities [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 2,108 | 1,837 | |||||||
Financial liabilities, at fair value | (216) | (221) | |||||||
Observable inputs (Level 2) [member] | Government and government sponsored debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 54,729 | 49,853 | |||||||
Financial liabilities, at fair value | (15,792) | (13,116) | |||||||
Observable inputs (Level 2) [member] | Corporate debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 13,971 | 15,098 | |||||||
Financial liabilities, at fair value | (5,681) | (3,580) | |||||||
Observable inputs (Level 2) [member] | Certificates of deposit, commercial paper and other money market instruments [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 12,933 | 1,491 | |||||||
Financial liabilities, at fair value | (32,709) | (7,377) | |||||||
Observable inputs (Level 2) [member] | Reverse repurchase and repurchase agreements [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 118,263 | 100,038 | |||||||
Financial liabilities, at fair value | (137,315) | (126,691) | |||||||
Observable inputs (Level 2) [member] | Non-asset-backed loans [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 9,990 | 5,710 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Observable inputs (Level 2) [member] | Equity cash products [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 7,115 | 7,733 | |||||||
Financial liabilities, at fair value | (110) | (388) | |||||||
Observable inputs (Level 2) [member] | Private equity investments [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 1 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Observable inputs (Level 2) [member] | Other [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | [2] | 912 | 898 | ||||||
Financial liabilities, at fair value | [2] | (158) | (131) | ||||||
Observable inputs (Level 2) [member] | Interest rate derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 126,010 | 150,325 | |||||||
Financial liabilities, at fair value | (119,337) | (143,890) | |||||||
Observable inputs (Level 2) [member] | Foreign exchange derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 71,828 | 54,907 | |||||||
Financial liabilities, at fair value | (70,392) | (53,346) | |||||||
Observable inputs (Level 2) [member] | Credit derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 9,470 | 11,357 | |||||||
Financial liabilities, at fair value | (9,332) | (11,312) | |||||||
Observable inputs (Level 2) [member] | Equity derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 10,496 | 9,848 | |||||||
Financial liabilities, at fair value | (15,138) | (18,527) | |||||||
Observable inputs (Level 2) [member] | Commodity derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 1,758 | 2,430 | |||||||
Financial liabilities, at fair value | (1,734) | (2,442) | |||||||
Significant unobservable inputs (Level 3) [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 12,702 | 15,598 | |||||||
Financial liabilities, at fair value | (5,630) | (5,681) | |||||||
Significant unobservable inputs (Level 3) [member] | Issued debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | (289) | (214) | |||||||
Significant unobservable inputs (Level 3) [member] | Assets and liabilities classified as held for sale [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 29 | ||||||||
Financial liabilities, at fair value | 0 | ||||||||
Significant unobservable inputs (Level 3) [member] | Asset-backed securities [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 592 | 626 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Significant unobservable inputs (Level 3) [member] | Government and government sponsored debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 25 | 49 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Significant unobservable inputs (Level 3) [member] | Corporate debt [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 881 | 871 | |||||||
Financial liabilities, at fair value | 0 | (4) | |||||||
Significant unobservable inputs (Level 3) [member] | Certificates of deposit, commercial paper and other money market instruments [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | (48) | (250) | |||||||
Significant unobservable inputs (Level 3) [member] | Reverse repurchase and repurchase agreements [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 0 | 0 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Significant unobservable inputs (Level 3) [member] | Non-asset-backed loans [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 3,592 | 6,657 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Significant unobservable inputs (Level 3) [member] | Equity cash products [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 139 | 112 | |||||||
Financial liabilities, at fair value | 0 | 0 | |||||||
Significant unobservable inputs (Level 3) [member] | Private equity investments [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 1,088 | 817 | |||||||
Financial liabilities, at fair value | 0 | (16) | |||||||
Significant unobservable inputs (Level 3) [member] | Other [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | [2] | 1,319 | 1,103 | ||||||
Financial liabilities, at fair value | [2] | 0 | 0 | ||||||
Significant unobservable inputs (Level 3) [member] | Interest rate derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 2,362 | 2,718 | |||||||
Financial liabilities, at fair value | (2,747) | (2,867) | |||||||
Significant unobservable inputs (Level 3) [member] | Foreign exchange derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 126 | 160 | |||||||
Financial liabilities, at fair value | (146) | (124) | |||||||
Significant unobservable inputs (Level 3) [member] | Credit derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 1,151 | 1,386 | |||||||
Financial liabilities, at fair value | (226) | (240) | |||||||
Significant unobservable inputs (Level 3) [member] | Equity derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 1,425 | 1,064 | |||||||
Financial liabilities, at fair value | (2,172) | (1,961) | |||||||
Significant unobservable inputs (Level 3) [member] | Commodity derivatives [member] | |||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||
Financial assets, at fair value | 2 | 6 | |||||||
Financial liabilities, at fair value | £ (2) | £ (5) | |||||||
|
Fair value of financial instruments - Analysis of movements in Level 3 assets and liabilities (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jan. 01, 2018 |
Dec. 31, 2017 |
Jan. 01, 2017 |
Dec. 31, 2016 |
||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | £ 541,312 | £ 522,023 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 483,447 | £ 220,083 | [1] | 449,415 | |||||||||||||||
Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 12,702 | 15,598 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 5,630 | 5,681 | |||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 7,072 | £ 10,761 | |||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 5,094 | ||||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | (7,182) | ||||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | (4) | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 15 | ||||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | (388) | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 21 | ||||||||||||||||||
Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 9,470 | ||||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 5,094 | ||||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | (7,182) | ||||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | (4) | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 15 | ||||||||||||||||||
Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (119) | ||||||||||||||||||
Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 165 | ||||||||||||||||||
Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 7,072 | 12,100 | £ 13,567 | ||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 5,094 | 2,742 | |||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | (7,182) | [2] | (2,476) | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | (4) | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 15 | (1,732) | |||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | 25 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | (388) | 377 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 21 | (325) | |||||||||||||||||
Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3] | 9,470 | |||||||||||||||||
Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (215) | ||||||||||||||||||
Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 137 | ||||||||||||||||||
Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | (227) | [4] | 998 | 1,375 | |||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 24 | [4] | 94 | ||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | (428) | [2],[4] | (207) | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | [4] | 0 | |||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 285 | [4] | (9) | ||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | [4] | 0 | ||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | (301) | [4] | 300 | ||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 213 | [4] | (250) | ||||||||||||||||
Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3],[4] | 137 | |||||||||||||||||
Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (157) | [4] | (310) | ||||||||||||||||
Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | [4] | 5 | ||||||||||||||||
Recurring fair value measurement [member] | Investment property [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 11 | 141 | 81 | ||||||||||||||||
Purchases, fair value measurement, assets | 0 | 62 | |||||||||||||||||
Sales, fair value measurement, assets | (104) | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | (5) | 0 | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |||||||||||||||||
Recurring fair value measurement [member] | Investment property [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 116 | ||||||||||||||||||
Recurring fair value measurement [member] | Investment property [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Recurring fair value measurement [member] | Investment property [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 4 | (2) | |||||||||||||||||
Non-recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 119 | ||||||||||||||||||
Non-recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | (165) | ||||||||||||||||||
Issued debt [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 0 | 0 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 289 | 214 | |||||||||||||||||
Trading portfolio liabilities [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 10 | 7 | ||||||||||||||||
Purchases, fair value measurement, liabilities | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, liabilities | 2 | [2] | (4) | ||||||||||||||||
Issues, fair value measurement, liabilities | 0 | ||||||||||||||||||
Settlements, fair value measurement, liabilities | 0 | 1 | |||||||||||||||||
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, liabilities | 2 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, liabilities | 0 | 0 | |||||||||||||||||
Trading portfolio liabilities [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | [3] | 4 | |||||||||||||||||
Trading portfolio liabilities [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |||||||||||||||||
Trading portfolio liabilities [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 337 | 683 | 840 | ||||||||||||||||
Purchases, fair value measurement, liabilities | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, liabilities | 218 | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, liabilities | (4) | ||||||||||||||||||
Settlements, fair value measurement, liabilities | 6 | 98 | |||||||||||||||||
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, liabilities | (219) | (31) | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, liabilities | 125 | 92 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | [3] | 480 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 19 | 0 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | (2) | (2) | |||||||||||||||||
Financial liabilities designated at fair value [member] | Issued debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 289 | 227 | 298 | ||||||||||||||||
Purchases, fair value measurement, liabilities | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, liabilities | 0 | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, liabilities | (4) | ||||||||||||||||||
Settlements, fair value measurement, liabilities | 4 | 71 | |||||||||||||||||
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, liabilities | (219) | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, liabilities | 125 | 0 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Issued debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | [3] | 214 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Issued debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 19 | 0 | |||||||||||||||||
Financial liabilities designated at fair value [member] | Issued debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |||||||||||||||||
Asset-backed loans [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 592 | 626 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 0 | |||||||||||||||||
Assets and liabilities held for sale [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 29 | ||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | ||||||||||||||||||
Assets and liabilities held for sale [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 0 | 574 | |||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | (574) | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 0 | ||||||||||||||||||
Assets and liabilities held for sale [member] | Non-recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 0 | (1,339) | |||||||||||||||||
Interest rate derivatives [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 2,362 | 2,718 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 2,747 | 2,867 | |||||||||||||||||
Interest rate derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | (385) | 1,040 | 899 | ||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 0 | 27 | |||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | 0 | [2] | 12 | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 96 | 15 | |||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | (343) | 419 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 58 | (202) | |||||||||||||||||
Interest rate derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3] | (150) | |||||||||||||||||
Interest rate derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (46) | (130) | |||||||||||||||||
Interest rate derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Foreign exchange derivatives [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 126 | 160 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 146 | 124 | |||||||||||||||||
Foreign exchange derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | (20) | 15 | 81 | ||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | 0 | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | (17) | (16) | |||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 8 | (3) | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (18) | (54) | |||||||||||||||||
Foreign exchange derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3] | 37 | |||||||||||||||||
Foreign exchange derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (30) | 2 | |||||||||||||||||
Foreign exchange derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 5 | |||||||||||||||||
Credit derivatives [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1,151 | 1,386 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 226 | 240 | |||||||||||||||||
Credit derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 925 | 1,020 | 1,370 | ||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 2 | 0 | |||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | 3 | [2] | 3 | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | (15) | (19) | |||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 1 | (71) | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | (2) | 0 | |||||||||||||||||
Credit derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3] | 1,146 | |||||||||||||||||
Credit derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | (210) | (263) | |||||||||||||||||
Credit derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Equity derivatives [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1,425 | 1,064 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 2,172 | 1,961 | |||||||||||||||||
Equity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | (747) | (1,082) | (970) | ||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 22 | 67 | |||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | (431) | [2] | (222) | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 221 | 11 | |||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 33 | (45) | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 175 | (1) | |||||||||||||||||
Equity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3] | (896) | |||||||||||||||||
Equity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 129 | 78 | |||||||||||||||||
Equity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Commodity derivatives [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 2 | 6 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 2 | 5 | |||||||||||||||||
Commodity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | 0 | 5 | (5) | ||||||||||||||||
Purchases, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, assets (liabilities) net | 0 | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, assets (liabilities) net | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Gains (losses) recognised in other comprehensive income, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets (liabilities) net | 0 | 7 | |||||||||||||||||
Commodity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Assets (liabilities), net | [3] | 0 | |||||||||||||||||
Commodity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category trading income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 3 | |||||||||||||||||
Commodity derivatives [member] | Recurring fair value measurement [member] | Net derivative financial instruments [member] | Significant unobservable inputs (Level 3) [member] | Net assets (liabilities) at fair value through profit or loss, category other income [Member] | |||||||||||||||||||
Net assets (liabilities) [abstract] | |||||||||||||||||||
Gains (losses) recognised in profit or loss, fair value measurement, assets (liabilities) net | 0 | 0 | |||||||||||||||||
Government and government sponsored debt [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 25 | 49 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 0 | |||||||||||||||||
Corporate debt [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 881 | 871 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 4 | |||||||||||||||||
Non-asset-backed loans [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 3,592 | 6,657 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 0 | |||||||||||||||||
Private equity investments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1,088 | 817 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 16 | |||||||||||||||||
Certificates of deposit, commercial paper and other money market instruments [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 0 | 0 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 48 | 250 | |||||||||||||||||
Certificates of deposit, commercial paper and other money market instruments [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 48 | 257 | 319 | ||||||||||||||||
Purchases, fair value measurement, liabilities | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, liabilities | 202 | 0 | |||||||||||||||||
Issues, fair value measurement, liabilities | 0 | ||||||||||||||||||
Settlements, fair value measurement, liabilities | 0 | 0 | |||||||||||||||||
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, liabilities | 0 | (31) | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, liabilities | 0 | 92 | |||||||||||||||||
Certificates of deposit, commercial paper and other money market instruments [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 250 | ||||||||||||||||||
Certificates of deposit, commercial paper and other money market instruments [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |||||||||||||||||
Certificates of deposit, commercial paper and other money market instruments [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 1 | |||||||||||||||||
Equity cash products [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 139 | 112 | |||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 0 | |||||||||||||||||
Other [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [5] | 1,319 | 1,103 | ||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | [5] | 0 | £ 0 | ||||||||||||||||
Other [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 0 | 199 | 223 | ||||||||||||||||
Purchases, fair value measurement, liabilities | 0 | 0 | |||||||||||||||||
Sales, fair value measurement, liabilities | 16 | 0 | |||||||||||||||||
Issues, fair value measurement, liabilities | 0 | ||||||||||||||||||
Settlements, fair value measurement, liabilities | 2 | 27 | |||||||||||||||||
Total gains or losses recognised in OCI, liabilities | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, liabilities | 0 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, liabilities | 0 | 0 | |||||||||||||||||
Other [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Financial liabilities | 16 | ||||||||||||||||||
Other [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | 0 | 0 | |||||||||||||||||
Other [member] | Financial liabilities designated at fair value [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial liabilities at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial liabilities [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, liabilities | (2) | (3) | |||||||||||||||||
Trading portfolio assets [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 3,841 | 2,245 | 2,065 | ||||||||||||||||
Purchases, fair value measurement, assets | 2,389 | 542 | |||||||||||||||||
Sales, fair value measurement, assets | (366) | [2] | (274) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | (33) | (56) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 130 | 40 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (267) | (67) | |||||||||||||||||
Trading portfolio assets [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 1,977 | |||||||||||||||||
Trading portfolio assets [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 11 | (5) | |||||||||||||||||
Trading portfolio assets [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 592 | 486 | 515 | ||||||||||||||||
Purchases, fair value measurement, assets | 100 | 46 | |||||||||||||||||
Sales, fair value measurement, assets | (99) | [2] | (69) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | (9) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 5 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (30) | 0 | |||||||||||||||||
Trading portfolio assets [member] | Asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 627 | |||||||||||||||||
Trading portfolio assets [member] | Asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | (11) | 3 | |||||||||||||||||
Trading portfolio assets [member] | Asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Government and government sponsored debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 25 | 40 | 3 | ||||||||||||||||
Purchases, fair value measurement, assets | 11 | 37 | |||||||||||||||||
Sales, fair value measurement, assets | 0 | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | 0 | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (35) | 0 | |||||||||||||||||
Trading portfolio assets [member] | Government and government sponsored debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 49 | |||||||||||||||||
Trading portfolio assets [member] | Government and government sponsored debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Government and government sponsored debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Corporate debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 881 | 963 | 969 | ||||||||||||||||
Purchases, fair value measurement, assets | 35 | 56 | |||||||||||||||||
Sales, fair value measurement, assets | (17) | [2] | (71) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | (23) | (2) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 15 | 27 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (6) | (30) | |||||||||||||||||
Trading portfolio assets [member] | Corporate debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 871 | |||||||||||||||||
Trading portfolio assets [member] | Corporate debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 6 | 14 | |||||||||||||||||
Trading portfolio assets [member] | Corporate debt [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 2,173 | 403 | 151 | ||||||||||||||||
Purchases, fair value measurement, assets | 2,239 | 369 | |||||||||||||||||
Sales, fair value measurement, assets | (239) | [2] | (87) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | (21) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 11 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (6) | (7) | |||||||||||||||||
Trading portfolio assets [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 166 | |||||||||||||||||
Trading portfolio assets [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 2 | (2) | |||||||||||||||||
Trading portfolio assets [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 119 | 91 | 77 | ||||||||||||||||
Purchases, fair value measurement, assets | 0 | 32 | |||||||||||||||||
Sales, fair value measurement, assets | (7) | [2] | (7) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | 0 | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 75 | 2 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (52) | 0 | |||||||||||||||||
Trading portfolio assets [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 68 | |||||||||||||||||
Trading portfolio assets [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 35 | (13) | |||||||||||||||||
Trading portfolio assets [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Trading portfolio assets [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 51 | 262 | 350 | ||||||||||||||||
Purchases, fair value measurement, assets | 4 | 2 | |||||||||||||||||
Sales, fair value measurement, assets | (4) | [2] | (40) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | (10) | (24) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 24 | 11 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (138) | (30) | |||||||||||||||||
Trading portfolio assets [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 196 | |||||||||||||||||
Trading portfolio assets [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | (21) | (7) | |||||||||||||||||
Trading portfolio assets [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 3,679 | 9,061 | £ 9,947 | 9,947 | |||||||||||||||
Purchases, fair value measurement, assets | 2,681 | 2,044 | |||||||||||||||||
Sales, fair value measurement, assets | (6,436) | [2] | (1,371) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | (238) | (1,765) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | 28 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (18) | (58) | |||||||||||||||||
Financial assets at fair value through income statement [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 7,519 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 8 | 100 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 163 | 136 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1,419 | 6,989 | 8,616 | ||||||||||||||||
Purchases, fair value measurement, assets | 16 | 0 | |||||||||||||||||
Sales, fair value measurement, assets | (4,432) | [2] | 0 | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | (238) | (1,706) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (4) | 0 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 6,073 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 4 | 79 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Non-asset-backed loans [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | 0 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 985 | 490 | 562 | ||||||||||||||||
Purchases, fair value measurement, assets | 295 | 31 | |||||||||||||||||
Sales, fair value measurement, assets | (37) | [2] | (106) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | 0 | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | 28 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (14) | (58) | |||||||||||||||||
Financial assets at fair value through income statement [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 688 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | (3) | |||||||||||||||||
Financial assets at fair value through income statement [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 53 | 36 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 19 | ||||||||||||||||||
Purchases, fair value measurement, assets | 11 | ||||||||||||||||||
Sales, fair value measurement, assets | [2] | 0 | |||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Financial assets at fair value through income statement [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 8 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through income statement [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through income statement [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1,256 | 1,582 | £ 769 | 769 | |||||||||||||||
Purchases, fair value measurement, assets | 2,359 | 2,013 | |||||||||||||||||
Sales, fair value measurement, assets | (1,967) | [2] | (1,265) | ||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | (59) | |||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | 0 | |||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | 0 | |||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | 0 | 0 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 750 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 4 | 24 | |||||||||||||||||
Financial assets at fair value through income statement [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 110 | 100 | |||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 105 | ||||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | [2] | (68) | |||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (32) | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 205 | |||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 103 | ||||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | [2] | (12) | |||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (14) | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 129 | |||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1 | ||||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | [2] | (17) | |||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (18) | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | 36 | |||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 1 | ||||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | [2] | (39) | |||||||||||||||||
Issues, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | IFRSs 9 transition impact included [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | [3] | £ 40 | |||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | 0 | ||||||||||||||||||
Financial assets at fair value through other comprehensive income [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains and losses in the period recognised in the income statement, assets | £ 0 | ||||||||||||||||||
Financial Investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 348 | 372 | |||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | (46) | ||||||||||||||||||
Settlements, fair value measurement, assets | (1) | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 25 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 40 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (42) | ||||||||||||||||||
Financial Investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 304 | 294 | |||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | (45) | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 23 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 34 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Private equity investments [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | (2) | ||||||||||||||||||
Financial Investments [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 40 | 73 | |||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | 0 | ||||||||||||||||||
Settlements, fair value measurement, assets | 0 | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 1 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 6 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | (42) | ||||||||||||||||||
Financial Investments [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Equity cash products [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | 2 | ||||||||||||||||||
Financial Investments [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Financial assets | 4 | £ 5 | |||||||||||||||||
Purchases, fair value measurement, assets | 0 | ||||||||||||||||||
Sales, fair value measurement, assets | (1) | ||||||||||||||||||
Settlements, fair value measurement, assets | (1) | ||||||||||||||||||
Total gains or losses recognised in OCI, assets | 1 | ||||||||||||||||||
Transfers into Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Transfers out of Level 3 of fair value hierarchy, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category trading [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | 0 | ||||||||||||||||||
Financial Investments [member] | Other [member] | Recurring fair value measurement [member] | Significant unobservable inputs (Level 3) [member] | Financial assets at fair value through profit or loss, category other income [member] | |||||||||||||||||||
Financial assets [abstract] | |||||||||||||||||||
Total gains or losses recognised in OCI, assets | £ 0 | ||||||||||||||||||
|
Fair value of financial instruments - Analysis of movements in Level 3 assets and liabilities (Narrative) (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[2] | Dec. 31, 2017 |
Jun. 30, 2017 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disclosure of detailed information about financial instruments [line items] | |||||||||||||
Derivative financial assets | £ 229,002 | [1] | £ 237,987 | £ 237,987 | [3] | ||||||||
Derivative financial liabilities | 225,089 | [1] | £ 238,345 | 238,345 | [3] | ||||||||
Significant unobservable inputs (Level 3) [member] | Recurring fair value measurement [member] | |||||||||||||
Disclosure of detailed information about financial instruments [line items] | |||||||||||||
Derivative financial assets | 5,066 | 5,334 | £ 7,872 | ||||||||||
Derivative financial liabilities | £ 5,293 | £ 5,197 | £ 6,874 | ||||||||||
|
Fair value of financial instruments - Unrealised gains and losses recognised in the period on Level 3 assets and liabilities held at period end (Details) - GBP (£) £ in Millions |
6 Months Ended | |
---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
|
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | £ 2,319 | £ 1,685 |
Other income | 77 | 30 |
Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (133) | (212) |
Other income | 116 | 100 |
Other comprehensive income | 0 | 25 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (17) | (87) |
Significant unobservable inputs (Level 3) [member] | Investment property [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | 0 |
Other income | 0 | 0 |
Other comprehensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 0 | 0 |
Significant unobservable inputs (Level 3) [member] | Net derivative financial instruments [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (155) | (305) |
Other income | 0 | 0 |
Other comprehensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (155) | (305) |
Trading portfolio liabilities [member] | Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | 0 |
Other income | 0 | 0 |
Other comprehensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 0 | 0 |
Financial liabilities designated at fair value [member] | Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 18 | 45 |
Other income | 0 | (2) |
Other comprehensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 18 | 43 |
Trading portfolio assets [member] | Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | (3) | (25) |
Other income | 0 | 0 |
Other comprehensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | (3) | (25) |
Financial assets at fair value through income statement [member] | Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 7 | 73 |
Other income | 116 | 102 |
Other comprehensive income | 0 | 0 |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | 123 | 175 |
Financial assets at fair value through other comprehensive income [member] | Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | |
Other income | 0 | |
Other comprehensive income | 0 | |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | £ 0 | |
Financial Investments [member] | Significant unobservable inputs (Level 3) [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Trading income | 0 | |
Other income | 0 | |
Other comprehensive income | 25 | |
Total unrealised gains and losses recognised during the period on Level 3 assets and liabilities held at period end | £ 25 |
Fair value of financial instruments - Sensitivity analysis of valuations using unobservable inputs (Details) - Recurring fair value measurement [member] - Significant unobservable inputs (Level 3) [member] - GBP (£) £ in Millions |
Jun. 30, 2018 |
Dec. 31, 2017 |
---|---|---|
Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | £ 676 | £ 726 |
Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 37 |
Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (885) | (947) |
Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | (37) |
Issued debt [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Issued debt [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Issued debt [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Issued debt [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Assets and liabilities classified as held for sale [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Assets and liabilities classified as held for sale [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Assets and liabilities classified as held for sale [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Assets and liabilities classified as held for sale [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Asset-backed loans [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 1 |
Asset-backed loans [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Asset-backed loans [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Asset-backed loans [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Corporate debt [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 4 | 4 |
Corporate debt [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Corporate debt [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (4) | (3) |
Corporate debt [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Certificates of deposit, commercial paper and other money market instruments [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Certificates of deposit, commercial paper and other money market instruments [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Certificates of deposit, commercial paper and other money market instruments [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Certificates of deposit, commercial paper and other money market instruments [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Non-asset-backed loans [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 88 | 243 |
Non-asset-backed loans [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Non-asset-backed loans [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (207) | (468) |
Non-asset-backed loans [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Equity cash products [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 93 | 12 |
Equity cash products [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 24 |
Equity cash products [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (166) | (8) |
Equity cash products [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | (24) |
Private equity investments [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 157 | 133 |
Private equity investments [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 13 |
Private equity investments [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (172) | (138) |
Private equity investments [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | (13) |
Other [member] | Favourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 2 | 5 |
Other [member] | Favourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Other [member] | Unfavourable changes [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (2) | (5) |
Other [member] | Unfavourable changes [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Interest rate derivatives [member] | Favourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 94 | 114 |
Interest rate derivatives [member] | Favourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Interest rate derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (144) | (138) |
Interest rate derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Foreign exchange derivatives [member] | Favourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 9 | 6 |
Foreign exchange derivatives [member] | Favourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Foreign exchange derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (14) | (6) |
Foreign exchange derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Credit derivatives [member] | Favourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 132 | 106 |
Credit derivatives [member] | Favourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Credit derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (78) | (79) |
Credit derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Equity derivatives [member] | Favourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 96 | 99 |
Equity derivatives [member] | Favourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Equity derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (97) | (99) |
Equity derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Commodity derivatives [member] | Favourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 1 | 3 |
Commodity derivatives [member] | Favourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | 0 | 0 |
Commodity derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Income statement [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | (1) | (3) |
Commodity derivatives [member] | Unfavourable changes [member] | Derivatives [member] | Equity [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Sensitivity analysis valuation due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, equity | £ 0 | £ 0 |
Fair value of financial instruments - Fair value adjustments (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Dec. 31, 2017 |
---|---|---|
Exit price adjustments derived from market bid-offer spreads [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | £ (397) | £ (391) |
Uncollateralised derivative funding [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | (38) | (45) |
Derivative credit valuation adjustments [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | (123) | (103) |
Derivative debit valuation adjustments [member] | ||
Disclosure of detailed information about financial instruments [line items] | ||
Fair value adjustments | £ 184 | £ 131 |
Fair value of financial instruments - Comparison of carrying amounts and fair values for assets and liabilities not held at fair value (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[2] | Dec. 31, 2017 |
Dec. 31, 2016 |
||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial assets [abstract] | |||||||||||||||
Cash collateral and settlement balances | £ 91,549 | [1] | £ 74,769 | £ 77,172 | [3] | ||||||||||
Loans and advances at amortised cost | 134,820 | [1] | 317,744 | 324,590 | [3] | ||||||||||
Reverse repurchase agreements and other similar secured lending | 533 | [1] | 597 | 12,546 | [3] | ||||||||||
Assets included in disposal groups classified as held for sale | 1,761 | [1],[4] | 1,193 | 1,193 | [3],[4] | ||||||||||
Financial liabilities [abstract] | |||||||||||||||
Cash collateral and settlement balances | (85,448) | [1] | (65,925) | (68,143) | [3] | ||||||||||
Repurchase agreements and other similar secured borrowing | (8,645) | [1] | (15,053) | (40,338) | [3] | ||||||||||
Debt securities in issue | (57,905) | [1] | (69,386) | (69,386) | [3] | ||||||||||
Subordinated liabilities | (17,190) | [1],[4] | (24,193) | (24,193) | [3],[4] | £ (23,871) | |||||||||
Liabilities included in disposal groups classified as held for sale | (1,762) | [1],[4] | £ 0 | 0 | [3],[4] | ||||||||||
Fair value [member] | Financial liabilities at amortised cost, class [member] | |||||||||||||||
Financial liabilities [abstract] | |||||||||||||||
Banks | (39,685) | (12,341) | |||||||||||||
Current and demand accounts | (71,876) | (146,232) | |||||||||||||
Savings accounts | (27,697) | (134,369) | |||||||||||||
Other time deposits | (54,748) | (106,325) | |||||||||||||
Cash collateral and settlement balances | (85,448) | (68,143) | |||||||||||||
Repurchase agreements and other similar secured borrowing | (8,645) | (40,338) | |||||||||||||
Debt securities in issue | (58,342) | (70,824) | |||||||||||||
Subordinated liabilities | (18,251) | (25,451) | |||||||||||||
Liabilities included in disposal groups classified as held for sale | (1,660) | ||||||||||||||
Fair value [member] | Financial assets at amortised cost, class [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Cash collateral and settlement balances | 91,549 | 77,172 | |||||||||||||
Reverse repurchase agreements and other similar secured lending | 533 | 12,546 | |||||||||||||
Assets included in disposal groups classified as held for sale | 1,658 | 1,195 | |||||||||||||
Fair value [member] | Financial assets at amortised cost, class [member] | Home loans [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 12,352 | 145,262 | |||||||||||||
Fair value [member] | Financial assets at amortised cost, class [member] | Credit cards, unsecured and other retail lending [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 31,306 | 55,106 | |||||||||||||
Fair value [member] | Financial assets at amortised cost, class [member] | Finance lease receivables [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 3,222 | 2,964 | |||||||||||||
Fair value [member] | Financial assets at amortised cost, class [member] | Corporate loans [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 88,199 | 122,209 | |||||||||||||
Gross exposure [member] | Financial liabilities at amortised cost, class [member] | |||||||||||||||
Financial liabilities [abstract] | |||||||||||||||
Banks | (39,685) | (12,336) | |||||||||||||
Current and demand accounts | (71,876) | (146,255) | |||||||||||||
Savings accounts | (27,681) | (134,339) | |||||||||||||
Other time deposits | (54,748) | (106,259) | |||||||||||||
Cash collateral and settlement balances | (85,448) | (68,143) | |||||||||||||
Repurchase agreements and other similar secured borrowing | (8,645) | (40,338) | |||||||||||||
Debt securities in issue | (57,905) | (69,386) | |||||||||||||
Subordinated liabilities | (17,190) | (24,193) | |||||||||||||
Liabilities included in disposal groups classified as held for sale | (1,660) | ||||||||||||||
Gross exposure [member] | Financial assets at amortised cost, class [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Cash collateral and settlement balances | 91,549 | 77,172 | |||||||||||||
Reverse repurchase agreements and other similar secured lending | 533 | 12,546 | |||||||||||||
Assets included in disposal groups classified as held for sale | 1,658 | 1,164 | |||||||||||||
Gross exposure [member] | Financial assets at amortised cost, class [member] | Home loans [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 13,282 | 147,002 | |||||||||||||
Gross exposure [member] | Financial assets at amortised cost, class [member] | Credit cards, unsecured and other retail lending [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 29,298 | 55,767 | |||||||||||||
Gross exposure [member] | Financial assets at amortised cost, class [member] | Finance lease receivables [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | 3,120 | 2,854 | |||||||||||||
Gross exposure [member] | Financial assets at amortised cost, class [member] | Corporate loans [member] | |||||||||||||||
Financial assets [abstract] | |||||||||||||||
Loans and advances at amortised cost | £ 89,120 | £ 124,076 | |||||||||||||
|
Fair value of financial instruments (Narrative) (Details) - GBP (£) |
6 Months Ended | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apr. 01, 2018 |
Jun. 30, 2018 |
Dec. 31, 2017 |
Jun. 30, 2017 |
Jan. 01, 2018 |
[3] | |||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Loans and advances at amortised cost | £ 134,820,000,000 | [1] | £ 324,590,000,000 | [2] | £ 317,744,000,000 | |||||||||||||
Liabilities included in disposal groups classified as held for sale | 1,762,000,000 | [1],[4] | 0 | [2],[4] | £ 0 | |||||||||||||
non-financial assets [Member] | Gross carrying amount [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Liabilities included in disposal groups classified as held for sale | (100,000,000) | |||||||||||||||||
Liabilities [member] | Gross carrying amount [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Liabilities included in disposal groups classified as held for sale | £ (100,000,000) | |||||||||||||||||
Recurring fair value measurement [member] | Commodity derivatives [member] | Derivative financial liabilities [Member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Transfers out of Level 1 into Level 2 of fair value hierarchy, liabilities held at end of reporting period | 950,000,000 | |||||||||||||||||
Recurring fair value measurement [member] | Derivative financial assets [Member] | Commodity derivatives [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Transfers out of Level 1 into Level 2 of fair value hierarchy, assets held at end of reporting period | 1,023,000,000 | |||||||||||||||||
Significant unobservable inputs (Level 3) [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Description of existence of third-party credit enhancement | Structured and brokered certificates of deposit issued by Barclays Group are insured up to $250,000 per depositor by the Federal Deposit Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks pay for deposit insurance coverage. | |||||||||||||||||
Description of whether third-party credit enhancement is reflected in fair value measurement | The carrying value of these issued certificates of deposit that are designated under the IAS 39 fair value option includes this third party credit enhancement. | |||||||||||||||||
Significant unobservable inputs (Level 3) [member] | Brokered certificates of deposit [Member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Deposits | £ 3,862,000,000 | 4,070,000,000 | ||||||||||||||||
Significant unobservable inputs (Level 3) [member] | Recurring fair value measurement [member] | Financial assets at fair value through income statement [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Sales, fair value measurement, assets | 6,436,000,000 | [5] | £ 1,371,000,000 | |||||||||||||||
Exit price adjustments derived from market bid-offer spreads [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Fair value adjustments | 397,000,000 | 391,000,000 | ||||||||||||||||
Exit price adjustments derived from market bid-offer spreads [member] | Significant unobservable inputs (Level 3) [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Increase (decrease) in fair value adjustments of derivatives | (11,000,000) | |||||||||||||||||
Uncollateralised derivative funding [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Fair value adjustments | 38,000,000 | 45,000,000 | ||||||||||||||||
Uncollateralised derivative funding [member] | Significant unobservable inputs (Level 3) [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Increase (decrease) in fair value adjustments of derivatives | 7,000,000 | |||||||||||||||||
Derivative credit valuation adjustments [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Fair value adjustments | 123,000,000 | 103,000,000 | ||||||||||||||||
Derivative credit valuation adjustments [member] | Significant unobservable inputs (Level 3) [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Increase (decrease) in fair value adjustments of derivatives | (19,000,000) | |||||||||||||||||
Derivative debit valuation adjustments [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Fair value adjustments | (184,000,000) | (131,000,000) | ||||||||||||||||
Derivative debit valuation adjustments [member] | Significant unobservable inputs (Level 3) [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Increase (decrease) in fair value adjustments of derivatives | (53,000,000) | |||||||||||||||||
Max [member] | Significant unobservable inputs (Level 3) [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Increase in fair value measurement due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, assets (liabilities) | 623,000,000 | 763,000,000 | ||||||||||||||||
Decrease in fair value measurement due to change in one or more unobservable inputs to reflect reasonably possible alternative assumptions, assets (liabilities) | (765,000,000) | (984,000,000) | ||||||||||||||||
Goverment bonds [member] | Held-to-maturity [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Loans and advances at amortised cost | 5,100,000,000 | |||||||||||||||||
Goverment bonds [member] | Recurring fair value measurement [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Transfers out of Level 1 into Level 2 of fair value hierarchy, assets held at end of reporting period | 3,807,000,000 | |||||||||||||||||
Non-asset-backed loans [member] | Significant unobservable inputs (Level 3) [member] | Recurring fair value measurement [member] | Financial assets at fair value through income statement [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Sales, fair value measurement, assets | 4,432,000,000 | [5] | £ 0 | |||||||||||||||
Non-asset-backed loans [member] | Significant unobservable inputs (Level 3) [member] | Recurring fair value measurement [member] | UK Banking Businesses [member] | Barclays Bank UK Plc [Member] | Financial assets at fair value through income statement [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Sales, fair value measurement, assets | £ 4,400,000,000 | |||||||||||||||||
Financial instruments at amortised cost, category [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 31,000,000 | 253,000,000 | ||||||||||||||||
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 1,000,000 | 119,000,000 | ||||||||||||||||
Increase (decrease) in aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | (222,000,000) | |||||||||||||||||
Financial instruments at amortised cost, category [member] | Amoritisation and releases [Member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Other decreases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | (1,000,000) | (22,000,000) | ||||||||||||||||
Financial instruments at amortised cost, category [member] | UK Banking Businesses [member] | Barclays Bank UK Plc [Member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Other decreases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | (222,000,000) | 0 | ||||||||||||||||
Financial instruments at fair value [member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 124,000,000 | 109,000,000 | ||||||||||||||||
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 44,000,000 | 34,000,000 | ||||||||||||||||
Increase (decrease) in aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | 25,000,000 | |||||||||||||||||
Financial instruments at fair value [member] | Amoritisation and releases [Member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Other decreases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | (14,000,000) | (104,000,000) | ||||||||||||||||
Financial instruments at fair value [member] | UK Banking Businesses [member] | Barclays Bank UK Plc [Member] | ||||||||||||||||||
Disclosure of detailed information about financial instruments [line items] | ||||||||||||||||||
Additions, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | £ (15,000,000) | |||||||||||||||||
Other decreases, aggregate difference between fair value at initial recognition and transaction price yet to be recognised in profit or loss | £ 0 | |||||||||||||||||
|
Subordinated Liabilities (Details) - GBP (£) £ in Millions |
6 Months Ended | 12 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Dec. 31, 2017 |
|||||||||||
Subordinated liabilities [abstract] | ||||||||||||
Subordinated liabilities | £ 24,193 | [1],[2] | £ 23,871 | |||||||||
Issuances | 0 | 3,041 | ||||||||||
Redemptions | (3,075) | (1,378) | ||||||||||
Other | (3,928) | [3] | (1,341) | |||||||||
Subordinated liabilities | [2] | £ 17,190 | [4] | £ 24,193 | [1] | |||||||
|
Subordinated Liabilities (Narrative) (Details) € in Millions, ¥ in Millions, £ in Millions, $ in Millions |
6 Months Ended | 12 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|---|
Apr. 01, 2018
GBP (£)
|
Jun. 30, 2018
GBP (£)
|
Dec. 31, 2017
GBP (£)
|
Jun. 30, 2018
EUR (€)
|
Jun. 30, 2018
GBP (£)
|
Jun. 30, 2018
JPY (¥)
|
Jun. 30, 2018
USD ($)
|
|||
Disclosure of detailed information about borrowings [line items] | |||||||||
Redemptions | £ 3,075 | £ 1,378 | |||||||
Barclays UK [member] | BBUKPLC [member] | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Increase (decrease) in subordinated liabilities | [1] | (3,019) | |||||||
Subordinated liabilities [Member] | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Redemptions | £ 3,075 | ||||||||
Subordinated liabilities [Member] | 7.75% Contingent Capital Notes | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | £ 713 | $ 1,000 | |||||||
Borrowings, interest rate | 7.75% | 7.75% | 7.75% | 7.75% | |||||
Subordinated liabilities [Member] | 7.7% Undated Subordinated Notes | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | £ 72 | $ 99 | |||||||
Borrowings, interest rate | 7.70% | 7.70% | 7.70% | 7.70% | |||||
Subordinated liabilities [Member] | CMS-link Subordinated loans | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | € 235 | £ 206 | |||||||
Subordinated liabilities [Member] | ShinGinko Tokyo Limited | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | 10 | ¥ 1,500 | |||||||
Subordinated liabilities [Member] | The Daisan Bank Limited [member] | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | 7 | ¥ 1,000 | |||||||
Subordinated liabilities [Member] | Fixed or Floating Interest Rate [Member] | Fixed or Floating Rate Subordinated Callable Notes | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | 500 | ||||||||
Subordinated liabilities [Member] | Fixed interest rate [member] | 6% Subordinated Notes One and Two | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | € 1,750 | £ 1,532 | |||||||
Borrowings, interest rate | 6.00% | 6.00% | 6.00% | 6.00% | |||||
Subordinated liabilities [Member] | Floating interest rate [member] | Subordinated Notes One | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Notional amount | € 40 | £ 35 | |||||||
Borrowings Maturity Date | 2018 | ||||||||
Subordinated liabilities [Member] | Barclays UK [member] | BBUKPLC [member] | |||||||||
Disclosure of detailed information about borrowings [line items] | |||||||||
Increase (decrease) in subordinated liabilities | £ (3,019) | ||||||||
|
Provisions (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[3] | Dec. 31, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | £ 1,233 | [1],[2] | £ 3,643 | £ 3,302 | [2],[4] | |||||||||||
Payment protection insurance redress [Member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | 0 | 1,606 | ||||||||||||||
Other customer redress [Member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | 179 | 639 | ||||||||||||||
Legal, competition and regulatory matters [member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | 463 | 435 | ||||||||||||||
Redundancy and restructuring [member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | 67 | 106 | ||||||||||||||
Undrawn contractually committed facilities and guarantees [Member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | [5] | 202 | 79 | |||||||||||||
Onerous contracts [member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | 74 | 143 | ||||||||||||||
Sundry provisions [member] | ||||||||||||||||
Disclosure of provisions [line items] | ||||||||||||||||
Provisions | £ 248 | £ 294 | ||||||||||||||
|
Provisions (Narrative) (Details) - UK Banking Businesses [member] - BBUKPLC [member] - GBP (£) £ in Millions |
6 Months Ended | |||
---|---|---|---|---|
Apr. 01, 2018 |
Jun. 30, 2018 |
|||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | [1] | £ (2,289) | ||
Payment protection insurance redress [Member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | £ (1,698) | |||
Other customer redress [Member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | (412) | |||
Legal, competition and regulatory matters [member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | (2) | |||
Redundancy and restructuring [member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | (16) | |||
Undrawn contractually committed facilities and guarantees [Member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | (87) | |||
Onerous contracts [member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | (48) | |||
Sundry provisions [member] | ||||
Disclosure of provisions [line items] | ||||
Increase (decrease) in provisions | £ (26) | |||
|
Retirement benefits (Narrative) (Details) - GBP (£) £ in Billions |
Jun. 30, 2018 |
Dec. 31, 2017 |
Sep. 30, 2017 |
Sep. 30, 2016 |
---|---|---|---|---|
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | £ 0.9 | £ 0.7 | ||
United Kingdom Retirement Fund (UKRF) [member] | ||||
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | £ 1.1 | £ 1.0 | ||
United Kingdom Retirement Fund (UKRF) [member] | Deficit contributions 30 September 2016 valuation [Member] | ||||
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | £ 7.9 | |||
Funding level percentage | 81.50% | |||
United Kingdom Retirement Fund (UKRF) [member] | Deficit contributions 30 September 2017 valuation [Member] | ||||
Disclosure of fair value of plan assets [line items] | ||||
Surplus (deficit) in plan | £ (4.8) | |||
Funding level percentage | 86.80% |
Retirement benefits - Deficit reduction contributions (Narrative) (Details) - United Kingdom Retirement Fund (UKRF) [member] - Deficit contributions 30 September 2016 valuation [Member] £ in Billions |
Jun. 30, 2018
GBP (£)
|
---|---|
2018 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | £ 0.5 |
2019 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 0.5 |
2020 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 0.5 |
2021 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 1.0 |
2022 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 1.0 |
2023 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 1.0 |
2024 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 1.0 |
2025 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | 1.0 |
2026 [member] | |
Disclosure of fair value of plan assets [line items] | |
Deficit reduction contributions | £ 1.0 |
Called up share capital (Details) £ in Millions |
6 Months Ended | |||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2018
GBP (£)
| ||||||||
Beginning Balance, equity | £ 65,734 | [1] | ||||||
Ending Balance, equity | 48,192 | [2] | ||||||
Ordinary share capital [member] | ||||||||
Beginning Balance, equity | 2,342 | |||||||
Movements | 0 | |||||||
Ending Balance, equity | 2,342 | |||||||
Preference share capital [member] | ||||||||
Beginning Balance, equity | 19 | |||||||
Movements | 0 | |||||||
Ending Balance, equity | 19 | |||||||
Share premium [member] | ||||||||
Beginning Balance, equity | 12,092 | |||||||
Movements | 0 | |||||||
Ending Balance, equity | 12,092 | |||||||
Called up share capital and share premium [member] | ||||||||
Beginning Balance, equity | 14,453 | [3] | ||||||
Movements | 0 | |||||||
Ending Balance, equity | £ 14,453 | [3] | ||||||
|
Called up share capital (Narrative) (Details) |
Jun. 30, 2018
£ / shares
shares
|
Jun. 30, 2018
€ / shares
shares
|
Jun. 30, 2018
$ / shares
shares
|
Dec. 31, 2017
£ / shares
shares
|
Dec. 31, 2017
€ / shares
shares
|
Dec. 31, 2017
$ / shares
shares
|
---|---|---|---|---|---|---|
Ordinary shares [member] | ||||||
Issued share capital | 2,342,000,000 | 2,342,000,000 | 2,342,000,000 | 2,342,000,000 | 2,342,000,000 | 2,342,000,000 |
Par value per share | £ / shares | £ 1 | £ 1 | ||||
Sterling 1000 Preference Shares [member] | ||||||
Issued share capital | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
Par value per share | £ / shares | £ 1 | £ 1 | ||||
Euro Preference Shares [member] | ||||||
Issued share capital | 31,856 | 31,856 | 31,856 | 31,856 | 31,856 | 31,856 |
Par value per share | € / shares | € 100 | € 100 | ||||
US Dollar Preference Shares 100 par value [Member] | ||||||
Issued share capital | 58,133 | 58,133 | 58,133 | 58,133 | 58,133 | 58,133 |
Par value per share | $ / shares | $ 100 | $ 100 | ||||
US Dollar Preference Shares Point Twenty-five Par Value [member] | ||||||
Issued share capital | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 |
Par value per share | $ / shares | $ 0.25 | $ 0.25 |
Other equity instruments (Narrative) (Details) - GBP (£) £ in Millions, shares in Millions |
Apr. 01, 2018 |
Jun. 30, 2018 |
Dec. 31, 2017 |
Jun. 30, 2017 |
Dec. 31, 2016 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity | £ 48,192 | [1] | £ 65,734 | [2] | £ 66,167 | £ 70,955 | ||||||||
Other equity instruments [member] | ||||||||||||||
Equity | £ 6,912 | [3] | £ 8,982 | [3] | £ 7,736 | [3] | £ 6,486 | |||||||
Other equity instruments [member] | UK Banking Businesses [member] | BBUKPLC [member] | At one securities [Member] | ||||||||||||||
Increase (decrease) in number of ordinary shares issued | (2,070) | |||||||||||||
|
Other reserves (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Dec. 31, 2017 |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | [2] | £ 3,071 | [1] | £ 3,808 | [3] | |||||
Currency translation reserve [member] | ||||||||||
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | 3,434 | 3,084 | ||||||||
Available for sale reserve [member] | ||||||||||
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | 0 | 396 | ||||||||
Fair value through other comprehensive income reserve [member] | ||||||||||
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | (215) | 0 | ||||||||
Cash flow hedging reserve [member] | ||||||||||
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | (219) | 184 | ||||||||
Own credit reserve [member] | ||||||||||
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | (252) | (179) | ||||||||
Other [member] | ||||||||||
Disclosure of reserves within equity [line items] | ||||||||||
Total Reserves | £ 323 | £ 323 | ||||||||
|
Other reserves (Narrative) (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 01, 2018 |
Jun. 30, 2018 |
Dec. 31, 2017 |
|||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | [2] | £ 3,071 | [1] | £ 3,808 | [3] | ||||||
Amount of reclassifications or changes in presentation, equity | £ 0 | ||||||||||
Retained earnings [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Amount of reclassifications or changes in presentation, equity | £ 0 | ||||||||||
IFRSs 9 [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Fair value previously recognised in the available for sale reserve are now recorded in fair value through other comprehensive income | 260 | ||||||||||
Currency translation reserve [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | 3,434 | 3,084 | |||||||||
Increase (decrease) in equity | 350 | ||||||||||
Available for sale reserve [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | 0 | 396 | |||||||||
Fair value through other comprehensive income reserve [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | (215) | 0 | |||||||||
Increase (decrease) in equity | (611) | ||||||||||
Changes in fair value | (329) | ||||||||||
Net gains transferred to net profits | 151 | ||||||||||
Tax credit | (33) | ||||||||||
Fair value through other comprehensive income reserve [member] | IFRSs 9 [member] | Retained earnings [member] | Increase (decrease) due to changes in accounting policy [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Amount of reclassifications or changes in presentation, equity | (136) | ||||||||||
Cash flow hedging reserve [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | (219) | 184 | |||||||||
Increase (decrease) in equity | (403) | ||||||||||
Changes in fair value | (376) | ||||||||||
Net gains transferred to net profits | 161 | ||||||||||
Tax credit | 134 | ||||||||||
Own credit reserve [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | (252) | (179) | |||||||||
Increase (decrease) in equity | 73 | ||||||||||
Tax spread | 98 | ||||||||||
Tax credit | 25 | ||||||||||
Other reserves and treasury shares [member] | |||||||||||
Disclosure of reserves within equity [line items] | |||||||||||
Other reserves | £ 323 | £ 323 | |||||||||
|
Contingent liabilities and commitments (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Dec. 31, 2017 |
---|---|---|
Disclosure of contingent liabilities [line items] | ||
Contingent liabilities | £ 18,380 | £ 19,012 |
Documentary credits and other short-term trade related transactions | 1,055 | 812 |
Standby facilities, credit lines and other commitments | 244,246 | 314,761 |
Commitments | 245,301 | 315,573 |
Guarantees and letters of credit pledged as collateral security [member] | ||
Disclosure of contingent liabilities [line items] | ||
Contingent liabilities | 14,051 | 14,275 |
Performance guarantees, acceptances and endorsements [member] | ||
Disclosure of contingent liabilities [line items] | ||
Contingent liabilities | £ 4,329 | £ 4,737 |
Contingent liabilities and commitments (Narrative) (Details) - UK Banking Businesses [member] - BBUKPLC [member] £ in Millions |
Apr. 01, 2018
GBP (£)
|
---|---|
Standby facilities, credit lines and other commitments [member] | |
Disclosure of contingent liabilities [line items] | |
Increase (decrease) in commitments | £ (67,791) |
Guarantees and letters of credit pledged as collateral security [member] | |
Disclosure of contingent liabilities [line items] | |
Increase (decrease) in contingent liabilities | £ (793) |
Legal, competition and regulatory matters (Narrative) (Details) £ in Millions |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 48 Months Ended | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2018
GBP (£)
|
Nov. 30, 2017
GBP (£)
|
Jan. 31, 2017
GBP (£)
|
Feb. 28, 2016
GBP (£)
|
Sep. 30, 2013
GBP (£)
|
Oct. 31, 2008
GBP (£)
|
Dec. 31, 2017
GBP (£)
|
Jun. 30, 2018
GBP (£)
|
Dec. 31, 2017
GBP (£)
|
Dec. 31, 2016
GBP (£)
|
Dec. 31, 2015
GBP (£)
lawsuits
|
Dec. 31, 2012
GBP (£)
|
Dec. 31, 2008
GBP (£)
|
Dec. 31, 2008
GBP (£)
|
Nov. 30, 2008
GBP (£)
|
Apr. 25, 2008
GBP (£)
|
|
Investigations into certain advisory services agreements and other matters and civil action [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | Barclays Bank PLC entered into two advisory services agreements with Qatar Holding LLC (Qatar Holding) in June and October 2008 (the Agreements). The FCA commenced an investigation into whether the Agreements may have related to Barclays PLC’s capital raisings in June and November 2008 (the Capital Raisings). The existence of the June 2008 advisory services agreement was disclosed, but the entry into the advisory services agreement in October 2008 and the fees payable under the Agreements, which amounted to a total of £322m payable over a period of five years, were not disclosed in the announcements or public documents relating to the Capital Raisings. The SFO also commenced an investigation into the Agreements and into a $3bn loan (the Loan) provided by Barclays Bank PLC in November 2008 to the State of Qatar. | |||||||||||||||
Service agreement fees payable | £ 322.0 | |||||||||||||||
Advisory service fees payable, term | 5 years | |||||||||||||||
Loans to government | £ 3,000.0 | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. PCP has made a claim against Barclays Bank PLC for damages of up to £1,477m plus interest and costs. This amount does not necessarily reflect Barclays Bank PLC’s potential financial exposure if a ruling were to be made against it in that matter. | |||||||||||||||
SFO Proceedings [member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Information about contingent liabilities that disclosure is not practicable | In June 2017, the SFO charged Barclays PLC with two offences of conspiring with certain former senior officers and employees of Barclays to commit fraud by false representations relating to the Agreements and one offence of unlawful financial assistance contrary to section 151 of the Companies Act 1985 in relation to the Loan. In February 2018, the SFO also charged Barclays Bank PLC with the same offence in respect of the Loan. In May 2018, the Crown Court dismissed all charges against Barclays PLC and Barclays Bank PLC. In July 2018, the SFO made an application to the High Court seeking to reinstate against Barclays PLC and Barclays Bank PLC all of the charges dismissed by the Crown Court. Barclays intends to defend the application brought by the SFO. | |||||||||||||||
FCA Proceedings and other investigations [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Loss contingency, Financial penalty warning | £ 50.0 | |||||||||||||||
Civil action [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In January 2016, PCP Capital Partners LLP and PCP International Finance Limited (PCP) served a claim on Barclays Bank PLC seeking damages for fraudulent misrepresentation and deceit, arising from alleged statements made by Barclays Bank PLC to PCP in relation to the terms on which securities were to be issued to potential investors, allegedly including PCP, in the November 2008 capital raising. PCP seeks damages of up to £1,477m (plus interest from November 2017) and costs. Barclays Bank PLC is defending the claim and trial is scheduled to commence in October 2019. | |||||||||||||||
Loss Contingency, Damages Sought, claimed amounts, Value | £ 1,477.0 | |||||||||||||||
Investigations into LIBOR and other benchmarks [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In 2012, Barclays Bank PLC announced that it had reached settlements with the Financial Services Authority (FSA) (as predecessor to the FCA), the US Commodity Futures Trading Commission (CFTC) and the DoJ in relation to their investigations concerning certain benchmark interest rate submissions, and Barclays Bank PLC paid total penalties of £290m. The settlement with the DoJ was made by entry into a Non-Prosecution Agreement (NPA) which has now expired. Barclays PLC, Barclays Bank PLC and Barclays Capital Inc. (BCI) have reached settlements with certain other regulators and law enforcement agencies. Barclays Bank PLC continues to respond to requests for information from the SFO in relation to its ongoing LIBOR investigation, including in respect of Barclays Bank PLC. The investigation by the prosecutor’s office in Trani, Italy also remains pending. | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Losses on litigation settlements | £ 290.0 | |||||||||||||||
USD LIBOR Cases in MDL Court [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial purposes before a single judge in the US District Court in the Southern District of New York (SDNY) (MDL Court). | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | Aside from the settlements discussed above, it is not currently practicable to provide an estimate of any further financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Number of lawsuits with specified damages sought | lawsuits | 5 | |||||||||||||||
USD LIBOR Cases in MDL Court [Member] | Lawsuits with specified damages sought [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Loss Contingency, Damages Sought, claimed amounts, Value | £ 1,250.0 | |||||||||||||||
USD LIBOR Cases in MDL Court [Member] | Exchange-Based Class claims [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 20.0 | |||||||||||||||
USD LIBOR Cases in MDL Court [Member] | OTC Class claims [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | 120.0 | |||||||||||||||
USD LIBOR Cases in MDL Court [Member] | Debt Securities Class claims [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | 7.1 | |||||||||||||||
USD LIBOR Cases in MDL Court [Member] | Issued loans linked to USD LIBOR [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 4.0 | |||||||||||||||
EURIBOR Case in the SDNY [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 94.0 | |||||||||||||||
Foreign Exchange investigations [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In 2015 Barclays reached settlements with the CFTC, the DoJ, the New York State Department of Financial Services (NYDFS), the Board of Governors of the Federal Reserve System (Federal Reserve) and the FCA (together, the 2015 Resolving Authorities) in relation to investigations into certain sales and trading practices in the Foreign Exchange market. In connection with these settlements, Barclays paid total penalties of approximately $2.38bn and agreed to undertake certain remedial actions. | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | Aside from the settlements discussed above, and a provision of £240m recognised in Q417, it is not currently practicable to provide an estimate of any further financial impact of the actions described on Barclays or what effect they might have on Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Losses on litigation settlements | 2,380.0 | |||||||||||||||
Number of years probation | 3 years | |||||||||||||||
Provisions recognised | £ 240.0 | |||||||||||||||
Foreign Exchange investigations [Member] | Fines settlement [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 650.0 | |||||||||||||||
Foreign Exchange investigations [Member] | Violation of NPA [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 60.0 | |||||||||||||||
Foreign Exchange investigations [Member] | Disgorgement and restitution settlement [member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Litigation settlements approved, value | £ 12.9 | |||||||||||||||
Civil actions in respect of Foreign Exchange [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | Following settlement of certain investigations referred to above in ‘Foreign Exchange Investigations’ a number of individuals and corporates in a range of jurisdictions have threatened or brought civil actions against Barclays and other banks in relation to Foreign Exchange or may do so in future. Certain of these cases have been dismissed or have been settled subject to final approval from the relevant court (and in the case of class actions, the right of class members to opt out of the settlement and to seek to file their own claims). | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of any further financial impact of the actions described above on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Consolidated FX Action [Member] | Barclays Capital Inc [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | 384.0 | |||||||||||||||
Civil actions in respect of ISDAFIX [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In 2014, a number of ISDAFIX related civil actions were filed in the SDNY on behalf of proposed class of plaintiffs, alleging that Barclays Bank PLC, a number of other banks and one broker violated the Antitrust Act and several state laws by engaging in a conspiracy to manipulate the USD ISDAFIX. In 2016, Barclays Bank PLC and BCI entered into a settlement agreement with plaintiffs to resolve the consolidated action and paid $30m, fully resolving all ISDAFIX-related claims that were or could have been brought by the class. The court entered an order granting final approval of the settlement in June 2018. | |||||||||||||||
Civil actions in respect of ISDAFIX [Member] | Barclays Capital Inc [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 30.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | There have been various investigations and civil litigation relating to secondary market trading of US residential mortgage-backed securities (RMBS) and US commercial mortgage-backed securities (CMBS). | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of any further financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Losses on litigation settlements | £ 2,000.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | United States Residential Mortgages [Member] | Government sponsored enterprises [Member] | RMBS Repurchase Requests [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | £ 200.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | United States Residential Mortgages [Member] | Other customers [Member] | RMBS Repurchase Requests [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | 3,000.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | Private-label securitisations [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | 39,000.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | Other private-label securitisations [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | 34,000.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | Subsquently repurchased [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | 500.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | Originated and sold to third parties by Acquired Subsidiary [Member] | RMBS Repurchase Requests [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | 19,400.0 | |||||||||||||||
Original unpaid principal balance at time of sale | £ 2,100.0 | |||||||||||||||
US residential and commercial mortgage-related activity and litigation [Member] | Sponsored securitisations [Member] | RMBS Repurchase Requests [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Revenue | £ 5,000.0 | |||||||||||||||
Alternative trading systems and high-frequency trading [Member] | Barclays Capital Inc [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In 2014, the NYAG filed a complaint (NYAG Complaint) against Barclays PLC and BCI in the Supreme Court of the State of New York alleging, amongst other things, that Barclays PLC and BCI engaged in fraud and deceptive practices in connection with LX, Barclays’ SEC-registered ATS. In February 2016, Barclays reached separate settlement agreements with the SEC and the NYAG to resolve those agencies’ claims against Barclays PLC and BCI relating to the operation of LX and paid $35m to each. | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | The class actions seek unspecified monetary damages and injunctive relief. It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Alternative trading systems and high-frequency trading [Member] | Securities and Exchange Commission [Member] | Barclays Capital Inc [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 35.0 | |||||||||||||||
Alternative trading systems and high-frequency trading [Member] | New York Attorney General [Member] | Barclays Capital Inc [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 35.0 | |||||||||||||||
Electricity market action [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Loss Contingency, Damages Sought, claimed amounts, Value | £ 139.3 | |||||||||||||||
Losses on litigation settlements | £ 29.0 | £ 105.0 | ||||||||||||||
Electricity market action [Member] | Civil penalty [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | 70.0 | |||||||||||||||
Electricity market action [Member] | Disgorgement [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Losses on litigation settlements | £ 35.0 | |||||||||||||||
American Depositary Shares [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | Barclays PLC, Barclays Bank PLC and various former members of Barclays Bank PLC's Board of Directors have been named as defendants in a securities class action consolidated in the SDNY that alleges misstatements and omissions in offering documents for certain American Depositary Shares issued by Barclays Bank PLC in April 2008 with an original face amount of approximately $2.5 billion (the April 2008 Offering). The plaintiffs assert claims under the Securities Act of 1933, alleging misstatements and omissions concerning (amongst other things) Barclays Bank PLC’s portfolio of mortgage-related (including US subprime-related) securities, Barclays Bank PLC’s exposure to mortgage and credit market risk, and Barclays Bank PLC’s financial condition. The plaintiffs have not specifically alleged the amount of their damages. In June 2016, the SDNY certified the action as a class action. In September 2017, the SDNY granted the defendants’ motion for summary judgment. The plaintiffs are appealing this decision. | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of the financial impact of the action described on Barclays or what effect that it might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Issued capital | £ 2,500.0 | |||||||||||||||
Civil actions in respect of the US Anti-Terrorism Act [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | An amended civil complaint (the Amended Complaint), filed in the US Federal Court in the EDNY by a group of approximately 350 plaintiffs, alleges that Barclays Bank PLC and a number of other banks engaged in a conspiracy and violated the ATA by facilitating US dollar denominated transactions for the Government of Iran and various Iranian banks, which in turn funded Hezbollah and other attacks that injured or killed the plaintiffs’ family members. The plaintiffs seek to recover for pain, suffering and mental anguish pursuant to the provisions of the ATA, which allows for the tripling of any proven damages and attorneys' fees. Defendants have moved to dismiss the Amended Complaint. In November 2017, a separate civil complaint was filed in the US Federal Court in the SDNY by a group of approximately 160 plaintiffs, alleging claims under the ATA against Barclays Bank PLC and a number of other banks substantially similar to those in the Amended Complaint. The defendants have moved to dismiss this complaint. | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Portuguese Competition Authority investigation [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | The Portuguese Competition Authority is investigating whether competition law was infringed by the exchange of information about retail credit products amongst 15 banks in Portugal, including Barclays, over a period of 11 years with particular reference to mortgages, consumer lending and lending to small and medium enterprises. Barclays is cooperating with the investigation. | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of the financial impact of the action described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. | |||||||||||||||
Period under investigation of competition law infringment | 11 years | |||||||||||||||
BDC Finance LLC [Member] | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In 2008, BDC filed a complaint in the NY Supreme Court alleging that Barclays Bank PLC breached the Agreement when it failed to transfer approximately $40m of alleged excess collateral in response to BDC’s 2008 demand (Demand). | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | It is not currently practicable to provide an estimate of the financial impact of the actions described on Barclays or what effect they might have upon Barclays’ operating results, cash flows or financial position in any particular period. BDC has made claims against Barclays totalling $298m plus attorneys’ fees, expenses, and pre-judgement interest. This amount does not necessarily reflect Barclays’ potential financial exposure if a ruling were to be made against it. | |||||||||||||||
Alleged excess collateral in response to demand | £ 40.0 | |||||||||||||||
Litigation settlements approved, value | £ 298.0 | |||||||||||||||
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax [Member] | Barclays PLC | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Explanation of general nature of dispute and of reason for non-disclosure of information regarding contingent liability | In March 2018 HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective effect and unless withdrawn by HMRC would correspond to assessments of approximately £184m, inclusive of interest, of which Barclays would expect to attribute an amount of approximately £130m to Barclays Bank UK PLC and £54m to Barclays Bank PLC. At Barclays’ request, HMRC is conducting a further review, and if the assessments are not withdrawn Barclays is able to challenge the assessments by initiating proceedings with the First Tier Tribunal (Tax Chamber). | |||||||||||||||
Loss Contingency, Damages Sought, claimed amounts, Value | £ 54.0 | |||||||||||||||
Information about contingent liabilities that disclosure is not practicable | The total amount of the HMRC assessments is approximately £184m, inclusive of interest | |||||||||||||||
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax [Member] | Barclays UK [member] | Barclays PLC | ||||||||||||||||
Disclosure of contingent liabilities [line items] | ||||||||||||||||
Loss Contingency, Damages Sought, claimed amounts, Value | £ 130.0 |
Related party transactions - Group Financial Statements (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
Jan. 01, 2018 |
[2] | Dec. 31, 2017 |
[3] | ||||||||
Disclosure of transactions between related parties [line items] | |||||||||||||
Income | £ 7,253 | £ 7,301 | |||||||||||
Operating expenses | (6,384) | £ (5,159) | |||||||||||
Assets | 903,345 | [1] | £ 1,127,536 | £ 1,129,343 | |||||||||
Liabilities | 855,153 | [1] | £ 1,063,952 | £ 1,063,609 | |||||||||
Parent [member] | |||||||||||||
Disclosure of transactions between related parties [line items] | |||||||||||||
Income | (77) | ||||||||||||
Operating expenses | (72) | ||||||||||||
Assets | 662 | ||||||||||||
Liabilities | 21,437 | ||||||||||||
Subsidiaries [member] | |||||||||||||
Disclosure of transactions between related parties [line items] | |||||||||||||
Income | 1 | ||||||||||||
Operating expenses | (2,045) | ||||||||||||
Assets | 2,749 | ||||||||||||
Liabilities | £ 2,588 | ||||||||||||
|
Related party transactions (Narrative) (Details) |
Jun. 30, 2018 |
---|---|
Parent [member] | Ordinary shares [member] | |
Disclosure of transactions between related parties [line items] | |
Percentage of issued share capital | 100.00% |
Transition disclosures - Reconciliation of impairment allowance and provisions (Details) £ in Millions |
Jan. 01, 2018
GBP (£)
|
|||
---|---|---|---|---|
Undrawn contractually committed facilities [member] | Guarantee contracts [member] | Impairment allowance under IAS 39 or provision under IAS 37 [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Opening/Beginning balance | £ 79 | |||
Loans and advances at amortised cost [member] | Impairment allowance under IAS 39 or provision under IAS 37 [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Opening/Beginning balance | 4,652 | [1] | ||
Financial assets at fair value through other comprehensive income, category [member] | Impairment allowance under IAS 39 or provision under IAS 37 [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Opening/Beginning balance | 38 | |||
On-balance sheet [member] | Impairment allowance under IAS 39 or provision under IAS 37 [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Opening/Beginning balance | 4,690 | |||
Impairment and provision [member] | Impairment allowance under IAS 39 or provision under IAS 37 [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Opening/Beginning balance | 4,769 | |||
IFRSs 9 [member] | Undrawn contractually committed facilities [member] | Guarantee contracts [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Closing/Ending balance | 420 | |||
IFRSs 9 [member] | Undrawn contractually committed facilities [member] | Guarantee contracts [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Reclassification impact | 0 | |||
Additional impairment allowance | 341 | |||
IFRSs 9 [member] | Loans and advances at amortised cost [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Closing/Ending balance | 7,108 | [1] | ||
IFRSs 9 [member] | Loans and advances at amortised cost [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Reclassification impact | (52) | [1] | ||
Additional impairment allowance | 2,508 | [1] | ||
IFRSs 9 [member] | Financial assets at fair value through other comprehensive income, category [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Closing/Ending balance | 3 | |||
IFRSs 9 [member] | Financial assets at fair value through other comprehensive income, category [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Reclassification impact | (38) | |||
Additional impairment allowance | 3 | |||
IFRSs 9 [member] | On-balance sheet [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Closing/Ending balance | 7,111 | |||
IFRSs 9 [member] | On-balance sheet [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Reclassification impact | (90) | |||
Additional impairment allowance | 2,511 | |||
IFRSs 9 [member] | Impairment and provision [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Closing/Ending balance | 7,531 | |||
IFRSs 9 [member] | Impairment and provision [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | ||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||||
Reclassification impact | (90) | |||
Additional impairment allowance | £ 2,852 | |||
|
Transition disclosures - Movement in loans and advances at amortsed cost (Details) - GBP (£) £ in Millions |
6 Months Ended | ||||
---|---|---|---|---|---|
Jun. 30, 2018 |
Jun. 30, 2017 |
||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||||
Opening balance | [1] | £ 317,744.0 | |||
Disposal of business | [1] | (184,655.0) | |||
Movement during the period | [1] | 1,731.0 | |||
Closing balance | [1] | 134,820.0 | |||
Credit impairment charges and other provisions | 156.0 | £ 656.0 | |||
Off-balance sheet loan commitments and financial guarantee contracts | |||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||||
Credit impairment charges and other provisions | 202.0 | ||||
Gross exposure [member] | |||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||||
Opening balance | [1] | 324,846.0 | |||
Disposal of business | [1] | (187,591.0) | |||
Movement during the period | [1] | 1,510.0 | |||
Closing balance | [1] | 138,765.0 | |||
Allowance account for credit losses of financial assets | 143.0 | ||||
Gross exposure [member] | Off-balance sheet loan commitments and financial guarantee contracts | |||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||||
Credit impairment charges and other provisions | 263.7 | ||||
Impairment allowance [member] | |||||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | |||||
Opening balance | [1] | 7,102.0 | |||
Disposal of business | [1] | (2,936.0) | |||
Movement during the period | [1] | (221.0) | |||
Closing balance | [1] | 3,945.0 | |||
Allowance account for credit losses of financial assets | £ 7.0 | ||||
|
Transition disclosures (Narrative) (Details) - GBP (£) £ in Millions |
Jan. 01, 2018 |
Jun. 30, 2018 |
---|---|---|
Gross exposure [member] | ||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||
Impairment allowance | £ 143 | |
IFRSs 9 [member] | Gross exposure [member] | ||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||
Financial assets at fair value through profit or loss, mandatorily measured at fair value | £ 130,200 | |
IFRSs 9 [member] | Cash collateral and settlement balances, assets [member] | ||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||
Impairment | 5 | |
IFRSs 9 [member] | Other assets [member] | ||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||
Impairment | 1 | |
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | ||
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments [line items] | ||
Increase (decrease) in impairment allowance | 2,760 | |
Increase (decrease) in equity | (17) | |
Increase (decrease) in allowance account for credit losses of financial assets, equity | £ (2,200) |
Transition disclosures - Balance sheet movement - impact of transition to IFRS 9 and IFRS 15 (Details) - GBP (£) £ in Millions |
6 Months Ended | 12 Months Ended | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 01, 2018 |
Jun. 30, 2018 |
Dec. 31, 2017 |
|||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | [1] | £ 1,129,343 | £ 1,129,343 | ||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | £ 0 | |||||||||||||||||||
Ending balance, assets | 1,127,536 | [3] | 903,345 | [4] | 1,129,343 | [1] | |||||||||||||||
Beginning balance, liabilities | [1] | 1,063,609 | 1,063,609 | ||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Ending balance, liabilities | 1,063,952 | [3] | 855,153 | [4] | 1,063,609 | [1] | |||||||||||||||
Beginning Balance, equity | 65,734 | [1] | 65,734 | [1] | 70,955 | ||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Ending Balance, equity | 48,192 | [4] | 65,734 | [1] | |||||||||||||||||
Beginning balance, Total liabilities and equity | [1] | 1,129,343 | 1,129,343 | ||||||||||||||||||
Amount of reclassifications or changes in presentation, equity and liabilities | 0 | ||||||||||||||||||||
Ending balance, Total liabilities and equity | 903,345 | [4] | 1,129,343 | [1] | |||||||||||||||||
Called up share capital and share premium [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 14,453 | [5] | 14,453 | [5] | 14,462 | ||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
Ending Balance, equity | [5] | 14,453 | 14,453 | ||||||||||||||||||
Other reserves [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 3,808 | [5] | 3,808 | [5] | 4,295 | ||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Ending Balance, equity | [5] | 3,071 | 3,808 | ||||||||||||||||||
Retained earnings [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 38,490 | 38,490 | 42,190 | ||||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Ending Balance, equity | 23,754 | 38,490 | |||||||||||||||||||
Other equity instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 8,982 | [5] | 8,982 | [5] | 6,486 | ||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Ending Balance, equity | [5] | 6,912 | 8,982 | ||||||||||||||||||
Total equity excluding non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 65,733 | 65,733 | 67,433 | ||||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Ending Balance, equity | 48,190 | 65,733 | |||||||||||||||||||
Non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 1 | [6] | 1 | [6] | 3,522 | ||||||||||||||||
Amount of reclassifications or changes in presentation, equity | 0 | ||||||||||||||||||||
Ending Balance, equity | [6] | 2 | 1 | ||||||||||||||||||
Trading portfolio liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Financial liabilities designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Deposits from banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | (37,906) | ||||||||||||||||||||
Deposits at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 399,189 | ||||||||||||||||||||
Items in course of collection due to other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | (446) | ||||||||||||||||||||
Customer accounts [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | (429,426) | ||||||||||||||||||||
Cash collateral and settlement balances, liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 68,143 | ||||||||||||||||||||
Repurchase agreements and other similar secured borrowing [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Debt securities in issue [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Subordinated liabilities [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Current tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Deferred tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Retirement benefit liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Accruals, deferred income and other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | (8,416) | ||||||||||||||||||||
Other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 8,862 | ||||||||||||||||||||
Provisions [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Trading portfolio assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Financial assets designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | (116,282) | |||||||||||||||||||
Financial assets at fair value through income statement [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 116,282 | |||||||||||||||||||
Financial assets at fair value through other comprehensive income, category [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Cash and balances at central banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Items in the course of collection from other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | (2,153) | |||||||||||||||||||
Loans and advances to banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | (36,209) | |||||||||||||||||||
Loans and advances to customers [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | (365,553) | |||||||||||||||||||
Cash collateral and settlement balances, assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 77,172 | |||||||||||||||||||
Loans and advances at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 324,590 | |||||||||||||||||||
Reverse repurchase agrememnts and other similar secured lending [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Financial Investments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Investments in associates and joint ventures [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Intangible assets and goodwill [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Property, plant and equipment [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Current tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Deferred tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Retirement benefit assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Prepayments, accrued income and other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | (1,850) | |||||||||||||||||||
Other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 4,003 | |||||||||||||||||||
Assets included in disposal groups classified as held for sale [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Gross exposure [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,129,343 | 1,129,343 | |||||||||||||||||||
Ending balance, assets | 1,129,343 | ||||||||||||||||||||
Beginning balance, liabilities | 1,063,609 | 1,063,609 | |||||||||||||||||||
Ending balance, liabilities | 1,063,609 | ||||||||||||||||||||
Beginning Balance, equity | 65,734 | 65,734 | |||||||||||||||||||
Ending Balance, equity | 65,734 | ||||||||||||||||||||
Beginning balance, Total liabilities and equity | 1,129,343 | 1,129,343 | |||||||||||||||||||
Ending balance, Total liabilities and equity | 1,129,343 | ||||||||||||||||||||
Gross exposure [member] | Called up share capital and share premium [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 14,453 | 14,453 | |||||||||||||||||||
Ending Balance, equity | 14,453 | ||||||||||||||||||||
Gross exposure [member] | Other reserves [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 3,808 | 3,808 | |||||||||||||||||||
Ending Balance, equity | 3,808 | ||||||||||||||||||||
Gross exposure [member] | Retained earnings [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 38,490 | 38,490 | |||||||||||||||||||
Ending Balance, equity | 38,490 | ||||||||||||||||||||
Gross exposure [member] | Other equity instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 8,982 | 8,982 | |||||||||||||||||||
Ending Balance, equity | 8,982 | ||||||||||||||||||||
Gross exposure [member] | Total equity excluding non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 65,733 | 65,733 | |||||||||||||||||||
Ending Balance, equity | 65,733 | ||||||||||||||||||||
Gross exposure [member] | Non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 1 | 1 | |||||||||||||||||||
Ending Balance, equity | 1 | ||||||||||||||||||||
Gross exposure [member] | Trading portfolio liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 37,352 | 37,352 | |||||||||||||||||||
Ending balance, liabilities | 37,352 | ||||||||||||||||||||
Gross exposure [member] | Financial liabilities designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 173,718 | 173,718 | |||||||||||||||||||
Ending balance, liabilities | 173,718 | ||||||||||||||||||||
Gross exposure [member] | Deposits from banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Deposits at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 399,189 | 399,189 | |||||||||||||||||||
Ending balance, liabilities | 399,189 | ||||||||||||||||||||
Gross exposure [member] | Items in course of collection due to other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Customer accounts [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Cash collateral and settlement balances, liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 68,143 | 68,143 | |||||||||||||||||||
Ending balance, liabilities | 68,143 | ||||||||||||||||||||
Gross exposure [member] | Repurchase agreements and other similar secured borrowing [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 40,338 | 40,338 | |||||||||||||||||||
Ending balance, liabilities | 40,338 | ||||||||||||||||||||
Gross exposure [member] | Debt securities in issue [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 69,386 | 69,386 | |||||||||||||||||||
Ending balance, liabilities | 69,386 | ||||||||||||||||||||
Gross exposure [member] | Subordinated liabilities [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 24,193 | 24,193 | |||||||||||||||||||
Ending balance, liabilities | 24,193 | ||||||||||||||||||||
Gross exposure [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 238,345 | 238,345 | |||||||||||||||||||
Ending balance, liabilities | 238,345 | ||||||||||||||||||||
Gross exposure [member] | Current tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 494 | 494 | |||||||||||||||||||
Ending balance, liabilities | 494 | ||||||||||||||||||||
Gross exposure [member] | Deferred tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Retirement benefit liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 287 | 287 | |||||||||||||||||||
Ending balance, liabilities | 287 | ||||||||||||||||||||
Gross exposure [member] | Accruals, deferred income and other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 8,862 | 8,862 | |||||||||||||||||||
Ending balance, liabilities | 8,862 | ||||||||||||||||||||
Gross exposure [member] | Provisions [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 3,302 | 3,302 | |||||||||||||||||||
Ending balance, liabilities | 3,302 | ||||||||||||||||||||
Gross exposure [member] | Trading portfolio assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 113,755 | 113,755 | |||||||||||||||||||
Ending balance, assets | 113,755 | ||||||||||||||||||||
Gross exposure [member] | Financial assets designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Financial assets at fair value through income statement [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | [7] | 116,282 | 116,282 | ||||||||||||||||||
Ending balance, assets | [7] | 116,282 | |||||||||||||||||||
Gross exposure [member] | Financial assets at fair value through other comprehensive income, category [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Cash and balances at central banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 171,036 | 171,036 | |||||||||||||||||||
Ending balance, assets | 171,036 | ||||||||||||||||||||
Gross exposure [member] | Items in the course of collection from other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Loans and advances to banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Loans and advances to customers [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Cash collateral and settlement balances, assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 77,172 | 77,172 | |||||||||||||||||||
Ending balance, assets | 77,172 | ||||||||||||||||||||
Gross exposure [member] | Loans and advances at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 324,590 | 324,590 | |||||||||||||||||||
Ending balance, assets | 324,590 | ||||||||||||||||||||
Gross exposure [member] | Reverse repurchase agrememnts and other similar secured lending [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 12,546 | 12,546 | |||||||||||||||||||
Ending balance, assets | 12,546 | ||||||||||||||||||||
Gross exposure [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 237,987 | 237,987 | |||||||||||||||||||
Ending balance, assets | 237,987 | ||||||||||||||||||||
Gross exposure [member] | Financial Investments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 58,963 | 58,963 | |||||||||||||||||||
Ending balance, assets | 58,963 | ||||||||||||||||||||
Gross exposure [member] | Investments in associates and joint ventures [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 718 | 718 | |||||||||||||||||||
Ending balance, assets | 718 | ||||||||||||||||||||
Gross exposure [member] | Intangible assets and goodwill [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 4,885 | 4,885 | |||||||||||||||||||
Ending balance, assets | 4,885 | ||||||||||||||||||||
Gross exposure [member] | Property, plant and equipment [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,519 | 1,519 | |||||||||||||||||||
Ending balance, assets | 1,519 | ||||||||||||||||||||
Gross exposure [member] | Current tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 376 | 376 | |||||||||||||||||||
Ending balance, assets | 376 | ||||||||||||||||||||
Gross exposure [member] | Deferred tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 3,352 | 3,352 | |||||||||||||||||||
Ending balance, assets | 3,352 | ||||||||||||||||||||
Gross exposure [member] | Retirement benefit assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 966 | 966 | |||||||||||||||||||
Ending balance, assets | 966 | ||||||||||||||||||||
Gross exposure [member] | Prepayments, accrued income and other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 4,003 | 4,003 | |||||||||||||||||||
Ending balance, assets | 4,003 | ||||||||||||||||||||
Gross exposure [member] | Assets included in disposal groups classified as held for sale [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,193 | 1,193 | |||||||||||||||||||
Ending balance, assets | 1,193 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,129,343 | 1,129,343 | |||||||||||||||||||
Ending balance, assets | 1,129,343 | ||||||||||||||||||||
Beginning balance, liabilities | 1,063,609 | 1,063,609 | |||||||||||||||||||
Ending balance, liabilities | 1,063,609 | ||||||||||||||||||||
Beginning Balance, equity | 65,734 | 65,734 | |||||||||||||||||||
Ending Balance, equity | 65,734 | ||||||||||||||||||||
Beginning balance, Total liabilities and equity | 1,129,343 | 1,129,343 | |||||||||||||||||||
Ending balance, Total liabilities and equity | 1,129,343 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Called up share capital and share premium [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 14,453 | 14,453 | |||||||||||||||||||
Ending Balance, equity | 14,453 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Other reserves [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 3,808 | 3,808 | |||||||||||||||||||
Ending Balance, equity | 3,808 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Retained earnings [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 38,490 | 38,490 | |||||||||||||||||||
Ending Balance, equity | 38,490 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Other equity instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 8,982 | 8,982 | |||||||||||||||||||
Ending Balance, equity | 8,982 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Total equity excluding non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 65,733 | 65,733 | |||||||||||||||||||
Ending Balance, equity | 65,733 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning Balance, equity | 1 | 1 | |||||||||||||||||||
Ending Balance, equity | 1 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Trading portfolio liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 37,352 | 37,352 | |||||||||||||||||||
Ending balance, liabilities | 37,352 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Financial liabilities designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 173,718 | 173,718 | |||||||||||||||||||
Ending balance, liabilities | 173,718 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Deposits from banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 37,906 | 37,906 | |||||||||||||||||||
Ending balance, liabilities | 37,906 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Deposits at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Items in course of collection due to other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 446 | 446 | |||||||||||||||||||
Ending balance, liabilities | 446 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Customer accounts [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 429,426 | 429,426 | |||||||||||||||||||
Ending balance, liabilities | 429,426 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Cash collateral and settlement balances, liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Repurchase agreements and other similar secured borrowing [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 40,338 | 40,338 | |||||||||||||||||||
Ending balance, liabilities | 40,338 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Debt securities in issue [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 69,386 | 69,386 | |||||||||||||||||||
Ending balance, liabilities | 69,386 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Subordinated liabilities [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 24,193 | 24,193 | |||||||||||||||||||
Ending balance, liabilities | 24,193 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 238,345 | 238,345 | |||||||||||||||||||
Ending balance, liabilities | 238,345 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Current tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 494 | 494 | |||||||||||||||||||
Ending balance, liabilities | 494 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Deferred tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Retirement benefit liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 287 | 287 | |||||||||||||||||||
Ending balance, liabilities | 287 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Accruals, deferred income and other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 8,416 | 8,416 | |||||||||||||||||||
Ending balance, liabilities | 8,416 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 0 | 0 | |||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Provisions [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, liabilities | 3,302 | 3,302 | |||||||||||||||||||
Ending balance, liabilities | 3,302 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Trading portfolio assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 113,755 | 113,755 | |||||||||||||||||||
Ending balance, assets | 113,755 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Financial assets designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 116,282 | 116,282 | |||||||||||||||||||
Ending balance, assets | 116,282 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Financial assets at fair value through income statement [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | [7] | 0 | 0 | ||||||||||||||||||
Ending balance, assets | [7] | 0 | |||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Financial assets at fair value through other comprehensive income, category [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Cash and balances at central banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 171,036 | 171,036 | |||||||||||||||||||
Ending balance, assets | 171,036 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Items in the course of collection from other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 2,153 | 2,153 | |||||||||||||||||||
Ending balance, assets | 2,153 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Loans and advances to banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 36,209 | 36,209 | |||||||||||||||||||
Ending balance, assets | 36,209 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Loans and advances to customers [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 365,553 | 365,553 | |||||||||||||||||||
Ending balance, assets | 365,553 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Cash collateral and settlement balances, assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Loans and advances at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Reverse repurchase agrememnts and other similar secured lending [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 12,546 | 12,546 | |||||||||||||||||||
Ending balance, assets | 12,546 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 237,987 | 237,987 | |||||||||||||||||||
Ending balance, assets | 237,987 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Financial Investments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 58,963 | 58,963 | |||||||||||||||||||
Ending balance, assets | 58,963 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Investments in associates and joint ventures [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 718 | 718 | |||||||||||||||||||
Ending balance, assets | 718 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Intangible assets and goodwill [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 4,885 | 4,885 | |||||||||||||||||||
Ending balance, assets | 4,885 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Property, plant and equipment [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,519 | 1,519 | |||||||||||||||||||
Ending balance, assets | 1,519 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Current tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 376 | 376 | |||||||||||||||||||
Ending balance, assets | 376 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Deferred tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 3,352 | 3,352 | |||||||||||||||||||
Ending balance, assets | 3,352 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Retirement benefit assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 966 | 966 | |||||||||||||||||||
Ending balance, assets | 966 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Prepayments, accrued income and other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,850 | 1,850 | |||||||||||||||||||
Ending balance, assets | 1,850 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 0 | 0 | |||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
Gross exposure [member] | Published IAS 39 [member] | Assets included in disposal groups classified as held for sale [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Beginning balance, assets | 1,193 | £ 1,193 | |||||||||||||||||||
Ending balance, assets | £ 1,193 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | (15) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | (1,859) | ||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 2 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 341 | ||||||||||||||||||||
Increase (decrease) in equity | (17) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | (2,200) | ||||||||||||||||||||
Amount of reclassifications or changes in presentation, equity and liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in equity and liabilities | (15) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity and liabilities | (1,859) | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Called up share capital and share premium [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other reserves [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | (139) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | 3 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Retained earnings [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 122 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | (2,203) | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other equity instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Total equity excluding non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | (17) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | (2,200) | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, equity | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Trading portfolio liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial liabilities designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 46,365 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deposits from banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deposits at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | (18,860) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Items in course of collection due to other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Customer accounts [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Cash collateral and settlement balances, liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | (2,218) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Repurchase agreements and other similar secured borrowing [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | (25,285) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Debt securities in issue [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Subordinated liabilities [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Current tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deferred tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Retirement benefit liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Accruals, deferred income and other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Provisions [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, liabilities | 341 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Trading portfolio assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 413 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial assets designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial assets at fair value through income statement [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2],[7] | 0 | |||||||||||||||||||
Increase (decrease) in assets | [7] | 23,929 | |||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | [7] | 0 | |||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial assets at fair value through other comprehensive income, category [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 52,354 | |||||||||||||||||||
Increase (decrease) in assets | 934 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Cash and balances at central banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Items in the course of collection from other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Loans and advances to banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Loans and advances to customers [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Cash collateral and settlement balances, assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | (2,398) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | (5) | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Loans and advances at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 5,109 | |||||||||||||||||||
Increase (decrease) in assets | (9,453) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | (2,502) | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Reverse repurchase agrememnts and other similar secured lending [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | (11,949) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial Investments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | (57,463) | |||||||||||||||||||
Increase (decrease) in assets | (1,500) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Investments in associates and joint ventures [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | (19) | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Intangible assets and goodwill [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Property, plant and equipment [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Current tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deferred tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 649 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Retirement benefit assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Prepayments, accrued income and other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 28 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | (1) | ||||||||||||||||||||
IFRSs 9 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Assets included in disposal groups classified as held for sale [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [2] | 0 | |||||||||||||||||||
Increase (decrease) in assets | 0 | ||||||||||||||||||||
Increase (decrease) in allowance account for credit losses of financial assets, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 1,127,536 | ||||||||||||||||||||
Ending balance, liabilities | 1,063,952 | ||||||||||||||||||||
Ending Balance, equity | 63,584 | ||||||||||||||||||||
Ending balance, Total liabilities and equity | 1,127,536 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Called up share capital and share premium [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending Balance, equity | 14,453 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Other reserves [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending Balance, equity | 3,672 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Retained earnings [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending Balance, equity | 36,476 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Other equity instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending Balance, equity | 8,982 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Total equity excluding non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending Balance, equity | 63,583 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending Balance, equity | 1 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Trading portfolio liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 37,352 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Financial liabilities designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 220,083 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Deposits from banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Deposits at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 380,329 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Items in course of collection due to other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Customer accounts [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Cash collateral and settlement balances, liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 65,925 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Repurchase agreements and other similar secured borrowing [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 15,053 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Debt securities in issue [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 69,386 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Subordinated liabilities [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 24,193 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 238,345 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Current tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 494 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Deferred tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Retirement benefit liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 287 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Accruals, deferred income and other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 8,862 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Provisions [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, liabilities | 3,643 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Trading portfolio assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 114,168 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Financial assets designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Financial assets at fair value through income statement [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | [7] | 140,211 | |||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Financial assets at fair value through other comprehensive income, category [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 53,288 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Cash and balances at central banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 171,036 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Items in the course of collection from other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Loans and advances to banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Loans and advances to customers [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Cash collateral and settlement balances, assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 74,769 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Loans and advances at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 317,744 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Reverse repurchase agrememnts and other similar secured lending [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 597 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 237,987 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Financial Investments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Investments in associates and joint ventures [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 699 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Intangible assets and goodwill [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 4,885 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Property, plant and equipment [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 1,519 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Current tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 376 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Deferred tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 3,979 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Retirement benefit assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 966 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Prepayments, accrued income and other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 0 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 4,119 | ||||||||||||||||||||
IFRSs 9 [member] | Gross exposure [member] | Assets included in disposal groups classified as held for sale [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Ending balance, assets | 1,193 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 67 | |||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
Increase (decrease) in equity | 67 | ||||||||||||||||||||
Increase (decrease) in equity and liabilities | 67 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Called up share capital and share premium [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other reserves [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Retained earnings [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 67 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other equity instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Total equity excluding non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 67 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Non-controlling interests [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in equity | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Trading portfolio liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial liabilities designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deposits from banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deposits at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Items in course of collection due to other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Customer accounts [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Cash collateral and settlement balances, liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Repurchase agreements and other similar secured borrowing [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Debt securities in issue [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Subordinated liabilities [Member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Current tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deferred tax liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Retirement benefit liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Accruals, deferred income and other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other liabilities [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Provisions [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in liabilities | 0 | ||||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Trading portfolio assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial assets designated at fair value [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial assets at fair value through income statement [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2],[7] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial assets at fair value through other comprehensive income, category [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Cash and balances at central banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Items in the course of collection from other banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Loans and advances to banks [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Loans and advances to customers [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Cash collateral and settlement balances, assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Loans and advances at amortised cost [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Reverse repurchase agrememnts and other similar secured lending [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Derivative financial instruments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Financial Investments [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Investments in associates and joint ventures [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Intangible assets and goodwill [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Property, plant and equipment [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Current tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Deferred tax assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | (22) | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Retirement benefit assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Prepayments, accrued income and other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 0 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Other assets [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | 89 | |||||||||||||||||||
IFRSs 15 [member] | Increase (decrease) due to changes in accounting policy required by IFRSs [member] | Assets included in disposal groups classified as held for sale [member] | |||||||||||||||||||||
Disclosure of reclassifications or changes in presentation [line items] | |||||||||||||||||||||
Increase (decrease) in assets | [2] | £ 0 | |||||||||||||||||||
|
Barclays Bank PLC parent condensed balance sheet (Details) - GBP (£) £ in Millions |
Jun. 30, 2018 |
Jan. 01, 2018 |
[2] | Dec. 31, 2017 |
Jun. 30, 2017 |
Dec. 31, 2016 |
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||||||
Cash and balances at central banks | £ 121,800 | [1] | £ 171,036 | £ 171,036 | [3] | ||||||||||||||||
Cash collateral and settlement balances | 91,549 | [1] | 74,769 | 77,172 | [3] | ||||||||||||||||
Loans and advances at amortised cost | 134,820 | [1] | 317,744 | 324,590 | [3] | ||||||||||||||||
Reverse repurchase agreements and other similar secured lending | 533 | [1] | 597 | 12,546 | [3] | ||||||||||||||||
Trading portfolio assets | 116,554 | [1] | 114,168 | 113,755 | [3] | ||||||||||||||||
Financial assets at fair value through the income statement | 142,443 | [1] | 116,282 | [3] | |||||||||||||||||
Derivative financial instruments | 229,002 | [1] | 237,987 | 237,987 | [3] | ||||||||||||||||
Financial investments | 0 | [1] | 58,963 | [3] | |||||||||||||||||
Financial assets at fair value through other comprehensive income | 53,302 | [1] | 53,288 | 0 | [3] | ||||||||||||||||
Investments in associates and joint ventures | 713 | [1] | 699 | 718 | [3] | ||||||||||||||||
Goodwill and intangible assets | 1,330 | [1] | 4,885 | 4,885 | [3] | ||||||||||||||||
Property, plant and equipment | 951 | [1] | 1,519 | 1,519 | [3] | ||||||||||||||||
Current tax assets | 1,272 | [1],[4] | 376 | 376 | [3],[4] | ||||||||||||||||
Deferred tax assets | 3,247 | [1],[4] | 3,979 | 3,352 | [3],[4] | ||||||||||||||||
Retirement benefit assets | 1,124 | [1],[4] | 966 | 966 | [3],[4] | ||||||||||||||||
Other assets | 2,944 | [1] | 4,119 | 4,003 | [3] | ||||||||||||||||
Assets included in disposal groups classified as held for sale | 1,761 | [1],[4] | 1,193 | 1,193 | [3],[4] | ||||||||||||||||
Total assets | 903,345 | [1] | 1,127,536 | 1,129,343 | [3] | ||||||||||||||||
Liabilities | |||||||||||||||||||||
Deposits at amortised cost | 193,990 | [1] | 380,329 | 399,189 | [3] | ||||||||||||||||
Cash collateral and settlement balances | 85,448 | [1] | 65,925 | 68,143 | [3] | ||||||||||||||||
Repurchase agreements and other similar secured borrowing | 8,645 | [1] | 15,053 | 40,338 | [3] | ||||||||||||||||
Debt securities in issue | 57,905 | [1] | 69,386 | 69,386 | [3] | ||||||||||||||||
Subordinated liabilities | 17,190 | [1],[4] | 24,193 | 24,193 | [3],[4] | £ 23,871 | |||||||||||||||
Trading portfolio liabilities | 45,965 | [1] | 37,352 | 37,352 | [3] | ||||||||||||||||
Financial liabilities designated at fair value | 212,393 | [1] | 173,718 | [3] | |||||||||||||||||
Derivative financial instruments | 225,089 | [1] | 238,345 | 238,345 | [3] | ||||||||||||||||
Current tax liabilities | 667 | [1],[4] | 494 | 494 | [3],[4] | ||||||||||||||||
Deferred tax liabilities | [4] | 0 | [1] | 0 | [3] | ||||||||||||||||
Retirement benefit liabilities | 265 | [1],[4] | 287 | 287 | [3],[4] | ||||||||||||||||
Other liabilities | 4,601 | [1] | 8,862 | 8,862 | [3] | ||||||||||||||||
Provisions | 1,233 | [1],[4] | 3,643 | 3,302 | [3],[4] | ||||||||||||||||
Liabilities included in disposal groups classified as held for sale | 1,762 | [1],[4] | 0 | 0 | [3],[4] | ||||||||||||||||
Total liabilities | 855,153 | [1] | £ 1,063,952 | 1,063,609 | [3] | ||||||||||||||||
Equity | |||||||||||||||||||||
Called up share capital and share premium | [4] | 14,453 | [1] | 14,453 | [3] | ||||||||||||||||
Other reserves | [4] | 3,071 | [1] | 3,808 | [3] | ||||||||||||||||
Retained earnings | 23,754 | [1] | 38,490 | [3] | |||||||||||||||||
Other equity instruments | [4] | 6,912 | [1] | 8,982 | [3] | ||||||||||||||||
Total equity | 48,192 | [1] | 65,734 | [3] | £ 66,167 | £ 70,955 | |||||||||||||||
Total liabilities and equity | 903,345 | [1] | 1,129,343 | [3] | |||||||||||||||||
Barclays Bank PLC | |||||||||||||||||||||
Assets | |||||||||||||||||||||
Cash and balances at central banks | 115,924 | 165,713 | [5] | ||||||||||||||||||
Cash collateral and settlement balances | 80,263 | 61,545 | [5] | ||||||||||||||||||
Loans and advances at amortised cost | 163,028 | 364,670 | [5] | ||||||||||||||||||
Reverse repurchase agreements and other similar secured lending | 3,796 | 22,964 | [5] | ||||||||||||||||||
Trading portfolio assets | 80,903 | 79,836 | [5] | ||||||||||||||||||
Financial assets at fair value through the income statement | 168,108 | 117,182 | [5] | ||||||||||||||||||
Derivative financial instruments | 228,839 | 232,288 | [5] | ||||||||||||||||||
Financial investments | 0 | 54,583 | [5] | ||||||||||||||||||
Financial assets at fair value through other comprehensive income | [6] | 50,854 | 0 | [5] | |||||||||||||||||
Investments in associates and joint ventures | 138 | 165 | [5] | ||||||||||||||||||
Investments in subsidiaries | 14,307 | 14,614 | [5] | ||||||||||||||||||
Goodwill and intangible assets | 161 | 3,498 | [5] | ||||||||||||||||||
Property, plant and equipment | 116 | 565 | [5] | ||||||||||||||||||
Current tax assets | 1,008 | 115 | [5] | ||||||||||||||||||
Deferred tax assets | 1,651 | 1,863 | [5] | ||||||||||||||||||
Retirement benefit assets | 1,122 | 959 | [5] | ||||||||||||||||||
Other assets | 2,321 | 4,440 | [5] | ||||||||||||||||||
Assets included in disposal groups classified as held for sale | 1,761 | 0 | [5] | ||||||||||||||||||
Total assets | 914,300 | 1,125,000 | [5] | ||||||||||||||||||
Liabilities | |||||||||||||||||||||
Deposits at amortised cost | 228,174 | 427,185 | [5] | ||||||||||||||||||
Cash collateral and settlement balances | 71,763 | 59,258 | [5] | ||||||||||||||||||
Repurchase agreements and other similar secured borrowing | 15,579 | 49,883 | [5] | ||||||||||||||||||
Debt securities in issue | 46,133 | 55,874 | [5] | ||||||||||||||||||
Subordinated liabilities | 17,217 | 24,203 | [5] | ||||||||||||||||||
Trading portfolio liabilities | 56,384 | 41,542 | [5] | ||||||||||||||||||
Financial liabilities designated at fair value | 206,255 | 169,044 | [5] | ||||||||||||||||||
Derivative financial instruments | 225,022 | 229,227 | [5] | ||||||||||||||||||
Current tax liabilities | 439 | 242 | [5] | ||||||||||||||||||
Deferred tax liabilities | 0 | 0 | [5] | ||||||||||||||||||
Retirement benefit liabilities | 145 | 149 | [5] | ||||||||||||||||||
Other liabilities | 2,992 | 7,331 | [5] | ||||||||||||||||||
Provisions | 974 | 3,028 | [5] | ||||||||||||||||||
Liabilities included in disposal groups classified as held for sale | 1,762 | 0 | [5] | ||||||||||||||||||
Total liabilities | 872,839 | 1,066,966 | [5] | ||||||||||||||||||
Equity | |||||||||||||||||||||
Called up share capital and share premium | 14,453 | 14,453 | [5] | ||||||||||||||||||
Other reserves | 421 | 1,093 | [5] | ||||||||||||||||||
Retained earnings | 19,675 | 33,506 | [5] | ||||||||||||||||||
Other equity instruments | 6,912 | 8,982 | [5] | ||||||||||||||||||
Total equity | 41,461 | 58,034 | [5] | ||||||||||||||||||
Total liabilities and equity | £ 914,300 | £ 1,125,000 | [5] | ||||||||||||||||||
|
Barclays Bank PLC parent condensed balance sheet (Narrative) (Details) - GBP (£) £ in Millions |
12 Months Ended | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 01, 2018 |
Dec. 31, 2017 |
Jun. 30, 2018 |
|||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Other assets | £ 4,119 | [1] | £ 4,003 | [2] | £ 2,944 | [3] | |||||||||||
Other liabilities | 8,862 | [1] | 8,862 | [2] | 4,601 | [3] | |||||||||||
Loans and advances at amortised cost | 317,744 | [1] | 324,590 | [2] | 134,820 | [3] | |||||||||||
Cash collateral and settlement balances | 74,769 | [1] | 77,172 | [2] | 91,549 | [3] | |||||||||||
Deposits at amortised cost | 380,329 | [1] | 399,189 | [2] | 193,990 | [3] | |||||||||||
Cash collateral and settlement balances | 65,925 | [1] | 68,143 | [2] | 85,448 | [3] | |||||||||||
Amount of reclassifications or changes in presentation, assets | [4] | 0 | |||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | 0 | ||||||||||||||||
Items in the course of collection from other banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [4] | (2,153) | |||||||||||||||
Prepayments, accrued income and other assets [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [4] | (1,850) | |||||||||||||||
Loans and advances to banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [4] | (36,209) | |||||||||||||||
Loans and advances to customers [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | [4] | (365,553) | |||||||||||||||
Items in course of collection due to other banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | (446) | ||||||||||||||||
Deposits from banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | (37,906) | ||||||||||||||||
Customer accounts [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, liabilities | £ (429,426) | ||||||||||||||||
Barclays Bank PLC | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Other assets | 4,440 | [5] | 2,321 | ||||||||||||||
Other liabilities | 7,331 | [5] | 2,992 | ||||||||||||||
Loans and advances at amortised cost | 364,670 | [5] | 163,028 | ||||||||||||||
Cash collateral and settlement balances | 61,545 | [5] | 80,263 | ||||||||||||||
Deposits at amortised cost | 427,185 | [5] | 228,174 | ||||||||||||||
Cash collateral and settlement balances | 59,258 | [5] | £ 71,763 | ||||||||||||||
Barclays Bank PLC | Items in the course of collection from other banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (1,011) | ||||||||||||||||
Barclays Bank PLC | Prepayments, accrued income and other assets [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (3,429) | ||||||||||||||||
Barclays Bank PLC | Loans and advances to banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (37,255) | ||||||||||||||||
Barclays Bank PLC | Loans and advances to customers [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (388,960) | ||||||||||||||||
Barclays Bank PLC | Items in course of collection due to other banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (446) | ||||||||||||||||
Barclays Bank PLC | Prepayments, accrued income, and other liabilities [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (6,885) | ||||||||||||||||
Barclays Bank PLC | Deposits from banks [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (38,364) | ||||||||||||||||
Barclays Bank PLC | Customer accounts [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Amount of reclassifications or changes in presentation, assets | (448,079) | ||||||||||||||||
Barclays Bank PLC | Previously stated [member] | |||||||||||||||||
Consolidated and separate financial statements [line items] | |||||||||||||||||
Items in course of collection from other banks | 1,011 | ||||||||||||||||
Prepayments, accrued income and other assets | 3,429 | ||||||||||||||||
Items in the course of collection due to other banks | 446 | ||||||||||||||||
Accruals, deferred income and other liabilities | 6,885 | ||||||||||||||||
Loans and advances to banks | 37,255 | ||||||||||||||||
Loans and advances to customers | 388,960 | ||||||||||||||||
Deposits from banks | 38,364 | ||||||||||||||||
Deposits from customers | £ 448,079 | ||||||||||||||||
|
Label | Element | Value | ||||
---|---|---|---|---|---|---|
Equity, adjusted balance | c070_EquityAdjustedBalance | £ 70,955,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | 0 | ||||
Issued capital and share premium [member] | ||||||
Equity, adjusted balance | c070_EquityAdjustedBalance | 14,462,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | 0 | [1] | |||
Other reserves [member] | ||||||
Equity, adjusted balance | c070_EquityAdjustedBalance | 4,120,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | (175,000,000) | [1] | |||
Other equity interest [member] | ||||||
Equity, adjusted balance | c070_EquityAdjustedBalance | 6,486,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | 0 | [1] | |||
Non-controlling interests [member] | ||||||
Equity, adjusted balance | c070_EquityAdjustedBalance | 3,522,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | 0 | [2] | |||
Retained earnings [member] | ||||||
Equity, adjusted balance | c070_EquityAdjustedBalance | 42,365,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | 175,000,000 | ||||
Equity attributable to owners of parent [member] | ||||||
Equity, adjusted balance | c070_EquityAdjustedBalance | 67,433,000,000 | ||||
Amount of reclassifications or changes in presentation | ifrs-full_AmountOfReclassificationsOrChangesInPresentation | £ 0 | ||||
|
$NJI6X)"44:1@ A9A(3+9&BUT1$5]/..-7O#A,W8SS&C
M#AUZ2L!+#DQ.$\-I[%JX B88873INX!F(<[5/[%S!]@Y.2:[I(9A*(=FSN4=
M.+P]/;[,ZQ;6)U)>8WZ5K*!3P#6[3'YM'C:[+9-UQ>^**I_5CM^*^EXT]?OD
M^L/O*NQZ8_?V'QM?!&4+O_Z%_ )02P,$% @ W'L&39E ]2324,,+2V&C#OV#A&&8 D?=%8WS77]Y06QPB3T'BYO( CDK/5+"'[5
M!=X%0R"@ NJ:U/D&*K&<-/(/]V9^TB\BB4G4"I.F4
M1!KJ'-]O#\?4XP/@5P>C6N=+NPC_J%
MI\[%X&W=U/6RPGAJNE;0>
M7A@N@S'M%.XFH^H$W(3ZA_8)<"0D8(,EUX#JG1;, ,-7$!=3QIJ[X:R1
)^&ER)?*:\AJTPXN%#^$,.1WR[:9#
M"\8843-!V8!/!EHPO!I9H?D?C *I*5"0-* BR>_Y3I^,]H))>.6[!%3\DID#
M)K$Z-
4?V4E6]S>D])!;7HE7_"X1-,_1PHF9K_ E=0 1Z=
MA!HE*I>^I.R=1SVI!"M:O(RK-&D=QC\'/M'6"7PB\)EPG^JPL5!R_D%X4606
M!V+'L^]$O.+MD8>S*6,R'47Z%\R[D+T6G!\R=HU"$^8T8O@"LYT1+*C/)?A:
MB1/_A[ZH\(Z_6[6X2_S=.XNWZP+[58%]$MC_M\
0G_['XA\!N56 7!7:?]KB&X7\588M#U6#K.$Z.%*9OXR@OLO/$
MWO)X*1_P<=R_"UO+UI&3\7BU\0(J8SR@E
=J*&[^!^="?C(S:KE%)#:R6VQ$"5T;O-X;@+^ CX*6&PBST)G9P1GT/P
M4&8T"89 0>&"@O#+!>Y!J2#D;;Q,FG0N&8C+_57]<^S=]W(6%NY1/
9-WXD&!YVHD:OH/_
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M2G*%,]3@"YL#!94/VP^XM^.
1M_9DVZE S$]?Y5_4OLW?=R$18>4#YUE6MS>D=)!;48I'O$\2O,
M_1PHF9O_#E>0'AZ<^!HE2AN_I!RL0S6K>"M*O$QKI^,Z3G\.R4S;)O"9P!?"
M7:S#ID+1^6?A1)$9'(F9SKX7X8KW1^[/I@S)>!3QGS=O??9:\-M]QJY!:,:<
M)@Q?8=X0S*LO)?A6B1/_C\X/V_QDTV(2^
FFQ33RTS4_/6X+[#<%
M]E%@O_;/C^]Z_(A)D_MW1=CJ4#78)HZ3(Z49NCC*J^PRL0_Q%MD;?!KW'\(V
MLG/D:CQ>;;R VA@/:&5WAS/4X@M; @6U#]M/N+?3G$V!-_W\A-CRCHO_4$L#
M!!0 ( -Q[!DU70#!BN0$ -,# 9 >&PO=V]R:W-H965T^@P7B2G'J[R$6P!9W3G(M6NS*U(LN5=$\HN)(ZO3.'
MOA'\J